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Introduction
Around 5 million children have been born worldwide through the use of in vitro fertilization (IVF), 
an assisted reproductive technology first used successfully in 1978 [1]. In Europe in 2009, the mean 
pregnancy rate per embryo transfer was around 32% [2]. In order to achieve even better results 
in the future, we need to gain knowledge on all aspects of the treatment, including early embryo 
development. Understanding processes underlying pre-implantation embryo development 
will lead to improvements in embryo culture and selection, and thereby eventually to increased 
pregnancy rates. 
 It has been known that some aspects of cells in a pre-implantation embryo are very different 
from somatic cells, such as cell cycle regulation, gene expression profiles, chromatin dynamics and 
chromosome segregation. Therefore, studying embryonic cells is crucial for our understanding of 
pre-implantation development. In this thesis, we describe the research we performed in human 
pre-implantation embryos derived from IVF. 
 Chromosomal abnormalities are detected at high frequencies in human IVF-embryos. The aim of 
our research was to investigate processes possibly underlying these abnormalities: the regulation of 
chromosome segregation and the organization of chromatin structure. 
Chromosomal abnormalities in pre-implantation embryos
In every cell of a human body, 23 pairs of chromosomes contain the genetic material, the DNA. 
During every mitotic cell division, duplicated chromosomes are equally separated over the two 
daughter cells, a process called chromosome segregation. Tight regulation of chromosome 
segregation is essential in order to prevent aneuploidy (an incorrect number of chromosomes) and 
maintain genetic integrity. In somatic cells, several mechanisms cooperate to prevent chromosome 
missegregation. Surprisingly, chromosomal abnormalities are detected at high frequencies in 
human pre-implantation embryos [3-14], resembling the genetic instability observed in human 
cancers [11,15]. This suggests a decreased functionality or even a lack of the somatic mechanisms 
guarding chromosome segregation during the first mitotic divisions of an embryo [7]. Next to that, 
histone modifications, epigenetic marks that are important for chromatin structure and correct 
chromosome segregation, are different in oocytes and spermatozoa and need to be re-established 
in early embryos. The research described in this thesis aimed to investigate both the mechanisms 
regulation chromosome segregation and the re-establishment of epigenetics marks in human pre-
implantation embryos, in order to shed light on the possible causes of chromosomal abnormalities. 
The following paragraphs give a concise description of mitosis, epigenetics an chromatin 
organization, regulation of chromosome segregation, and the investigated processes. 
Mitosis
The cell cycle consist of four phases. In the G1 phase, the cell prepares for DNA replication. In the 
subsequent S phase, DNA replication takes place. Thereafter, in the G2 phase, the cell prepares for 
division. These three phases together are also called interphase. After G2 the fourth cell cycle phase, 
called mitosis, begins. During mitosis, duplicated chromosomes are separated and the cell divides 
[16-17]. 
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Figure 1 — Schematic representation of a chromosome at the time of cell division. Indicated are the 
centromeres and kinetochores, at which the spindles attach.
Mitosis consists of five phases. During prophase, chromosomes in the nucleus condense and the 
centrosomes separate and start to form the mitotic spindle. During prometaphase, the nuclear 
envelope breaks down and the spindle attaches to the kinetochores of the condensed chromosomes 
(Figure 1). Attached chromosomes then move to the equatorial plane, resulting in alignment at the 
metaphase plate during metaphase. Once this alignment is achieved, the anaphase promoting 
complex/cyclosome (APC/C) is activated and anaphase begins. During anaphase, chromosome 
segregation takes place: sister chromatids are separated to opposites sites of the cell. Eventually, in 
telophase, a cleavage furrow forms and the cell divides. Also, the nuclear envelopes are reformed and 
the chromosomes decondense, resulting in two new interphase nuclei [18-19]. Figure 2 illustrates 
these phases of mitosis in the first mitotic division of an embryo.
Figure 2 — Schematic representation of the first mitotic cell cycle of an embryo. After fertilization of an 
oocyte by a sperm cell, one paternal and one maternal pronucleus are formed in the zygote during the G1 
phase. After S phase en G2 phase, mitosis begins, eventually resulting in the first cell division. (Adopted from 
[20]) 
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Epigenetics and chromatin organization
The term ‘epigenetics’ refers to heritable marks and changes in the genome, which do not alter 
the underlying DNA sequence. Epigenetic marks, such as DNA methylation [21] and histone 
modifications [22-26], determine the structure of chromatin and chromosomes, which is essential for 
nuclear architecture, cell potency, gene expression and chromosome segregation. In this paragraph, 
we briefly describe the structure of chromatin and the characteristics and function of the most 
prominent chromatin domains. 
DNA  
histone  
nucleosome  
chromosome chromatin  
histone tail  
modications  
me1/2/3  
P  
ac  … 
Figure 3 — Schematic representation of the structure of a chromosome. DNA is wrapped around a histone 
octamer, together called nucleosome, forming the basic repeating subunit of chromatin. Amino acids in the 
histone tails are subject to posttranslational enzymatic modifications, such as (mono-/di-/tri-) methylation, 
phosphorylation, and acetylation.
In every somatic cell nucleus, DNA is wrapped around a histone octamer, together called a 
nucleosome, forming the basic repeating subunit of chromatin (Figure 3). Nucleosomes consist of 
eight histones of different types: two histone H2A-H2B dimers and one histone H3-H4 tetramer, 
and are linked by histone H1 and linker DNA. The presence of certain histone variants and post-
translational modifications at amino acid residues in the N-terminal tail of histones influence the 
structure of chromatin. Examples of such histone variants are H2AZ, H3.3 and CENP-A. Histone 
modifications are for example methylation, phosphorylation, ubiquitination and acetylation (Figure 
3). Both histone variants and histone modifications have distinct biochemical properties, which 
result in a certain configuration of chromatin. Together with chromatin-associated proteins and 
non-coding RNAs, this determines chromatin structure and defines chromatin domains [22-26]. 
1
General introduction 
13
Functional chromatin domains are essential to maintain chromosome structure and to regulate 
gene expression.
 The two most prominent chromatin domains are euchromatin and heterochromatin. Euchromatin 
is an ‘open’, decondensed form of chromatin, associated with transcription. It is characterized 
by di- and trimethylation of histone H3 at lysine 4 and lysine 36 (H3K4me2/3, H3K36me2/3). 
Heterochromatin is a condensed, silenced form of chromatin, associated with transcriptional 
repression. There are two forms of heterochromatin: constitutive and facultative heterochromatin, 
each characterized by different epigenetic marks. 
Heterochromatin
Facultative heterochromatin is associated with the regulation of gene expression and can, 
depending on the situation, also become transcriptionally active. It is formatted by Polycomb 
group (PcG) proteins. These proteins catalyze the monoubiquitination of lysine 119 on histone H2A 
(H2AK119Ub1) [27] and the di- and trimethylation of lysine residue 27 of histone H3 (H3K27me2/3) 
[28-29]. PcG proteins are essential regulators in development; they play a crucial role in cell fate 
decisions and differentiation [29-32].
 Constitutive heterochromatin (cHC) is mostly associated with structural functions, for example 
defining the centromeres (Figure 1) and telomeres. These chromatin domains do not change, 
but remain condensed throughout the cell cycle and are inherited by the daughter cells after 
cell division. cHC is modified by Suv39h1/h2 histone methyltransferases (HMTs) [33-35], which 
trimethylate histone H3 at lysine 9 (H3K9me3). H3K9me3 subsequently recruits heterochromatin 
protein 1 (HP1) [36-37] and HMTs which trimethylate histone H4 at lysine 20 (H4K20me3) [38] and 
histone H3 at lysine 64 (H3K64me3) [39]. H3K9me3 also recruits DNA methyltransferases, eventually 
leading to establishment of a condensed, transcriptionally repressed state [33,38,40-41]. 
Pericentric heterochromatin and chromosome segregation
A cHC domain important for chromosome segregation is pericentric heterochromatin (pHC) [34]. 
These chromatin domains are located adjacent to the centromeric region of each chromosome 
(Figure 1) and characterized by classic cHC marks, such as H3K9me3, H4K20me3 and abundant DNA 
methylation [42]. 
 During mitosis, different protein complexes are formed in the centromeric region of chromosomes, 
such as the kinetochores, which bind the microtubules of the mitotic spindle, and the (inner) 
centromeres, which connect the sister chromatids (Figure 1) [43]. These complexes are crucial for 
correct chromosome segregation, not only because of their structural role, but also because they 
are part of the mitotic checkpoint (see below). The localization of the centromeres is specified by 
chromatin regions that contain certain histone modifications and histone variants, such as the 
centromere-specific histone H3 variant CENP-A (CenH3) [25]. pHC plays a role in the formation of 
these regions. It also limits CENP-A incorporation, thereby serving as a boundary for the centromeric 
region and ensuring precise CENP-A localization [25]. This is crucial for correct centromere function 
and chromosome segregation, as both overexpression of CENP-A and disruption of pHC marks have 
been linked to chromosome missegregation [34,44].
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As pHC is essential for correct chromosome segregation, we aimed to investigate pHC dynamics in 
human pre-implantation embryos. These dynamics might differ from what has been described for 
somatic cells, since chromatin structure and domains have to be re-established after fertilization 
(see below).
Chromatin structure re-establishment in pre-implantation embryos
At the time of fertilization, the parental gametes, the oocyte and the spermatozoon, are very 
dissimilar. This extends to the structure of their chromatin. Maternal DNA is present in nucleosomes, 
as in somatic cells, and is marked with histone modifications inherited from the oocyte. In contrast, 
the DNA in the spermatozoon is wrapped around protamines, as a result from the histone-to-
protamine exchange during spermatogenesis (Figure 3). Protamine-based chromatin is much 
more condensed than nucleosome-based chromatin, enabling the formation of the very small 
sperm head. During the first stages of pre-implantation development, dramatic changes occur in 
chromatin organization: the paternal protamines are replaced by maternally provided histones and 
these histones are modified in order to re-establish the paternal chromatin structure and form a 
functional embryonic genome (Figure 4). 
nucleosomes  
spermatocyte  
nucleus
 
sperm 
protamines  
zygote  
pronuclei  
  
nucleosomes  
Figure 4 — Schematic representation of the configuration of chromatin from spermatocytes to zygotes, 
showing the transition from nucleosomes to protamines during spermatogenesis and the re-establishment 
of a nucleosome-based chromatin structure in the zygote.
Mechanisms of chromatin structure re-establishment have been studied extensively in mouse 
embryos, especially for pHC (for reviews see [45-48]). In short, pHC in mouse spermatozoa is largely 
devoid of canonical cHC marks and the paternal pHC signature has to be re-established after 
fertilization. The H3K9/HP1 pathway has been shown not to be involved in this process. Instead, 
maternally provided PRC1 and PRC2 transiently establish pHC, which becomes marked with 
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H3K27me3 [49-50]. During the 8-cell stage the H3K9/HP1 pathway takes over and the two parental 
genomes become equivalent for H3K9me3 [50-51]. Other pHC associated marks, such as H3K64me3 
and H4K20me3, remain undetected until after compaction and implantation, respectively [39,52-
53]. Thus, in mouse pre-implantation embryos the PRC1/2 pathway operates as a transient backup 
mechanism for pHC formation [50]. 
 Although findings in early mouse embryos are often assumed to be universal for mammalian 
embryos [47-48,54], epigenetic regulation of early development is known to differ between mammals 
[55]. Importantly, it is not known how the process of pHC re-establishment is regulated in human 
pre-implantation embryos. As mentioned above, we aimed to investigate the dynamics of pHC in 
human embryos. Interestingly, during human spermatogenesis not all nucleosomes are replaced 
by protamines. Whereas mouse spermatozoa retain 1% of their histones [56], this percentage is 
reported to be higher and more variable in human spermatozoa (4-30%) [57-60]. Therefore, for 
several years researchers have speculated about an epigenetic contribution of human spermatozoa 
to embryo development. In our study, we investigated the mechanism of pHC re-establishment in 
human pre-implantation embryos and the possible contribution of sperm-derived histones to this 
process.
Regulation of chromosome segregation
In order to prevent missegregation of chromosomes during mitosis (see above), the onset of 
anaphase has to be delayed as long as chromosomes are not or not correctly attached to the 
mitotic spindle. As described above, the APC/C regulates anaphase entry. In case of the presence 
of unattached chromosomes, the mitotic checkpoint complex (MCC) inhibits the APC/C. The MCC 
consists of diverse proteins (Mad2, Bub3, BubR1) which localize at the unattached kinetochore and 
inhibit Cdc20, an essential cofactor of APC/C. Once all chromosomes have reached attachment, the 
MCC is inactivated and APC/C is no longer inhibited, enabling anaphase onset (Figure 5) [61].  
 The chromosomal passenger complex (CPC) consists of Survivin, Borealin, INCENP and Aurora 
kinase B (Aurora B / AURKB), and has diverse roles during mitosis, for example in chromosome 
condensation and cytokinesis [61,63-66]. At the start of mitosis, Aurora B phosphorylates histone H3 
at serine 10 (H3pS10) (Figure 5) along the chromosome arms (Figure 1). Later, during prometaphase, 
the CPC localizes to the inner centromeric region, where it exerts is role in the correction of 
misattached chromosomes (non-bipolar attachments: for review see [66]). Recently, it has been 
proposed that the localization of the CPC at the inner centromere is regulated by two histone 
modifications, phosphorylation of histone H2A at threonine 120 (H2ApT120) and phosphorylation 
of histone H3 at threonine 3 (H3pT3), which are catalyzed by Bub1 and Haspin respectively [67-68] 
(Figure 5). Aurora B in turn phosphorylates and thereby further activates Haspin, leading to a positive 
feedback loop for accumulation of the CPC at the inner centromere [69] (Figure 5). At the centromere, 
the CPC regulates kinetochore-microtubule attachments. Incorrect attachments, for example when 
both sister chromatids are attached to the same spindle pole, are destabilized by the CPC in order 
to promote correct attachments. This destabilization also leads to unattached kinetochores, which 
activate the MCC (Figure 5). Destabilization of incorrect attachments is thought to be mediated by 
Aurora B, which phosphorylates diverse targets at the kinetochore-microtubule interface, leading 
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to the release of the incorrect attached microtubule (Figure 5). When a correct, bipolar attachment 
is established, the pulling forces of the microtubules result in tension over the connected sister 
chromatids, and it is thought that Aurora B can then no longer reach its phosphorylation targets, 
resulting in a stable attachment [61]. This model for the localization and mechanism of action of the 
CPC is currently under debate. It is not yet completely clear whether inner centromeric localization 
of the CPC is necessary for correction of chromosome-spindle misattachments. Also, Aurora B 
might signal directly to the MCC in other, more direct ways [70-72]. For a detailed review of these 
possibilities, see [73].
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Figure 5 — Scheme of the regulation of mitotic progression by the mitotic checkpoint complex (MCC) and 
the chromosomal passenger complex (CPC). See text for explanation.
Together, the CPC and the MCC ensure the inhibition of the APC/C as long as not all chromosomes 
are correctly attached to the spindle. Thereby, these protein complexes are crucial to prevent 
chromosome missegregation. As described above, chromosomal abnormalities are common in 
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human pre-implantation embryos. Therefore, is has been suggested that there may be a decreased 
or even absence of mitotic checkpoint function in early embryos [7]. In our studies, we aimed to 
investigate the expression and localization of the chromosomal passenger complex in order to shed 
light on the possible underlying causes of chromosomal abnormalities in human embryos.
Research on human pre-implantation embryos
The Dutch ‘embryo law’ does not permit the use of good quality embryos that are intended for patient 
treatment and the fertilization of oocytes with the aim to create embryos for research. Therefore, 
in our studies into the earliest stages of pre-implantation embryo development we are limited 
to tripronuclear (3PN) zygotes and embryos resulting from 3PN zygotes. These zygotes mostly 
originate from an oocyte that is fertilized by two spermatozoa, resulting in one maternal pronucleus 
and two paternal pronuclei [74-76]. 3PN zygotes proceed through the first divisions normally and 
are capable of implantation, thus providing an ethically acceptable and relevant model for the first 
stages of pre-implantation embryo development [77-78]. To study later stages of development, from 
embryonic day 3 onwards, we are able to use good quality embryos that were first cryopreserved for 
patient treatment and later donated for research by these patients. 
 As may be clear from what is described above, human pre-implantation embryos for research are 
scarce and precious. This is a challenge for us, researchers, as we have to perform experiments with as 
little embryos as possible. Next to that, we have to optimize every experimental protocol for use on 
single embryos. When studying protein expression for example, we are not able to use the Western 
Blot technique, because we do not have enough cells. Instead, we use immunofluorescence, a less 
sensitive and quantitative technique through which we visualise protein expression and localization 
in single cells of single embryos. In order to optimize the use of our scarce material, in one of our 
studies we aimed to develop a method to perform sequential immunofluorescent analyses on the 
same preparation. Next to that, we optimized a protocol for gene expression analysis by RT-qPCR for 
application on single embryos in order to study gene expression in our studies. 
 In summary, research involving human pre-implantation embryos derived from IVF knows both 
ethical and methodological challenges. Despite these difficulties, we aim to increase our knowledge 
of human embryo development, as this will lead to the optimization of IVF procedures in the future.
Aims and outline of this thesis
 The aim of the research described in this thesis was to get more insight in mechanisms regulating 
chromosome segregation and chromatin organization in human pre-implantation embryos.  
 In chapter 2 we investigated how cHC is marked and re-established in human pre-implantation 
embryos. Our results demonstrate that human sperm cells retain histones with cHC marks, which 
contribute to paternal chromatin formation in embryos. These results show a mechanism for a 
paternal epigenetic contribution to embryo development. 
 In order to gain knowledge on the mechanisms regulating chromosome segregation, and 
possibly explaining the high rates of missegregation observed in human embryos, in chapter 3 we 
investigated the expression of CPC subunits. In contrast to somatic cells, in which Aurora kinase B is 
the enzymatic subunit of the CPC, in human pre-implantation embryos we found Aurora kinase C to 
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be the main enzymatic subunit. Further investigations into CPC localization are described in chapter 
5.
 In chapter 4 we describe a method we developed, which enables us to perform sequential 
immunofluorescent stainings on the same material. This is of great value, because it allows 
investigation of co-localization of proteins and it saves our scarce material, human pre-implantation 
embryos.
 In order to further elucidate the mechanism guarding chromosome segregation, in chapter 5 we 
investigated the dynamics of histone modifications that define CPC localization. Our results suggest 
that in human zygotes the mechanism regulating targeting of the CPC to the inner centromeres 
partially differs from that described in somatic cells. 
 In chapter 6 we summarize the most important conclusions from the studies described in the 
previous chapters and we discuss the implications for future research. 
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Abstract
The different configurations of maternal and paternal chromatin, acquired during oogenesis and 
spermatogenesis, have to be rearranged after fertilization to form a functional embryonic genome. 
In the paternal genome, nucleosomal chromatin domains are re-established after the protamine-to-
histone exchange. We investigated the formation of constitutive heterochromatin (cHC) in human 
pre-implantation embryos. Our results show that histones carrying canonical cHC modifications are 
retained in cHC regions of sperm chromatin. These modified histones are transmitted to the oocyte 
and contribute to the formation of paternal embryonic cHC. Subsequently, the modifications are 
recognized by H3K9/HP1 pathway maternal chromatin modifiers and propagated over the embryonic 
cleavage divisions. These results are in contrast to what has been described for mouse embryos, in 
which paternal cHC lacks canonical modifications and is initially established by Polycomb group 
proteins. Our results show intergenerational epigenetic inheritance of the cHC structure in human 
embryos.
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Introduction
Fertilization marks the fusion of two specialized gametes, oocyte and sperm. In mammalian zygotes, 
the maternal and paternal genome exist in an asymmetric chromatin configuration. Extensive 
reorganization of chromatin to the embryonic configuration is crucial for developmental potency [1]. 
During this process, some information of parental origin needs to be retained in order to maintain 
imprinting [2]. Other chromatin domains, such as the constitutive heterochromatin (cHC), need to 
be reorganized to the somatic configuration in order to function properly [3-4]. 
 Constitutive HC assembles mostly on telomeric, centromeric and pericentric regions, remains 
condensed throughout the cell cycle and is important for genome stability and chromosome 
segregation [5]. DNA sequences underlying cHC differ between species, but mainly consist of repeats 
and transposons. In mouse, most of the cHC is located pericentrically (pericentric heterochromatin 
(pHC)), a region with major satellite DNA repeats. In human, cHC is more dispersed across the 
genome [6]; classic satellite II and III DNA repeats localize to the pericentric region, but also to large 
blocks of cHC on chromosomes 1, 9, 16, the acrocentric chromosomes and Y [7], also referred to as 
“knobs” [5].
 The H3K9/HP1 pathway underlies formation of cHC. A central event is tri-methylation of histone 
H3 at lysine 9 (H3K9me3) by histone methyltransferases (HMTs) Suv39h1 and Suv39h2 [5,8-9]. 
H3K9me3 serves as a docking place for binding of heterochromatin protein 1 (HP1) isoforms, 
which results in chromatin compaction [5]. Subsequently, HP1 binds Suv4-20h1/2 HMTs, which tri-
methylate histone H4 at lysine 20 (H4K20me3) to further establish a compact chromatin structure 
[5,10]. Through an unidentified mechanism, H3K9me3 also facilitates tri-methylation of histone H3 at 
lysine 64 (H3K64me3), which has been suggested to stabilize cHC [11-12]. The H3K9/HP1 pathway is 
interwoven with methylation of DNA, another mechanism for gene silencing prominent in cHC [5,10]. 
Together, all modifications eventually lead to the establishment of a condensed, transcriptionally 
repressed state that is epigenetically heritable through cell division. 
 In mammalian oocytes, the maternal genome is marked by high levels of histone lysine methylation, 
whereas in spermatozoa the paternal genome is compacted with small proteins named protamines 
[13]. Current knowledge of resolution of this epigenetic asymmetry in early mammalian embryos 
is mainly based on mouse models [1]. Paternal pHC in mouse spermatozoa and zygotes is largely 
devoid of canonical cHC marks [14]. Re-establishment of the canonical pHC configuration is not 
performed by the H3K9/HP1 pathway. Instead, during the earliest embryonic stages, maternally 
provided Polycomb repressive complex 1 (PRC1) localizes to paternal pHC, which subsequently 
becomes enriched for Polycomb repressive complex 2 (PRC2)-mediated trimethylation of histone 
H3 on lysine 27 (H3K27me3) [3,15]. The core PRC1 complex contains an E3 ligase Ring1a/b, which 
interacts with one of the orthologs of the Drosophila posterior sex combs (PSC) (Mel18, Bmi1 
or Nspc1), a Polyhomeiotic (PH) ortholog (Phc1, Phc2 or Phc3), and a Polycomb ortholog (Cbx2, 
Cbx4, Cbx6, Cbx7 or Cbx8) [16]. The PRC2 core complex contains one of the HMTs Ezh1 or Ezh2, 
together with the regulatory subunits Suz12 and Eed [17]. In somatic cells, Polycomb complexes 
are known to regulate formation of facultative heterochromatin, a type of heterochromatin which 
is able to undergo changes in configuration in the context of regulation of gene expression. Thus, 
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in mouse pre-implantation embryos the paternal pericentric DNA temporarily assumes a facultative 
heterochromatin packaging, to circumvent the inactivity of the H3K9/HP1 pathway. The PRC1/2 
pathway thereby operates as a transient backup mechanism for pHC formation [3]. During the 8-cell 
stage of mouse embryo development, the H3K9/HP1 pathway takes over again and the pHC of both 
parental origins gradually becomes equivalent for H3K9me3 [3,18]. Other pHC associated marks, 
such as H3K64me3 and H4K20me3, remain undetected at paternal chromatin until after compaction 
and implantation, respectively [11-12,19]. 
 In this study we addressed chromatin dynamics on cHC during human pre-implantation embryo 
development. Our results identify striking differences with mouse: cHC in human embryos is not 
re-established by PRC1/2 action, but is transmitted and maintained by actors of the canonical H3K9/
HP1 pathway. We show that human spermatozoa retain and transmit nucleosomes with cHC marks, 
such as H3K9me3, to the embryo. These paternal marks are subsequently bound by maternal HP1 
and propagated over cell divisions. Based on this we propose a model in which paternal cHC is 
transmitted intergenerationally.
Methods
Collection and culture of human gametes and embryos
All human surplus material was donated for research according to guidelines of the local ethical 
committee. Surplus embryos and oocytes were donated with patients’ written informed consent 
after approval by the Dutch Central Committee on Research Involving Human Subjects (CCMO – 
NL28739.000.09).
 Ovarian stimulation, oocyte retrieval, IVF procedures and assessment of embryo morphology 
were performed as described [53]. Supernumerary good-quality embryos were cryopreserved. 
Cryopreservation was performed in a controlled rate freezer (in straws in culture medium with 1.5M 
dimethyl sulfoxide (DMSO). Straws were cooled to -6°C before seeding and subsequently cooled 
to -40°C at 0.3°C/min. Finally, straws were cooled rapidly at -25°C/min to -140°C, before immersion 
in liquid nitrogen and storage in nitrogen vapour. After donation for research, thawing of embryos 
was performed at room temperature by consecutive washes in decreasing DMSO concentrations in 
G-MOPS Plus medium (Vitrolife).
 Oocytes which failed to fertilize after IVF (0PN) were obtained 18 h post insemination at embryonic 
day (E) 1. Tripronuclear (3PN) embryos were used to study embryo development from E1 to E2. 
Surplus cryopreserved pre-implantation embryos of good quality were used to study embryonic 
developmental stages from E3 to E5 (for overview of stages see Supplementary Figure 1a). Embryo 
culture was performed in G1 Plus medium (Vitrolife) from E1 to E3 and thereafter in G2 Plus medium 
(Vitrolife) according to instructions of the manufacturer. Human surplus spermatozoa were obtained 
from IVF patients meeting the criteria for normospermia (WHO, 2010). These sperm samples 
underwent routine workup by layering on a discontinuous silica gel gradient (PureSperm, Nidacon 
International) and centrifugation at 1100rpm for 20 min. The resulting pellet was washed with G-IVF 
Plus medium (Vitrolife) at 1600rpm for 10 min and kept in 0.5mL G-IVF at 37°C, 6% CO2 in air. 
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Human U2OS cells (a gift from Dr. Kops [54]) were grown in Dulbecco’s Modified Eagle’s Medium 
(DMEM, Sigma) supplemented with 10% fetal bovine serum (FBS, Sigma) and 100 U/mL penicillin, 
100 µg/mL streptomycin (Invitrogen) and cultured at 37°C in a humidified chamber in the presence 
of 5% CO2. Cells were plated on poly-D-Lysine-coated 12-mm coverslips, fixed with methanol at 
-20°C for 10 min and then permeabilized with 0.2% TritonX-100 in phosphate buffered saline (PBS). 
Antibodies 
The following antibodies were used: rabbit polyclonal antibodies against H3K9me3 (1:500; Abcam 
ab8898), tetra-acetyl-Histone H4 (1:100; Upstate 06-598), H4K5ac (1:500; Abcam ab51997), H4K8ac 
(1:500; Upstate, 06-760), H4K12ac (1:500; Upstate 06-761), H4K20me3 (1:500; [55]), H3K64me3 (1:20; 
[11]) and H3K27me3 (1:200; [55]), mouse monoclonal antibodies against RING1A (1:200; Millipore 
05-1362), RING1B (1:400; [56]), PHC2 (1:50; [57]), EZH2 (undiluted; [58]), EED (undiluted; [58]), HP1α 
(1:500; Euromedex 2HP-1H5-AS) and H3 (1:1000; Active Motif 39763); rat monoclonal antibodies 
against H4K12ac (1:50; SciLight Biotechnology C2077001) and HP1β (1:500; Serotec MCA1946); 
and human anti-centromere antibodies (ACA) (human centromere antiserum; 1:1000, Fitzgerald 
Industries). 
 Primary antibodies were detected by labelling with the appropriate secondary antibodies 
conjugated with Alexa Fluor 488, 555, 594 or 633 (Invitrogen). 
Fixation and immunofluorescence of embryos 
After removal of the zona pellucida by incubation with Acidic Tyrode’s Solution (Sigma), embryos 
were washed twice in G-MOPS, fixed for 15 min in 4% paraformaldehyde (PFA) in PBS (pH 7.4) 
and permeabilized with 0.2% Triton-X 100 in PBS for 15 min at room temperature. Embryos were 
incubated in blocking solution (0.1% Tween-20 in PBS containing 2% bovine serum albumin (BSA) 
and 5% normal goat serum (NGS)) for 4h at room temperature, followed by incubation with primary 
antibodies in blocking solution overnight at 4ºC. Embryos were washed three times for 20 min 
in 0.1% Tween-20 in PBS containing 2% BSA before application of secondary antibodies. These 
were diluted 1:200 in blocking solution and embryos were incubated for 1h at room temperature, 
followed by three washing steps in 0.1% Tween-20 in PBS containing 2% BSA. Double antibody 
stainings were performed by mixing appropriate primary antibodies for simultaneous incubation, 
followed by detection with different secondary antibodies. Embryos were mounted on coverslips 
with Vectashield with 750 ng/ml 4,6-diamidino-2-phenylindole (DAPI) for DNA counterstaining 
(Vector Laboratories) [3]. 
 For live staining of DNA in 3PN zygotes, zygotes were incubated in medium containing 1 µg/mL 
Hoechst 33342 and imaged directly.
 To obtain chromosome spreads, embryos were incubated with 1.5 µg/ml colcemid (Invitrogen) 
for 8-16h to arrest cells at prometaphase. After zona pellucida removal, arrested embryos were 
incubated in hyposolution (25% fetal calf serum (FCS) in 0.5% sodium citrate) for 5 min and 
subsequently transferred to a drop of fixative (1% PFA with 0.2% Triton X-100, pH 9.2) on a glass slide. 
After horizontal drying for 1 hour, slides were washed with 0.08% Photo-Flo (Kodak) and air-dried 
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[59]. Slides with chromosome spreads were stored at -20°C until use. Surface spread preparations 
were processed for immunofluorescence as described above without permeabilization. 
 For each embryonic stage and antibody investigated 5-10 embryos were analysed unless otherwise 
stated. 
Single oocyte and embryo RT-qPCR 
mRNA levels were quantified in single oocytes and pre-implantation embryos at the following eight 
developmental stages: metaphase II oocytes (E0; n=7); zygotes (E1; n=5); 2 cell embryos (E1.5; n=5), 
4 cell (E2; n=4), 8 cell (E3; n=5), 12-16 cell (E3.5; n=5), morula (E4; n=4), and blastocyst (E5; n=5) 
(Supplementary Fig. 1a). Human embryonic stem cells (hESCs) (WA01 (H1) Lot 11, WiCell Research 
Institute) were used as a control.
 For quantitative RT–PCR (RT–qPCR) of single oocyte/embryos, the Taqman® PreAmp Cells-to-Ct Kit 
(Applied Biosystems) was used according to the manufacturer’s protocol with minor adjustments 
[21]. The zona pellucida was removed from the oocytes and embryos by incubation in 0.1% 
protease (Sigma) in G-MOPS medium for 3 min, prior to washing in G-MOPS medium and PBS. 
Lysis was performed for 5 min in 20 µl of Taqman® PreAmp Cells-to-Ct lysis solution and terminated 
by addition of 2 µl of stop solution. After 2 min of incubation the lysate was stored at -20°C until 
further processing within 1 week. Small pieces of hESC colonies containing 500-1000 cells were 
washed in PBS, and transferred to 50 µl Taqman® PreAmp Cells-to-Ct Lysis solution and terminated 
by addition of 5 µl Stop solution. RNA was reverse transcribed to cDNA within an hour at 37°C by 
adding 25 µl of 2× RT Buffer and 2.5 µl of 20× RT Enzyme Mix to each lysate, prior to inactivating 
the enzyme for 5 min at 95°C. For sequence-specific preamplification of cDNA, Taqman Gene 
Expression Assays (Assays-on-demand, Applied Biosystems) were pooled and diluted 1:100 with 1× 
TE buffer (10 mM Tris-HCl, 5 mM EDTA; pH 7.5) to a final concentration of 180nM of each primer. The 
following assays (Applied Biosystems) were used: ZP3 (Assay ID: Hs00610623_m1, amplicon size: 
74 bp), HPRT1 (Hs99999909_m1, 100 bp), SOX2 (Hs01053049_s1, 91 bp), OCT4 (Hs00999632_g1, 77 
bp), BMI1 (Hs00180411_m1, 105 bp), MEL18 (Hs00810639_m1, 64 bp), RING1A (Hs00968517_m1, 71 
bp), RING1B (Hs00200541_m1, 82 bp), PHC2 (Hs00189460_m1, 114 bp), CBX2 (Hs00364145_m1, 93 
bp), CBX7 (Hs00545603_m1, 54 bp), CBX8 (Hs00221034_m1, 64 bp), EZH1 (Hs00157470_m1, 65 bp), 
EZH2 (Hs00544830_m1, 86 bp), and EED (Hs00537777_m1, 110 bp). Assays were selected to be exon 
spanning and to recognize most of the validated (Ref Seq) splice variants of each gene of interest. 
 To 12.5 µl of cDNA, 25 µl of Taqman® PreAmp Master Mix and 12.5 µl of 0.2× pooled Taqman® Gene 
Expression Assays were added. After 10 cycles of preamplification (10 min at 95°C, followed by 10× 
15 s at 95°C and 4 min at 60°C), the preamplified cDNA (50 µl) was diluted with 100 µl of 0.5× TE 
buffer. qPCR was performed on an ABI Prism 7000 Sequence Detecting System (Applied Biosystems) 
using 10 µl of 2× Taqman® Gene Expression Master Mix, 1 µl of Taqman® Gene Expression Assay 
and 5 µl of nuclease-free water added to 4 µl of diluted preamplified cDNA. The two-step cycling 
parameters were as follows: one cycle of 2 min at 50°C, followed by one cycle of 10 min at 95°C to 
activate the polymerase and 40 cycles of 15 s at 95°C and 1 min at 60°C [21]. Results were analysed 
using Sequence Detection Software version 1.2.3 (Applied Biosystems) and expressed as cycle 
threshold (Ct) values (Supplementary Figure 3a). As a pre-amplification reaction of 10 cycles was 
Paternal heterochromatin formation in human embryos
29
2
performed, the detection limit of the qPCR was set at a cycle threshold value of 30 or less. Presence 
of a single PCR-product of expected amplicon size was verified by 2% agarose gel electrophoresis 
(Supplementary Figure 3b).
Heterologous intra cytoplasmic sperm injection 
All institutional and national guidelines for the care and use of laboratory animals were followed and 
mouse experiments were approved by the local committee on animal experiments, DEC Consult. 
B6D2 F1 female mice (Harlan) were used as oocyte donors and superovulation was induced by i.p. 
injection of 7.5 IU pregnant mare’s serum gonadotrophin (Intervet) followed by 7.5 IU human chorionic 
gonadotropin (hCG; Intervet) 48 h later [60-61]. Oocytes were isolated from the oviducts 13 h after 
hCG, and cumulus cells were removed by brief incubation in G-MOPS medium containing 80 IU/mL 
hyaluronidase (Sigma). Thereafter, the oocytes where washed and kept until after injection in freshly 
prepared mem-alpha medium (Life Technologies), supplemented with 10% (v/v) FCS, 21 µM HEPES, 
12.2 µM sodium lactate, 1 µM sodium pyruvate and 1 µM L-glutamin. Microinjection was performed 
using an inverted microscope equipped with an ICSI micromanipulation set-up (Narishige) and a 
piezo-actuated injector (Burleigh). An XYclone laser system (Hamilton Thorne) was used to breach 
the zona pellucida. Prior to installation a small volume of mercury (Sigma) was inserted in an Straight 
Piezo Drill Micropipette (Humagen). Spermatozoa were used either directly after collection from the 
epididymis or, to prevent oocyte activation, after heat inactivation (incubation at 50°C for 30 min 
[62]). For each injection series, an aliquot of spermatozoa was transferred to medium containing 12% 
polyvinyl pyrrolidone (Irvine Scientific). Spermatozoa were immobilized with a short piezo pulse 
applied to the neck piece. min Injections were performed at room temperature. Injected oocytes 
were warmed to 37°C and transferred after 5-10 min to G1 medium (Vitrolife) for culture at 37°C, 
5% CO2 in air. Oocytes injected with heat-inactivated spermatozoa (n=60) were fixed 22 hours after 
injection with 4% PFA as described above. Oocytes injected with normal spermatozoa were either 
fixed with 4% PFA 12-15 hours after injection (n=60) or transferred to medium containing 1.5 µg/ml 
colcemid and processed for chromosome spreads 7-9 hours later as described above (n=60). 
In vitro sperm decondensation 
Sperm head decondensation was achieved as described [48], with some modifications. First, 5 µL of 
a spermatozoa suspension was brought on a glass slide and spread out using the side of the pipet 
tip. After drying, the slides were incubated in decondensation buffer (2.5mM dithiothreitol (DTT) 
(Sigma), 0.2% Triton X-100 (Sigma) in PBS) for 10 min, followed by incubation for 3, 4 and 5 min with 
0.5% (v/v) heparin (5000U/mL, LEO Pharma BV) in decondensation buffer. Subsequently the slides 
were fixed in 4% PFA for 15 min, air dried, washed in Photo-Flo, and air dried. Slides were processed 
for immunofluorescence immediately as described above, starting with two washes in PBS-T. For 
each sperm sample, the optimal decondensation time was determined by sperm head morphology 
and ACA antibody accessibility. Preparations with optimal decondensation were used for further 
analysis. The presence of each histone modification under investigation was assessed in at least 100 
sperm cells with clearly distinguishable ACA staining, from at least three separate donors. 
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To obtain sperm DNA in a chromatin fiber-like structure, 5 µL of a spermatozoa suspension was 
added to 80 µL decondensation buffer, as described above and incubated for 10-20 min. Heparin was 
added to a concentration of 0.5% (v/v) and incubated for 10 min. Of this decondensed spermatozoa 
suspension, 5 µL was brought on a glass slide, spread out using the side of the pipet tip, and air dried. 
Slides were fixed in 4% PFA for 15 min and processed for immunofluorescence as described above. 
Immunofluorescence – Fluorescent In Situ Hybridization 
For immuno-FISH on in vitro decondensed spermatozoa, slides were first processed for FISH. The DNA 
probes used were Satellite DNA II/III probes for chromosomes 1 (pUC1.77 [63]), 9 (pHuR98 [64-65]), 16 
(pHuR195 [64-65]), and Y (RPN1305X [66]), and alpha satellite DNA probes for chromosomes 7 (pα7tl 
[67]) and X (pBamX5 [68]). Probes were fluorescently labelled using a BioPrime DNA labelling kit 
(Invitrogen), according to the instructions of the manufacturers. A hybridization mixture containing 
1 ng/µl of labeled probe in 50% formamide, 10% dextran sulfate, 1% Tween-20 and 0.1 µg/ml Human 
Cot-1 DNA (Invitrogen) in 2× standard saline citrate (SSC) was applied to each slide under a coverslip. 
Slides were denatured at 75°C for 3 min and hybridization was performed in a humid box at 37°C for 
6 h. After hybridization, slides were washed in 2× SSC/0.05% Tween-20 for 2 min at 42°C, 0.4 ×SSC for 
6 min at 60°C and in 2× SSC/0.05% Tween 20 for 2 min at room temperature. The slides were rinsed 
once in PBS before proceeding to immunofluorescence of H3K9me3 as described above. Immuno-
FISH was imaged simultaneously and for each probe co-localization for H3K9me3 and satellite DNA 
was measured in 10-12 randomly selected sperm cells from at least three separate donors. 
 For immuno-FISH on chromosome spreads of unfertilized oocytes or 3PN zygotes (5-7 per probe 
combination), slides were first processed for immunofluorescence of H3K9me3 as described above. 
Chromosome spreads were subsequently imaged and positions of chromosomes were recorded 
in the form of the XY-position of the microscope table. These coordinates were used to find the 
same chromosomes after FISH. Subsequently, FISH was performed as described [69] for either 
Satellite DNA II/III probes for chromosome 1 (pUC1.77 [63]) in combination with 9 (pHuR98 [64-65]), 
or 16 (pHuR195 [64-65]) in combination with Y (RPN1305X [66]). Probes were hybridized overnight 
followed by post-hybridization washes and imaging of the FISH signals. 
Imaging and image analysis 
Immunofluorescent images from whole mount embryos, heterologous zygotes, chromosome 
spreads and immuno-FISH on in vitro decondensed spermatozoa were aquired using a Zeiss Axio 
Imager M2 confocal laser scanning microscope, equipped with four diode lasers (405, 488, 555, 639 
nm), an Axiocam camera, and Zen 2009 (Carl Zeiss) software. For embryos, we recorded Z-series 
of 5 µm slices and for chromosome spreads, we recorded Z-series of 0.5 µm slices. Images were 
processed with Image J (version 1.42n) and Adobe Photoshop CS3 software.
 Imaging for immuno-FISH on chromosome spreads was performed on a Zeiss Axio Imager M1 
microscope (Carl Zeiss), equipped with a CoolCube 1m camera (MetaSystems), and Isis FISH Imaging 
System software (version 5.4.7, MetaSystems). Images of immunofluorescence and FISH were 
obtained in two rounds of imaging and merged using Image J. With the ROI Manager in Image J, 
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a selected area of one image was copied to the other images. Subsequently, selected areas were 
cropped and merged.
 For visualization of co-localization between H3K9me3 and satellite DNA the distribution of 
fluorescence intensities were plotted using the Straight lines selection tool in Image J. Subsequently, 
using the Analyze - Plot Profile tool, the distribution of fluorescence intensities along the selected line 
was obtained. Sperm cells were divided in three categories according to their profiles for H3K9me3 
and satellite DNA: 1) profiles were the peak intensities for H3K9me3 and FISH signal completely 
overlap, 2) profiles where the peak intensities are within a 1 µm distance and 3) profiles where the 
peak intensities are further apart. 
Results
Pronuclear morphology and cHC localization in human zygotes 
To determine the localization of cHC in human zygotes, pronuclear morphology was studied. Due 
to restrictions on the use of human embryos for research we were limited to tripronuclear (3PN) 
zygotes and embryos resulting from 3PN zygotes to study embryos at Embryonic day (E) 1 and 2 
(for overview of stages and source of embryos see Supplementary Figure 1a). Tripronuclear zygotes 
mostly originate from an oocyte that is fertilized by two spermatozoa, resulting in one maternal 
pronucleus and two paternal pronuclei [20]. Occasionally, when polar body extrusion fails, a 3PN 
zygote contains two maternal pronuclei and one paternal pronucleus. 3PN zygotes proceed 
through the first divisions normally and are capable of implantation, thus providing an ethically 
acceptable and relevant model for the first stages of pre-implantation embryo development [21-22]. 
From E3 onwards, embryos developed from diploid (2PN) zygotes and donated for research were 
used (Supplementary Figure 1a).
 Pronuclear morphology of human zygotes differs from mouse zygotes. In late stage mouse 
zygotes (G2 phase, also indicated as PN4/5 stage [23]), pronuclei are spherical and the DNA is spread 
throughout the pronucleus. A 4’-6-diamidino-2-phenylindole (DAPI)-intense ring-like structure 
around the nucleolar precursor body (NPB) contains the pHC [3-4] (Figure 1a). Human pronuclei also 
appear spherical under a stereomicroscope (Figure 1b). However, when pronuclei are examined at 
G2 phase (18-20 hours after fertilization [24], Supplementary Figure 1a) by DNA staining, the DNA 
content concentrates in the direction of the opposing pronucleus in both live and fixed conditions, 
resulting in a crescent shape (Figure 1c,d). The NPBs are also contained in DAPI-rich ring-like 
structures, but are smaller and more numerous when compared to mouse NPBs at that stage. In 
addition, a few DAPI-rich knobs are observed, similar in appearance to cHC blocks in human somatic 
cells [5]. Using human autoantibodies against the centromeres (ACA), we show that the centromeres 
are situated in close proximity to both the rings and knobs (Figure 1d). This confirms that these DAPI-
rich chromatin domains are located pericentrically and are likely to contain cHC in human embryos.
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Figure 1 — Pronuclear morphology of human zygotes differs from mouse zygotes. (a) Representative 
confocal image of a mouse zygote fixed 12-15 h post fertilization (G2 phase) with typical pronuclear 
morphology as observed by DNA staining (DAPI; n=10). Shown is a full projection of Z-sections. Pronuclei 
contain a ring-like structure called nucleolar precursor body (NPB) and pericentric heterochromatin 
can be observed as a ring with intense DAPI staining, surrounding the NPB. Paternal ( ) and maternal ( ) 
pronuclei are indicated, as is the polar body (pb). Scale bar, 10 µm. (b) Stereo micrograph of a human 3PN 
zygote showing typical pronuclear morphology. Detail shows a magnification of the boxed area. Scale bar, 
20 µm. (c) Representative confocal image of a human zygote 18-20 h post insemination (G2 phase) with 
typical pronuclear morphology as observed by live staining with Hoechst 33342 (n=6). Shown are three 
projections of consecutive Z-sections through the three pronuclei. DNA inside each pronucleus is contracted 
into a crescent shape containing several ring-like structures and denser stained “knobs”. Detail shows a 
magnification of a single Z-section through the boxed ring-like structure with attached knob (arrow). Scale 
bar, 10 µm. (d) Representative confocal image of a human zygote fixed 18-20 h post insemination (G2 phase) 
with typical pronuclear morphology (n=10). Shown is a full projection of Z-sections with DNA staining (DAPI; 
blue) and immunolocalization of the centromeres (ACA; white). Pronuclear morphology is not affected by 
fixation and DNA is observed in the same crescent shape with ring-like structures and DAPI-intense knobs 
(arrows). Centromeres are localized preferentially on the ring or in close proximity to a knob. Detail 1 and 2 
show magnifications of a single Z-section through the boxed ring-like structure and knob, respectively. Scale 
bar, 10 µm.
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PRC1/2 are not associated with cHC in cleavage stages 
Protein localization of PRC1 and PRC2 subunits was performed by immunofluorescence in 3PN 
zygotes fixed at G2 phase. The enzymatic PRC1 subunit RING1B was not detected (Figure 2a), 
whereas typical RING1B foci [25] were observed in nuclei from hU2OS cells and human blastocysts 
(Supplementary Figure 2a). Similar results were obtained for two other PRC1 subunits, RING1A and 
PHC2 (Supplementary Figure 2b,c), as well as for the core-components of PRC2, EZH2 (Figure 2b) 
and EED (Supplementary Figure 2d). 
 Subsequently, we characterized PRC2 activity by investigating the histone modification it 
catalyzes: H3K27me3. Immunodetection of H3K27me3 in 3PN zygotes at the G2 phase revealed a 
clear asymmetry for H3K27me3 staining, with one pronucleus showing intense staining throughout, 
whereas in the other two pronuclei staining levels were barely detectable (Figure 2c). These results 
are in accordance with our previous findings [20] and those of Zhang and colleagues [26]. Since 
metaphase II chromosomes in oocytes show high levels of H3K27me3 [26] and in analogy to what 
has been described in mouse [15,27] and other species [28-29], we propose the pronucleus with 
strong H3K27me3 staining to be of maternal origin. 
 In mouse zygotes, paternal pHC becomes increasingly enriched for H3K27me3 by PRC2 activity 
during G2 phase [3,30]. In contrast, in human zygotes arrested at the prometaphase stage, 
H3K27me3 levels remained barely detectable on paternal chromosomes, also at pericentric regions 
(Figure 2d). To determine whether PRC2 activity is upregulated during subsequent development, 
we performed immunostaining on whole-mount embryos of all stages of pre-implantation 
development from the zygote at E1 to the blastocyst at E5 (for overview of stages and source of 
embryos see Supplementary Figure 1a). On E1 and E2, H3K27me3 staining was restricted to one side 
of the nucleus, presumably marking the maternal chromatin. Overall levels of H3K27me3 decreased 
to become barely detectable at E3. From E4 onwards H3K27me3 levels increased and staining was 
distributed throughout the entire nucleus (Figure 2e). To exclude differences caused by the triploid 
state of the embryos examined at E1 and E2, we compared embryos at E3 and E4 developed from 
normal, dipronuclear zygotes (Figure 2e) with those developed from 3PN zygotes (Supplementary 
Figure 2e) and observed no differences. The lack of PRC2 activity at E1-3 is thus unlikely to be related 
to the triploid state of the embryos investigated. 
 Next, we analyzed the abundance of mRNA transcripts for subunits of PRC1 and PRC2 by RT-qPCR 
in oocytes and embryos of eight developmental stages (for overview of stages see Supplementary 
Figure 1a). The mRNA expression of most PRC1 and PRC2 subunits followed similar patterns 
throughout pre-implantation development: levels decreased from oocytes to the 8-cell stage at E3 
and increased again from E3.5 onwards (Supplementary Figure 3a), concomitant with the above 
described increase in trimethylation levels of H3K27. 
 Although observed high levels of H3K27me3 on maternal chromatin indicates PRC2 activity at some 
point during oocyte development, our failure to detect PRC1 and PRC2 at the paternal chromatin 
suggests the absence of these complexes in the zygote and the early embryo. Alternatively, our 
observations can also be explained by an inability of PRC complexes to target paternal chromatin. 
To differentiate between these possibilities we injected human spermatozoa into mouse oocytes, 
resulting in heterologous zygotes (Supplementary Figure 1b). When fixed at late G2 phase, the 
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Figure 2 — Polycomb Repressive Complex 1 and 2 are not associated with paternal cHC in cleavage stage 
human embryos. (a-c) Representative confocal images of human 3PN zygotes fixed at G2 phase. Shown are 
full projections of Z-sections. (a, b) Zygotes immunostained with PRC1 subunit RING1B (n=10) and PRC2 
subunit EZH2 (n=5) antibodies (green). No signal is observed to localize to the pronuclei. Scale bars, 30 µm. 
(c) Immunolocalization of H3K27me3 (green) in a 3PN zygote (n=15). Paternal ( ) and maternal ( ) pronuclei 
are indicated. H3K27me3 is detected broadly on maternal chromatin and only very low levels are observed 
on paternal chromatin with no enrichment at DAPI-intense, heterochromatic rings or knobs (arrows). Scale 
bar, 10 µm. (d) Representative chromosome spread of a 3PN zygote (n=5) arrested at prometaphase showing 
immunolocalization of H3K27me3 (green) and centromeres (ACA; white). Paternal ( ) and maternal ( ) 
chromosomes are indicated. H3K27me3 is detected broadly on maternal chromosomes and no H3K27me3 
enrichment is observed at paternal pericentric regions. Scale bar,10 µm. (e) Representative full projections of 
confocal Z-sections of human embryos at indicated stages (n=5-10 per embryonic stage). From embryonic 
day (E) 1 to 3, nuclei show an asymmetric staining pattern for H3K27me3 (green). Compared to overall H3 
levels as detected by a histone H3 antibody (white), H3K27me3 levels decrease gradually with each cell 
division. At E4, H3K27me3 is clearly detected throughout all nuclei. Arrows indicate the polar body, where 
H3K27me3 remains high. Detail shows a magnification of the boxed nucleus. Scale bars, 30 µm. (f) Mouse 
oocytes injected with human spermatozoa, fixed at PN4/5 stage (G2 phase). Shown is a representative 
confocal image of immunolocalization of Ring1b (green) in a heterologous zygote (n=30). Human paternal 
( ) and mouse maternal ( ) pronuclei are indicated. The human paternal pronucleus assumes a mouse-
like morphology and Ring1b is detected at distinct regions on the DAPI-intense ring around the nucleolar 
precursor bodies. Scale bar, 10 µm. (g) Representative chromosome spread from a heterologous zygote (n=5) 
arrested at prometaphase with immunolocalization of H3K27me3 (green). Human paternal ( ) and mouse 
maternal ( ) chromosomes are indicated. On human paternal chromosomes, H3K27me3 is detected and 
shows enrichment at distinct chromosome bands. Scale bars, 10 µm. 
human paternal pronucleus was observed to have adopted a mouse-like pronuclear morphology. 
We detected Ring1b staining at the ring surrounding the NPBs (Figure 2f ). This shows that mouse 
maternal Ring1b is able to access human paternal chromatin. When heterologous zygotes were 
arrested and fixed at prometaphase, H3K27me3 was detected in a banding pattern on human 
paternal chromatin in heterologous zygotes (Figure 2g). This is in contrast to barely detectable levels 
on paternal prometaphase chromosomes in human zygotes (Figure 2d). These results indicate that 
human sperm chromatin is intrinsically able to undergo PRC1/2 processing. Although we cannot 
completely rule out the possibility that the observed change in pronuclear structure positively 
affects accessibility of paternal cHC in heterologous zygotes, the low abundance of PRC1 and PRC2 
transcripts and the dilution of maternal H3K27me3 over divisions, suggests an absence of active 
PRC1/2 in early human embryos. Altogether, our results suggest that the PRC1/2 pathway does not 
have a role in paternal cHC establishment in human pre-implantation embryos. 
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H3K9me3 marks paternal chromatin on DAPI-rich regions
As the PRC1/2 pathway does not seem to be involved in build-up of cHC in early human embryos, 
we investigated the canonical H3K9/HP1 pathway by immunostaining for H3K9me3. In human 3PN 
zygotes at the late G2 phase, maternal pronuclei are abundantly marked by H3K9me3, as described 
before [20] (Figure 3a). Although signal in the paternal pronuclei was overall much lower, we did 
observe strong enrichment of H3K9me3 at the DAPI-rich knobs (Figure 3a). This parental asymmetry 
in H3K9me3 was confirmed by staining of prometaphase chromosome spreads: on paternal 
chromosomes enrichment was detected between the centromeres and on a few chromosome 
bands (Figure 3b). 
 Next, we investigated if our observations for H3K9me3 on the paternal chromatin in post-S-
phase human zygotes resulted from de novo H3K9 methyltransferase activity during S-phase. In 
approximately 10% of IVF oocytes that fail to fertilize after IVF, a sperm cell has penetrated, but failed 
to activate the oocyte [31]. Such spermatozoa frequently undergo a condensation of the paternal 
chromatin into chromatids, called premature chromatid condensation (PCC). In oocytes with sperm-
PCC, we detected strong H3K9me3 enrichment on paternal chromatids at pericentric regions and 
heterochromatic knobs (Figure 3c), indicating that this mark is independent of DNA replication in 
S-phase. 
Figure 3 — H3K9me3 is detected on DAPI-dense regions in paternal chromatin from cleavage stage 
human embryos. (a) Representative confocal image of a human 3PN zygote fixed at G2 phase (n=15). Shown 
is a full projection of Z-sections with immunolocalization of H3K9me3 (red). Paternal ( ) and maternal ( ) 
pronuclei are indicated. H3K9me3 is detected broadly on maternal chromatin and on paternal chromatin 
enrichment of H3K9me3 is detected at DAPI-intense, heterochromatic, regions (arrows). Detail shows a 
magnification of the boxed region. Scale bar, 10 µm. (b) Representative chromosome spread of a 3PN zygote 
arrested at prometaphase (n=30) showing immunolocalization of H3K9me3 (red) and centromeres (ACA; 
white). Paternal ( ) and maternal ( ) chromosomes are indicated. H3K9me3 is detected broadly on maternal 
chromosomes. On paternal chromosomes, H3K9me3 is observed at inner centromeric regions (arrows) 
and some distinct chromosome bands (arrows). Detail shows a magnification of the boxed chromosomes. 
Scale bar, 10 µm. (c) Representative chromosome spread of a human oocyte 18-20 h post insemination with 
fertilization failure (0PN) and presence of paternal chromatids after premature chromatid condensation 
(PCC; n=10). Shown is immunolocalization of H3K9me3 (red) and centromeres (ACA; white) on paternal 
chromatids. H3K9me3 is detected at distinct regions around the centromeres. Detail shows a magnification 
of the boxed chromatid (arrows indicate examples of the pericentromere and a H3K9me3 enriched band). 
Scale bar, 10 µm. (d) Representative full projections of confocal Z-sections of human embryos at indicated 
stages (n=5-10 per embryonic stage). On embryonic day (E) 1.5 and E2, H3K9me3 (red) is detected in an 
asymmetric pattern similar to the zygote. Levels on maternal chromatin remain high and arrows indicate 
H3K9me3 enriched regions on paternal chromatin. From E3 onwards, H3K9me3 was detected throughout 
the nucleus. Detail shows a magnification of the boxed nucleus. Scale bars, 30 µm. (e) Representative 
chromosome spread of an embryo at E3.5 arrested at the prometaphase of the 4th cleavage division with 
immunolocalization of H3K9me3 (red) and centromeres (ACA; white) (n=5). H3K9me3 was detected in a 
banding pattern on all chromosomes with enrichment at pericentric regions. Detail shows a magnification of 
the boxed chromosomes. Scale bar, 10 µm.
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To determine the fate of H3K9me3 on paternal chromatin in the zygote, we performed 
immunostaining of H3K9me3 on whole-mount embryos of all stages of pre-implantation 
development (Supplementary Figure 1a). In nuclei from E1 and E2 embryos, H3K9me3 staining was 
restricted to one side of the nucleus, presumably marking the maternal chromatin (Figure 3d). In 
contrast to H3K27me3, levels on maternal chromatin remained high during these stages and DAPI-
rich domains in the paternal chromatin remained positive for H3K9me3. From the 8-cell stage on, 
H3K9me3 was detected throughout the nucleus at DAPI-rich domains (Figure 3d). These findings 
were confirmed by H3K9me3 staining of prometaphase chromosomes of 8-cell (E3) embryos arrested 
at the prometaphase stage of the fourth cleavage division; the difference between maternal and 
paternal chromosomes was no longer obvious (Figure 3e). Taken together, these results show that 
H3K9me3 marks the paternal cHC in the zygote and suggest that this modification is maintained 
during subsequent cleavage divisions.
H3K9me3 marks satellite DNA repeats in human spermatozoa
In mouse spermatogenesis, pHC becomes devoid of H3K9me3 as elongation is completed and the 
mark is also not detected on the paternal chromatin in the zygote directly after fertilization [14,27]. 
However, in human spermatozoa, H3K9me3 enrichment has been observed at the pericentric region 
of chromosome 16 using ChIP-PCR [32]. To further investigate the presence of H3K9me3 in mature 
human spermatozoa, we performed immunolocalization of H3K9me3 and the centromeres (ACA) 
after in vitro decondensation. In virtually all spermatozoa H3K9me3 was prominently detected 
around the centromeres (Figure 4a). To investigate the location of retained H3K9me3 in more detail, 
human spermatozoa were subjected to extreme in vitro decondensation to obtain sperm chromatin 
in a fiber-like configuration. Whereas H3 was detected broadly, H3K9me3 was detected directly 
around the centromere, confirming its pericentric localization (Figure 4b). 
 In mouse elongating spermatids, pHC domains that still contain residual H3K9me3-bearing 
nucleosomes, also become enriched for nucleosomes with acetylation of histone H4 [14,33]. 
Although these modifications appear to be mutually exclusive at the nucleosome level, pHC 
temporarily exists in a bivalent state that may contribute to the reprogramming process [33]. To 
investigate if cHC in mature human spermatozoa exists in a similar bivalent state, H4 acetylation was 
detected by immunofluorescence. Acetylation of lysines 5, 8, and 12 of histone H4 (H4K5ac, H4K8ac, 
and H4K12ac), as well as a tetra-acetylated form of H4 (H4ac4) localized in a cap-like pattern, as 
described for human elongating spermatids [34] (Supplementary Figure 4). In contrast to mouse, 
acetylated forms of H4 were not specifically enriched around the centromeres and H4K12ac was not 
confined to H3K9me3 positive pHC domains (Figure 4c). 
 To investigate if human DNA repeat sequences underlying cHC are marked by H3K9me3 in sperm 
cells, we performed a combination of immunofluorescent analysis of H3K9me3 and fluorescent in 
situ hybridization (immuno-FISH). We investigated α-satellite repeats located on chromosomes 7 
and X and Sat II/III sequences of chromosomes 1, 9, 16, and Y. With exception of the X α-satellite, 
all repeat sequences investigated were observed to localize partially or completely to the region 
enriched for H3K9me3 in the majority of sperm cells investigated (Figure 4e and 4f, Supplementary 
Figure 5). These results demonstrate that DNA repeat sequences that form the cHC in humans are 
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enriched for H3K9me3 in sperm cells. To investigate if this is also the case after fertilization, we 
performed immuno-FISH on sperm-PCC in unfertilized oocytes and on paternal chromosomes of 
human zygotes arrested at prometaphase (Figure 4g). Probe signals for Sat II and III sequences on 
chromosomes 1, 9, 16, and Y were observed to consistently co-localize with the H3K9me3-positive 
regions. The satellite III repeat region located to the knob on the long arm of the Y chromosome is 
completely marked by H3K9me3. 
 Thus, DNA repeat sequences underlying cHC are enriched for H3K9me3 on paternal chromatin 
before and after fertilization. This suggests the delivery of these sequences in a canonical, 
heterochromatic conformation from the spermatozoon to the embryo. 
Sperm contributes modified histones marking cHC to zygotes 
Instead of the suggested inheritance of modified histones, our findings might also be explained 
by a scenario wherein paternally inherited nucleosomes are replaced by maternal ones, which 
are subsequently modified by maternal SUV39H1/2 activity. In mouse oocytes, Suv39h mediated 
modification of H3K9 is not active on paternal constitutive heterochromatin [3]. Any H3K9me3 
observed on human paternal chromatin after heterologous ICSI in mouse oocytes would thus be 
of sperm origin. First, we injected heat inactivated human spermatozoa (for experimental set up of 
heterologous ICSI see Supplementary Figure 1b), which have lost the ability to activate the oocyte 
[35] and directly undergo PCC after injection. In mouse oocytes with human sperm-PCC, we detected 
distinct H3K9me3-rich regions on the human paternal chromatids (Figure 5a), identical to sperm-
PCC in human oocytes (Figure 3c). Next, we injected normal human spermatozoa (Supplementary 
Figure 1b) and investigated zygotes at the late G2 phase. The human paternal pronucleus exhibited 
distinct domains of H3K9me3 on the DAPI-rich rings around the NPBs (Figure 5b), whereas this mark 
is absent from mouse paternal chromatin at this stage [3]. PRC1 is not targeted to the H3K9me3 
positive domains, as these two types of heterochromatin do not overlap on both PCC and the 
paternal pronucleus at G2 (Figure 5a,b). This reinforces previous findings that H3K9me3 impairs 
PRC1 targeting [3]. In heterologous zygotes arrested at prometaphase, the H3K9me3 staining 
pattern was similar to the one observed on human 3PN zygotes. Distinct H3K9me3 positive bands 
were observed on human paternal chromosomes (Figure 5c). Chromosome morphology of these 
heterologous spreads was generally good, and in some cases allowed (partial) karyotyping based 
on chromosome size and DAPI-banding pattern (Figure 5d). Strong enrichment of H3K9me3 on 
heterochromatin knobs was specifically observed on chromosomes 1, 9, 13, 14, 16, 21 and Y, on 
regions known to contain satellite II and III DNA repeats. 
 Altogether these data suggest that the H3K9me3 in human spermatozoa is retained during the 
remodeling that occurs in a mouse oocyte after gamete fusion. Based on our previous observations 
[36] and the data we presented here, we assume this also to be the case in human zygotes. Therefore, 
our results indicate a sperm origin of these modified histones in paternal embryonic chromatin.
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Figure 4 — H3K9me3 marks satellite DNA sequences at cHC regions on paternal chromatin in spermatozoa 
and zygotes. (a) Representative confocal image of a human in vitro decondensed spermatozoon. Shown 
is a full projection of Z-sections with immunolocalization of H3K9me3 (red) and centromeres (ACA; white) 
(n=100). Enrichment of H3K9me3 surrounding centromeres suggests pericentric localization. Dotted line 
indicates the nucleus of the spermatozoon. Scale bar, 10 µm. (b) Representative immunofluorescent image of 
human spermatozoa subjected to extreme in vitro decondensation. Chromatin contained in a nucleosomal 
structure was identified using a histone H3 antibody (green), in combination with immunolocalization of 
H3K9me3 (red) and centromeres (ACA; white) (n=100). H3K9me3 is detected directly neighbouring ACA 
signal, indicating pericentric localization. Scale bar, 20 µm. (c) Full projection of Z-sections of a human in 
vitro decondensed spermatozoon with immunolocalization of H3K9me3 (red) and H4K12ac (green) (full set 
of single channel images in Supplementary Figure 4). Graph shows distribution of fluorescent intensities 
along the line (c) for H3K9me3 (red) and H4K12ac (green) in arbitrary units. (d) Codetection of H3K9me3 
(red) and (peri)centric repeat sequences (white) in in vitro decondensed human spermatozoa (n=10-12) by 
immuno-FISH. DNA probes detecting satellite (Sat) DNA II/III repeat sequences at heterochromatic knobs on 
chromosomes 1, 9, 16 and Y and α satellite DNA sequences at centromeric locations (chromosomes 7 and 
X) are used. Shown are representative merged images of a single Z-section through the probe signal (full 
set of single channel images in Supplementary Figure 5). Graph shows distribution of fluorescent intensities 
along the line for H3K9me3 (red) and probe signal (grey) in arbitrary units. Scale bar, 5 µm. (e) Distribution of 
sperm cells according to their classification based on their profiles shown in (d). (f) Codetection of H3K9me3 
and (peri)centric repeat sequences by immuno-FISH on chromosome spreads. Upper panel: representative 
chromosome spread from the paternal chromosome set of a 3PN zygote arrested at prometaphase hybridized 
with DNA probes detecting satellite II/III sequences at chromosomes 1 (1qh, red) and 9 (9qh, green) (n=5). 
Lower panel: representative chromosome spread from paternal chromatids (PCC) in an unfertilized oocyte 
(0PN; n=7) hybridized with DNA probes detecting satellite II/III sequences at chromosomes 16 (16qh, red) and 
Y (yqh, green). DNA probes colocalize with areas of strong H3K9me3 (white) enrichment. Scale bars, 10 µm.
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Figure 5 — H3K9me3 on paternal embryonic chromatin originates from the human spermatozoon. To 
assess the origin of H3K9me3 on human paternal chromatin, human spermatozoa were injected into mouse 
oocytes. (a) Confocal analysis of fixed mouse oocytes 22 h after heterologous ICSI with heat inactivated 
human sperm (n=30). Shown is a full projection of Z-sections containing paternal chromatids ( ) with 
immunolocalization of H3K9me3 (red) and Ring1b (green). H3K9me3 is clearly detected at pericentric 
regions on each chromatid. Scale bar, 10 µm. (b) Representative confocal image of the paternal pronucleus of 
a heterologous zygote fixed 12-15 h after injection (G2 phase; n=30). Shown is a full projection of Z-sections 
with immunolocalization of H3K9me3 (red) and Ring1b (green). The human paternal pronucleus ( ) assumes 
a mouse-like morphology (PN4). H3K9me3 and Ring1b are detected in a non-overlapping fashion at distinct 
regions at the DAPI-intense ring around the nucleolar precursor bodies. Detail shows a magnification 
of the boxed ring. Scale bar, 10 µm. (c, d) Representative chromosome spread of a zygote resulting from 
heterologous ICSI arrested at prometaphase (n=30). Paternal ( ) and maternal ( ) chromosomes are indicated. 
Scale bars, 10 µm. (c) Mouse maternal chromosomes with immunolocalization of H3K9me3 (red), showing 
H3K9me3 ubiquitously on maternal chromosomes. (d) On paternal chromosomes, immunolocalization of 
H3K9me3 (red) and centromeres (ACA; white) revealed enrichment of H3K9me3 at the inner centromere 
of all chromosomes. Partial karyotyping of the paternal chromosomes identified strong enrichment on 
heterochromatin knobs on chromosomes 1, 9, 13, 14, 21 and Y. Chromosomes 16, 17 and 22 were not 
unambiguously identified in this spread. 
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Figure 6 — Paternal cHC marked by H3K9me3 also contains HP1β, H4K20me3 and H3K64me3. (a) 
Representative confocal image of a human 3PN zygote fixed 18-20 h post insemination with immunostaining 
of H3K9me3 (red) and HP1β (white) (n=5). Paternal ( ) and maternal ( ) pronuclei are indicated. Detail 
shows a magnification of the boxed region. HP1β was detected broadly on the maternal pronucleus and 
on heterochromatin knobs on the paternal pronucleus (arrows and detail), co-localizing with H3K9me3 
staining. Scale bar, 10 µm. (b, c) Representative merged confocal images of a human in vitro decondensed 
spermatozoon, a human 0PN oocyte with PCC, a human 3PN zygote at G2 phase and a human 3PN zygote 
arrested at prometaphase (n=5-10 per embryonic stage), all immunostained for (b) H4K20me3 (red) 
and centromeres (ACA; white (excluding G2 phase)) or (c) H3K64me3 (red) and centromeres (ACA; white 
(excluding G2 phase)). Shown are full projections of Z-sections. Paternal ( ) and maternal ( ) chromatin is 
indicated. Details shows magnifications of boxed regions. Full set of single channel images in Supplementary 
Figure 5. Both H4K20me3 and H3K64me3 were detected at pericentric regions in all stages, comparable to 
H3K9me3 and HP1β, but H3K64me3 staining was less intense in spermatozoa and 0PN PCC. (d, e) Dynamics 
of H4K20me3, HP1β, and H3K64me3 during human pre-implantation embryo development. Representative 
merged confocal images of human embryos at indicated developmental stages (n=5-10 per embryonic 
stage) with immunolocalization of (d) H4K20me3 (red) and HP1β (white) or (e) H3K64me3 (red). Shown 
are representative merged full projections of confocal Z-sections. Detail shows magnification of the boxed 
nucleus. Full set of single channel images in Supplemental Figure S6. On embryonic day (E) 1 and E2, all 
antibodies are detected in an asymmetric pattern similar to their expression the zygote. On condensed 
chromosomes, paternal H3K64me3 knobs are clearly visible (arrow). Whereas HP1β is observed strongly and 
throughout the nucleus from E3 onwards, H4K20me3 and H3K64me3 are more confined to DAPI-intense 
regions. 
Paternal cHC is marked by H3K9me3/HP1 pathway modifications 
As described, H3K9me3-binding HP1 proteins (isoforms α, β) and histone modifications H4K20me3 
and H3K64me3 are additional markers of cHC. To investigate the extent of cHC formation on the 
paternal chromatin, we determined the dynamics of these additional markers by immunofluorescent 
analysis in spermatozoa, unfertilized oocytes with PCC, 3PN zygotes, and all stages of pre-implantation 
development. As described in mouse [3], we also failed to detect HP1β in in vitro decondensed 
human spermatozoa (data not shown). However, in contrast to mouse, both HP1α and HP1β were 
readily detected at the DAPI-rich knobs in paternal pronuclei, co-localizing with H3K9me3 (Figure 6a, 
Supplementary Figure 6a). HP1β dynamics during embryo development followed the same pattern 
as H3K9me3, with asymmetric staining in the nucleus at E1 and E2 (Figure 6d, Supplementary Figure 
7a). From E3 onwards, staining was observed at DAPI-rich regions throughout the nucleus. 
 H4K20me3 was detected around the centromeres in decondensed human spermatozoa, similar 
to H3K9me3. After fertilization, H4K20me3 was detected ubiquitously at maternal chromatin, on 
DAPI-rich knobs at G2 phase in the paternal pronucleus, and at paternal pericentric regions in PCC 
and prometaphase chromosomes (Figure 6b, Supplementary Figure 6b). From the 2-cell stage 
onwards, H4K20me3 remained detectable in a pattern similar to H3K9me3, but staining appeared 
more constricted to the DAPI-rich regions (Fig. 6d, Supplementary Figure 7a). 
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H3K64me3 was observed at barely detectable levels in decondensed human spermatozoa. In 
unfertilized oocytes with paternal PCC, H3K64me3 was detected strongly at maternal chromatin, 
but barely at paternal chromatin. H3K64me3 levels appeared to increase after S-phase, as staining 
was observed on DAPI-rich knobs at G2 phase in the paternal pronucleus and prometaphase 
chromosomes (Figure 6c, Supplementary Figure 6b). From the 2-cell stage onwards, H3K64me3 
followed a pattern similar to H4K20me3 (Figure 6e, Supplementary Figure 7b). 
 These findings show that, in contrast to mouse, paternal cHC in human pre-implantation stage 
embryos contains a full suit of canonical cHC markers, all of them grouped in the H3K9/HP1 pathway. 
Since we found that maternal HP1 binds sperm-derived H3K9me3 and that H3K64me3 is increased 
at H3K9me3-positive regions, our data also shows that the modified histones contributed by the 
sperm cell enable further establishment and maintenance of cHC by the maternal machinery.
Discussion 
The current work identifies three major mechanistic differences in paternal cHC build-up between 
mouse and human: 1) human paternal cHC is transmitted from the spermatozoon to the zygote 
in a canonical conformation, which is subsequently propagated by the H3K9me3/HP1 pathway, 
2) in humans, paternal embryonic cHC remains under control of the H3K9/HP1 pathway and cHC 
is characterized by hallmarks as H4K20me3 and H3K64me3 much earlier in development than in 
mouse, and 3) a PRC1/2-mediated back-up mechanism, as described in mouse [3], does not seem 
to play a role. 
 Based on our results, we propose an intergenerational model for cHC build-up in the early 
human embryo (Figure 7): nucleosomes bearing H3K9me3 and H4K20me3 are transmitted by 
the spermatozoon and demarcate cHC domains in the zygote. H3K9me3 is detected and bound 
by maternally provided HP1 proteins, which in turn bind the SUV39H1/2 and SUV4-20H1/2 KMTs, 
enabling propagation of these marks. Low levels of H3K64me3 present in the sperm cell can 
contribute to the feedback loop that reinforces further heterochromatinization [12]. Together this 
results in the epigenetic propagation of the chromatin conformation of paternal cHC to the next 
generation. 
 In mouse, only 1% of sperm DNA remains histone associated [37]. Although transferred to the 
embryo [14], this low quantity of paternally-inherited nucleosomes might not allow similar protein-
based inheritance of heterochromatic DNA. Instead, paternal heterochromatic build-up is initiated 
through action of PRC1 [3]. Recent findings indicate that the histone demethylase Kdm2b binds 
to unmethylated CpG islands and directly recruits a subset of PRC1 complexes to chromatin in 
pluripotent stem cells [38]. This or an analogous binding cascade could enable a DNA-based paternal 
heterochromatin build-up in mouse embryos [38-39]. Thus, whereas mouse embryos seem to 
depend on sperm DNA sequence and a maternal store of Polycomb proteins to re-establish paternal 
cHC, in human embryos cHC is inherited from the sperm cell in the canonical configuration. 
 In mouse, Polycombs are key to regulation of genes associated with development [40]. Therefore, 
our failure to detect PRC1/2 activity in human cleavage stage embryos is remarkable. However, 
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immunofluorescence is not sensitive enough to detect possible presence and maintenance of 
H3K27me3 at a gene level. Genome wide chromatin analysis of human sperm cells previously 
identified H3K27me3 enrichment at developmental regulators [32,41]. If transferred to the embryo 
in a similar fashion as H3K9me3, these marks might be enough to prevent inappropriate gene 
expression. A global decline in H3K27me3 levels during pre-implantation development has also 
been described in bovine and porcine cleavage embryos, in which the embryonic stage with the 
lowest levels of H3K27me3 coincided with EGA [42]. Our findings are consisted with this, as the 
major wave of human EGA occurs around the 8 cell stage [43]. Global loss of H3K27me3 may thus be 
required for EGA in species where EGA occurs later than in mouse [42]. 
 In mouse embryos, transcription of major satellites, especially from the paternal genome, has 
recently been reported to be crucial for rearrangement of pHC [4]. In this light it is interesting that 
we observed strong H3K9me3 enrichment on satellite II/III DNA repeats on paternal chromatin in 
both spermatozoa and zygotes. Sat III repeat sequences are primate specific [44] and long non-
coding Sat III transcripts have been implicated in developmental regulation [45]. As long non-coding 
RNAs contribute to heterochromatin assembly during female X chromosome inactivation, Sat III 
transcripts may have a similar function in cHC maintenance [46]. It remains to be determined if such 
RNA-based mechanisms are needed for cHC organization in human embryos or if the self-sustaining 
loop of the full H3K9/HP1 pathway is sufficient.
 During mammalian spermiogenesis, histones are replaced by protamines. In humans, 5-15% of 
the DNA, encompassing specific genes, as well as (peri)centromeric DNA, appear to be protected 
against this removal and retain a nucleosomal structure (for review see [47]). Studies on human sperm 
have demonstrated that there is an increase in the nucleosome/protamine ratio when sperm from 
male factor subfertility patients are compared with sperm from fertile men, confirming incomplete 
chromatin remodelling during spermatid elongation [48]. Also, differences in composition of 
retained nucleosomes exist between these groups, with a more dispersed pattern throughout the 
genome in sperm from subfertility patients [41,48-50]. As we show that sperm-inherited modified 
histones contribute to cHC formation in the human zygote, the variability observed in retention of 
nucleosomes may interfere with cHC function in the zygote and impact upon embryo developmental 
potential. 
 Frequently, findings on chromatin dynamics in early mouse embryos are assumed to be universal 
for epigenetic reprogramming in mammalian embryos [51-52]. Our findings highlight the existence 
of divergent epigenetic developmental programs in mammals. Charting these differences will greatly 
improve our understanding of how heterochromatin features impact on embryo development. 
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Supplementary Figure 1 — Developmental time-frame for human oocytes and pre-implantation embryos 
used in this study. (a) Schematic representation of the stages of oocyte and embryo development used in 
this study. Oocytes that failed to fertilize were processed on E1 and checked for the presence of paternal 
chromatids (PCC). Zygotes that displayed three pronuclei (3PN) were either processed directly, incubated 
in colcemid for prometaphase arrest or allowed to develop until E1 or E2 and processed subsequently. 
Good quality diploid (2PN) embryos that had been cryopreserved on E3 or E4 were thawed and processed 
immediately or allowed to develop to E4 or E5 and processed subsequently. (b) Schematic representation 
of heterologous ICSI experiments: mouse oocytes are injected with normal or heat-inactivated human 
spermatozoa. Oocytes injected with normal spermatozoa are either fixed 12-15 h post injection at the PN4/5 
stage (corresponding to G2 phase) or prepared for chromosome spreads after incubation with colcemid to 
induce prometaphase arrest. Oocytes injected with heat inactivated spermatozoa fail to activate and remain 
at the metaphase II (MII) stage, while paternal chromatin is condensed into chromatids (PCC).
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Supplementary Figure 2 — Polycomb Repressive Complex 1 and 2 are not associated with paternal cHC in 
human embryos until after E3. (a) Immunolocalization of PRC1 subunit RING1B (green) in a U2OS cell nucleus 
and a blastocyst nucleus. Human U2OS cells spontaneously overexpress Polycomb group proteins and serve 
as a positive antibody control. Shown is a immunofluorescent image of a U2OS cell nucleus containing 
enrichment of RING1B in typical “polycomb bodies”25. Confocal analysis of human blastocytsts fixed on E5 
also shows several RING1B foci to be present in the nucleus (n=5). Shown is a representative full projection 
of Z-sections through a single nucleus. Scale bars, 10 µm. (b) Immunolocalization of PRC1 subunit RING1A 
(green) in a 3PN zygote and blastocyst. Representative confocal images of a 3PN zygote fixed 18-20 h post 
insemination and a blastocyst fixed on E5. Shown are full projections of Z-sections. RING1A is not detected 
in the zygote (n=5), but several foci can be observed in the blastocyst nucleus (n=5). Scale bars, 30 µm (3PN 
zygote) and 10 µm (blastocyst). (c) Immunolocalization of PRC1 subunit PHC2 (green) in a 3PN zygote and a 
U2OS cell nucleus. Representative confocal image of a human 3PN zygote fixed 18-20 h post insemination. 
Full projections of Z-sections fail to detect PHC2 in the zygote (n=5), but several foci can be observed in U2OS 
cells. Scale bar, 30 µm (3PN zygote), 10 µm (U2OS cell). (d) Immunolocalization of PRC2 subunit EED (green) in 
a 3PN zygote. Representative confocal image of a 3PN zygote fixed 18-20 h post insemination (n=5). Shown 
is a full projection of Z-sections. EED is not detected at DAPI-dense rings or knobs. Scale bar, 30 µm. (e) 
H3K27me3 dynamics in E3 and E4 embryos originating from 3PN embryos. Shown are representative full 
projections of confocal Z-sections of embryos fixed at indicated developmental stages (n=5 per stage), with 
immunolocalization of H3K27me3 (green) and histone H3 (white). Results are the same as in embryos from a 
2PN origin (compare with Figure 2e): compared to overall H3 levels, H3K27me3 levels are barely detectable at 
E3. At E4, high H3K27me3 levels are detected in all nuclei. Arrows indicate the polar body. Scale bars, 30 µm. 
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Supplementary Figure 3 —mRNA expression of PRC1/2 subunits in human oocytes and pre-implantation 
embryos. (a) mRNA expression levels of control genes and PRC1/2 subunits were quantified by RT-qPCR in 
single oocytes and pre-implantation embryos at the following eight developmental stages (Supplementary 
Figure 1): E0 (n=7); E1 (n=5); E1.5 (n=5), E2 (n=4), E3 (n=5), E3.5 (n=5), E4 (n=4), and E5 (n=5). Average cycle 
threshold (Ct) values are given and results are depicted as colours ranging from green to red, indicating 
expression levels ranging from high (green) to below detection threshold (≥30; red). ZP3, expressed only 
as a maternal transcript, HPRT1, expressed stably in somatic cells, and SOX2 and OCT4, transcription factors 
whose expression is known to increase during pre-implantation development, were used as controls. RNA 
isolated from human embryonic stem cells (hESCs) is used to verify detection of all investigated mRNAs with 
the chosen gene expression assays. Expression of the investigated mRNAs followed similar patterns: levels 
decreased from E0 to E3 and started increasing again around E4. Exceptions were expression of BMI1 and 
EED, which was not detected until E4, and CBX7, which was only detected in hESCs. (b) Verification of PCR 
products on agarose gel. DNA marker sizes are indicated in base pairs. Indicated beneath the gel lanes are the 
gene and the expected amplicon size in base pairs (bp).
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Supplementary Figure 4 — Acetylated forms of Histone 4 are not enriched at pericentric heterochromatin 
in mature human spermatozoa. Representative full projections of confocal Z-sections through human in 
vitro decondensed spermatozoa (n=100 per experiment). Upper panel: Full set of single channel images 
corresponding to merged image shown in Fig. 4c, with immunolocalization of H3K9me3 (red) and H4K12ac 
(monoclonal Rat antibody, green) relative to centromeres (ACA; white). H3K9me3 is enriched in the region 
surrounding the centromeres, but H4K12ac localizes in a cap-like pattern and is not specifically enriched at 
pHC. Lower panels: Immunolocalization of chromatin contained in a nucleosomal structure using a histone 
H3 antibody (green), together with H4K12ac (polyclonal Rabbit antibody), H4K5ac, H4K8ac and a tetra-
acetylated form of H4 (red) relative to centromeres (ACA; white). All acetylated forms of H4 were observed to 
be enriched in a cap-like pattern. Scale bar, 10 µm.
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Supplementary Figure 5 — Codetection of H3K9me3 and (peri)centric repeat sequences in in vitro 
decondensed human spermatozoa by immuno-FISH. Full set of single channel images corresponding 
to merged images shown in Figure 4d. DNA probes detecting satellite (Sat) DNA II or III repeat sequences 
at pericentric (chromosomes 1, 9, 16 and Y) and α satellite DNA sequences at centromeric locations 
(chromosomes 7 and X) are used. Shown are representative single Z-sections for all channels and the merged 
images. A dotted line was drawn through the probe signal following the length of the H3K9me3 cloud and 
the distribution of fluorescent intensities along this line were plotted for H3K9me3 (red) and probe signal 
(grey) in arbitrary units. Scale bar, 5 µm.
Supplementary Figure 6 — Paternal cHC marked by H3K9me3 also contains HP1α, H4K20me3 and 
H3K64me3. (a) Representative confocal image of a human 3PN zygote fixed 18-20 h post insemination 
(n=10). Shown is a full projection of Z-sections with immunolocalization of HP1α (red). Paternal ( ) and 
maternal ( ) pronuclei are indicated. HP1α was detected broadly on the maternal pronucleus and on DAPI-
dense knobs on the paternal pronucleus (arrows). Scale bar, 30 µm. (b) Full set of single channel images 
corresponding to merged images shown in Figure 6b/c. Dotted line indicates the sperm nucleus. Paternal ( ) 
and maternal ( ) chromatin is indicated. Detail shows a magnification of the boxed regions. Scale bar, 10 µm 
(all stages) and 30 µm (G2 phase).
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Supplementary Figure 7 — cHC markers HP1β, H4K20me3 and H3K64me3 are maintained during pre-
implantation development. (a, b) Full set of single channel images corresponding to merged images shown 
in Figure 6d/e. Detail shows a magnification of the boxed nucleus. Scale bars, 30 µm.
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Abstract
Background: Human embryos generated by in vitro fertilization demonstrate a high incidence of 
chromosomal segregation errors during the cleavage divisions. To analyze underlying molecular 
mechanisms, we investigated the behavior of the chromosomal passenger complex (CPC) in human 
oocytes and embryos. This important mitotic regulatory complex consists of INCENP, survivin, 
Borealin and Aurora B, with the meiotic kinase Aurora C as a possible alternative subunit. 
Methods: We analyzed mRNA expression by RT-qPCR of all members of the CPC in human oocytes, 
tripronuclear (3PN) zygotes, 2 cell and 4 cell embryos developed from 3PN zygotes, as well as 
good quality cryopreserved 8 cell, morula and blastocyst stage embryos. Protein expression and 
localization of CPC members was investigated by immunofluorescence in oocytes and embryos 
arrested at prometaphase, with a focus on Aurora B and Aurora C. Histone H3S10 phosphorylation, a 
known Aurora B kinase target, was investigated as an indicator of a functional CPC. 
Results: INCENP, Survivin and Borealin were detected at the inner centromere of prometaphase 
chromosomes in oocytes and all stages of preimplantation development investigated. Whereas 
Aurora B and C are both present in oocytes, Aurora C becomes the most prominent kinase in the CPC 
during the first three embryonic cell cycles. Moreover, Aurora C mRNA was upregulated together 
with Aurora B after activation of the embryonic genome and both proteins were detected in early 
day 4 embryos. Subsequently, only Aurora B was detected in blastocysts. 
Conclusions: In contrast to somatic cells, our results point to a specific role for Aurora C in the CPC 
during preimplantation embryo development. Although the presence of Aurora C in itself may not 
explain the high chromosome segregation error rate, differences between Aurora B and C, as well as 
regulation of the balance in expression of these kinases before and after activation of the embryonic 
genome, may help in identifying crucial factors. 
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Introduction
The introduction of fluorescence in situ hybridization (FISH) for preimplantation genetic diagnosis 
has enabled screening of human embryos for chromosomal aneuploidies before transfer in in vitro 
fertilization (IVF). This has led to an increasing body of evidence demonstrating that, in IVF derived 
embryos, an estimate of 80% of all preimplantation embryos have chromosomally abnormal cells 
[1,2]. The majority of the aneuploidies observed at this stage have originated during the first mitotic 
divisions of early preimplantation development, resulting in chromosomally mosaic embryos [3-8]. A 
study using an array-based method allowing genome-wide screening of the copy number in single 
embryonic cells from cleavage stage embryos, found the high frequency of chromosomal instability 
to be similar to human cancers [9]. Furthermore, considerable percentages of chromosomal 
mosaicism have also been reported for bovine, equine, porcine and non human primate embryos 
[10-13], both for in vitro and in vivo produced embryos (bovine: [12]; porcine [13]). This indicates that 
chromosome segregation in preimplantation embryos is more error prone than in other dividing 
cells. The molecular mechanisms that control chromosome segregation in cleavage stage embryos 
are not well described [14], raising the question if these differ from somatic mitotic cells.
 Correct segregation of chromatids to the two daughter cells during mitosis is crucial for maintaining 
genomic integrity and cells have a complex cell cycle machinery in place to regulate this process, 
including a checkpoint mechanism called the spindle assembly checkpoint (SAC) [15]. An important 
protein complex contributing to proper SAC functioning is the chromosomal passenger complex 
(CPC), named after its dynamic localization during mitosis. At the onset of mitosis, the CPC moves 
from the arms of the condensing chromosomes to the inner centromere. During the metaphase to 
anaphase transition, the CPC disassociates from the centromeres to localize to the microtubules 
of the central spindle in anaphase and telophase and to the midbody during cytokinesis. Parallel 
to its location, the CPC is involved in chromosome condensation, spindle assembly, the correction 
of erroneous microtubule-kinetochore interactions, signaling to the SAC, and the completion of 
cytokinesis (reviewed by [15]). The complex consists of four subunits: the inner centromere protein 
INCENP, Survivin, Borealin and the active enzymatic unit Aurora B kinase [16]. The role of the non-
enzymatic CPC members is localization of the kinase at the right place and time (reviewed in 
[16,17]). Aurora B binds to the so-called IN-box region of INCENP and in turn, INCENP regulates the 
localization of Aurora B by interacting with Borealin and survivin [18-20]. 
 Aurora B belongs to a family of serine/ threonine protein kinases, which in mammals also 
comprises the two other family members Aurora A and C. Although the three proteins share a high 
sequence similarity, each Aurora kinase has a specific localization pattern and function during cell 
division [21]. Aurora A is involved in centrosome maturation, bipolar spindle assembly and cell 
cycle progression in somatic cells [22-24] and oocytes [25]. Aurora C is the most recently described 
and least characterized family member that arose during mammalian evolution through gene 
duplication of Aurora B [26]. Expression was first described in the testis [27], where it is involved 
in chromatin condensation and proper attachment of homologous chromosomes during the first 
meiotic division [28]. Aurora C knockout mice are viable and males have normal testis weights, 
but reduced litter sizes with some males being sterile. Observed sperm abnormalities include 
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heterogeneous chromatin condensation, loose acrosomes and blunted heads. However, as multiple 
copies of the Aurora C gene (AURKC) are present in the mouse genome, a knockout approach is 
not reliable [29]. In contrast, male mice expressing a kinase-dead form of Aurora B as a transgene 
present with decreased testis weights, as well as severely impaired spermatogenesis and reduced 
littersize [30]. The relative importance of Aurora B vs C for male mouse meiosis remains uncertain, 
awaiting proper Aurora B and C knockout mouse models. Naturally occurring human mutations in 
AURKC, causing a severe truncation of the protein, have been described and are associated with 
male infertility [31]. This results from defective meiosis leading to the production of polyploid, multi-
flagellar spermatozoa with abnormal acrosomes [32]. Two females carrying the same homozygous 
mutation were reported to be fertile, indicating that Aurora C may be dispensable for completion of 
meiosis in the human female, but not in the male [32]. However, transcript profiling of human oocytes 
points to a prominent role for Aurora C [33]. Moreover, a recent study in mouse demonstrated that 
microinjection of an mRNA coding for a kinase dead form of Aurora C disrupts meiosis I in in vitro 
matured oocytes, suggesting an essential role for Aurora C [34]. This result is in contrast to previous 
findings on Aurora B function during mouse female meiosis [35,36], indicating the importance of 
Aurora B for female meiosis.
 Based on gonad specific expression and the homozygous mutation phenotype in man, Aurora 
C has been coined the germ cell specific homologue [35]. However, Aurora C is also expressed in 
various tumor lines [37], and its expression can be detected at a low level in other somatic tissues 
[38], including the pineal gland where it is implicated in circadian clock function [39]. Moreover, 
Aurora C was shown to fully support mitotic progression when replacing Aurora B in somatic cells 
[40]. It interacts with the other CPC proteins [41-43] and shares some substrates with Aurora B [42]. 
Therefore, in addition to a meiotic role, Aurora C may also have a tissue specific role in mitotic cells 
[40].
 To obtain a better understanding of regulation of chromosome segregation in human primary 
oocytes, the early fertilization stage (female meiosis II), zygotes and preimplantation embryos, we 
have investigated the expression of CPC subunits, including both Aurora B and C, in a unique series 
of human oocytes and embryos. The high level of gene expression of AURKC in human and mouse 
oocytes [33,34] and the prominent role of Aurora C in human male meiosis lead us to hypothesize 
that Aurora C could act as the preferred enzymatic subunit of the CPC at the reductional divisions in 
oocytes. Moreover, as in the human the first cleavage divisions are maternally directed [44,45], Aurora 
C might well continue to play a role in the control of mitosis before activation of the embryonic 
genome.
 We studied mRNA and in situ protein expression of all CPC members in human oocytes and all 
stages of human preimplantation embryo development. We observed that Aurora C can be detected 
at both the mRNA and protein level in oocytes and cleavage stage embryos. Yet, after the eight-cell 
stage and up to the morula stage, there was upregulation of both AURKB and AURKC mRNA and 
pericentromeric localization of both kinases on prometaphase chromosomes. In blastocysts Aurora 
C transcripts and protein were undetectable, and only Aurora B was found at the inner centromere 
of prometaphase chromosomes. Our results point to a specific role for Aurora C as the enzymatic 
subunit in the CPC during human female meiosis and preimplantation embryo development, up to 
complete replacement by Aurora B at the blastocyst stage. 
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Materials and Methods
Collection of human oocytes and spermatocytes 
Ovarian stimulation, oocyte retrieval and IVF procedures were performed as described previously 
[46,47]. At the day of oocyte retrieval (day 0), immature oocytes (metaphase I [MI]) were donated by 
couples undergoing ICSI treatment at the IVF laboratory of the University Medical Center Utrecht. 
Some mature oocytes (metaphase II [MII] stage) were donated in a case where on the day of oocyte 
retrieval no sperm cells could be obtained. MI oocytes were either processed immediately or allowed 
to mature in a 5% CO2 atmosphere at 37°C in G-IVF Plus medium (Vitrolife) overnight (18 h) and fixed 
at the MII stage. 
 Testis material was obtained after testicular spermatozoa extraction from a man (age 47) of proven 
fertility with previous vasectomy and subsequent vaso-vasostomy that did not succeed. Remnant 
cellular material was used. A Johnson score of 9.5 (range 9-10) was determined at the pathology 
department of the Radboud University Nijmegen Medical Center. The patient signed an informed 
consent for participation in a project approved by the Dutch Central Committee on Research 
Involving Humans Subjects (CCMO – NL12408.000.06).
Collection of human embryos
Under Dutch law, embryos are not allowed to be created for research. Therefore, human embryos are 
only available for research after embryo selection for transfer or cryopreservation. Exceptions to this 
rule are embryos resulting from abnormal fertilization, i.e. oocytes fertilized by two spermatozoa 
simultaneously or where the second polar body failed to extrude. Evaluation of the number of 
pronuclei 18-20h after insemination allows identification of such embryos, characterized by the 
presence of three pronuclei. This is observed in ~4% of all inseminated oocytes. To avoid potential 
triploid pregnancies these embryos normally are discarded [48]. We used triploid (3PN) embryos 
as a model for embryo development during the first cleavage divisions. Surplus good quality 
cryopreserved preimplantation embryos were used to study embryo developmental stages from 
day 3 to day 5 (Figure 1). Tripronuclear zygotes and surplus embryos were donated with written 
informed consent by couples undergoing routine IVF at the Erasmus MC University Medical Centre in 
the period between March and July 2010 and November 2000 and December 2007, respectively. The 
use of both types of surplus embryos was approved by the Dutch Central Committee on Research 
Involving Human Subjects (CCMO – NL28739.000.09) and the local institutional ethics committee. 
 Embryo culture and assessment of embryo morphology were performed as described previously 
[47]. Cryopreservation was performed in straws using a slow freezing standard protocol of 1.5 M 
dimethyl sulfoxide (DMSO) in culture medium containing 10% GPO (human plasma solution, CLB), 
as described previously [8]. Women donating cryopreserved embryos were aged between 29-41. 
A total of 90 embryos were thawed and 44 survived after consecutive washes in decreasing DMSO 
concentrations. Day 3 (8 cell) embryos were processed within 2 h after thawing. Early day 4 embryos 
(12-16 cell embryos) were randomized for either immediate processing, or culture until late day 
4 (fully compacted morulas) or day 5 (blastocysts). After randomization, embryo morphology 
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was evaluated. Only those of good morphological quality and showing the stage-appropriate 
characteristics were used to avoid a selection bias in embryo quality. 
in 
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Figure 1 — Schematic representation of the stages of oocyte and embryo development used in this 
study. MI and MII oocytes were fixed on the day of retrieval (day 0), or MI oocytes were left to mature to MII 
overnight. After fertilization, tripronuclear (3PN) zygotes were fixed at prometaphase of the first embryonic 
mitotic division or allowed to develop until 2 cell or 4 cell stage. Good quality diploid (2PN) 8 cell embryos or 
morulas that had been cryopreserved on day 3 or day 4 respectively, were thawed and immediately fixed or 
left in culture until reaching 12-16 cell, morula, or blastocyst stage.
Single oocyte and embryo RT-qPCR 
Quantification of mRNA levels was performed in individual single oocytes and preimplantation 
embryos of nine developmental stages (Figure 1): oocytes at MI (n=2) and MII (n=5), abnormally 
fertilized oocytes with three pronuclei (3PN; n=13), 2 cell embryos (3PN- 2 cell; n=10) and 4 cell 
embryos (3PN- 4 cell; n=4), both resulting from tripronuclear zygotes, and 8 cell embryos (n=12), 
12-16 cell embryos (n=6), morulas (MOR; n=5), and blastocysts (BLAS; n=10), all good quality 
embryos cryopreserved at days 3 and 4 (Figure 1). For single oocyte/ embryo RT-qPCR, the Taqman® 
PreAmp Cells-to-Ct Kit (Applied Biosystems) was used according to the manufacturer’s protocol with 
minor adjustments. The zona pellucida was removed from the oocytes and embryos by incubation 
in 0.1% protease (Sigma) in G-MOPS Plus medium (Vitrolife) for 3 min, prior to washing in G-MOPS 
Plus medium and 1X PBS. Lysis was performed for 5 min in 20 μl Taqman® PreAmp Cells-to-Ct lysis 
solution and terminated by addition of 2 μl of stop solution. After 2 min of incubation the lysate 
was stored at -20°C until further processing within one week. RNA was reverse transcribed to cDNA 
within an hour at 37°C by adding 25 μl of 2X RT Buffer and 2.5 μl of 20X RT Enzyme Mix to each 
lysate, prior to inactivating the enzyme for 5 min at 95°C. For sequence-specific preamplification 
of cDNA, Taqman Gene Expression Assays (Assays-on-demand, Applied Biosystems) were pooled 
and diluted 1:100 with 1X TE buffer (10 mM Tris-HCl, 5 mM EDTA; pH 7.5) to a final concentration of 
180 nM of each primer. The following assays were used: HPRT1 (Assay ID: Hs99999909_m1; amplicon 
size 100bp), AURKB (Hs00177782_m1; 130bp), AURKC (Hs00152930_m1; 91bp), Borealin (CDCA8; 
Hs00216479_m1; 127bp), Survivin (BIRC5; Hs00153353_m1; 93bp), INCENP (Hs00220336_m1; 62bp), 
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BRG1 (SMARCA4; Hs00231324_m1; 106bp) and ZP3 (Hs00610623_m1; 74bp). Assays were selected to 
recognize all validated (RefSeq) splice variants of each gene of interest, except for assays for INCENP 
(recognizing only NM_020238.2) and BIRC5 (recognizing NM_001012271.1 and NM_001168.2). To 
12.5 μl cDNA, 25 μl Taqman® PreAmp Master Mix and 12.5 μl of 0.2X pooled Taqman® Gene Expression 
Assays were added. After 10 cycles of preamplification (10 min at 95°C, followed by 10X 15 sec at 
95°C and 4 min at 60°C), the preamplified cDNA (50μl) was diluted with 100 μl 0.5X TE buffer. QPCR 
was performed on an ABI Prism 7000 Sequence Detecting System (Applied Biosystems) using 10μl 
2X Taqman® Gene Expression Master Mix, 1 μl Taqman® Gene Expression Assay and 5 μl nuclease-
free water added to 4μl diluted preamplified cDNA. The 2-step cycling parameters were as follows: 
one cycle of 2 min at 50°C, followed by one cycle of 10 min at 95°C to activate the polymerase and 
40 cycles of 15 sec at 95°C and 1 min at 60°C.
 Results were analyzed using Sequence Detection Software version 1.2.3 (Applied Biosystems) and 
expressed as cycle threshold (Ct) values. Presence of a single PCR-product of expected amplicon size 
was verified by 2% agarose gel electrophoresis. In order to be able to use a relative quantification 
approach to compare expression levels of AURKB and AURKC, we ensured that these commercial 
assays have similar amplification efficiencies, within the limits set by the supplier (E=100±10%). 
Additionally, linearity during the preamplification reaction was tested on a series of 1:2 diluted cDNA 
from oocytes and blastocysts. The averaged expression level at the MII oocyte stage was used as 
a reference to calculate the relative levels in all other stages, according to the 2-ΔCT method [49]. 
Differences in AURKB and AURKC expression across developmental stages were analyzed using the 
Mann-Whitney test in SPSS version 17.0. A p-value of 0.05 was considered statistically significant. To 
compare expression levels of AURKB directly to expression levels of AURKC, the relative expression 
for AURKB was calculated using AURKC as a reference. 
Antibodies
The following antibodies were used in this study: rabbit polyclonal antibodies against AURKC 
(ab38299, 1:100; Abcam), H3S10p (1:10,000; Cell Signalling), INCENP (1:1,000; Sigma), Borealin 
(1:2,000; kindly supplied by S. Wheatley, University of Nottingham Medical School, Nottingham, 
UK), Survivin (1:2,000, R&D Systems) and GFP (S.M.A. Lens, University Medical Centre Utrecht, The 
Netherlands). Mouse monoclonal antibodies against AURKB (1:250; BD Biosciences) and INCENP 
(1:1,000, Upstate). Human autoantibodies against the centromere (CREST, HCT-0100, 1:100, 
Immunovision and 1:2,000, Cortex Biochem). Primary antibodies were detected by labelling with 
the appropriate secondary antibodies conjugated with Alexa fluor 488, 555, 594 or 647 (Molecular 
Probes).
Overexpression of Aurora A, B and C kinase in U2OS cells
Human osteosarcoma cells (U2OS) were grown at 37°C with 5% CO2 in DMEM containing 6% FCS, 
glutamine, penicillin and streptomycin. Transfections were performed using a standard calcium 
phosphate protocol. U2OS cells were co-transfected with 1μg empty GFP vector, GFP-AURKA, GFP-
AURKB or GFP-AURKC together with an empty pcDNA3 vector (9 μg). Cells were first synchronized 
at the G1/S transition by incubation for 24 h with 2.5 mM thymidine and later arrested in mitosis by 
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incubation for 18 h with nocodazole (250 or 25 ng/ml; for harvesting or fixation of cells, respectively). 
Cells were harvested or fixed and used for cell lysis or immunofluorescence. Cell lysis and Western 
blotting was performed as described previously [50] and immunoprobed with anti-Aurora B and -C 
antibodies (1:250 and 1:500).
 For immunofluorescence, U2OS cells were grown on slides and fixed with PFA buffer (4% w/v PFA 
in PBS). The slides were washed in PBS and dehydrated with ice-cold methanol. Subsequently, cells 
were blocked with 3% (w/v) BSA in PBS-T (PBS, 0.01% v/v Tween-20) for 30 min at RT, and incubated 
with anti-Aurora C and CREST antibodies overnight at 4°C. Slides were washed three times in PBS-T 
and then incubated with secondary antibodies for 1-2 h. After rinsing in PBS-T, slides mounted with 
vectashield containing DAPI for counterstaining (Vector Laboratories).
Fixation and immunofluorescence of spermatocytes
Nuclear spreads were made as described previously [51], with minor modifications [52]. Briefly, a 
suspension of spermatogenic cells was made by pulverizing the testis tubuli with two ribbed 
forceps. After hypotonic treatment, cells were resuspended in 100 mM sucrose, pH 8.2 to obtain a 
cell concentration of about 15x106 cells/ml. From this suspension 10 μl was applied to a slide dipped 
in 1% (w/v) PFA solution, containing 0.15% (v/v) Triton X-100. After horizontal drying for 1.5 h in a 
humid chamber, slides were washed twice with 0.08% Kodak Photo-Flo and air-dried. Slides were 
stored at -80°C until use. 
 Surface spread preparations were processed for immunofluorescence as described [52]. Meiotic 
prophase I stages were approximated by DAPI staining annex nuclear morphology as based on 
previous experience with the synaptonemal complex marker SYCP3 (de Vries et al., unpublished 
results). Early and late pachytene substages were distinguished by the more prominent DAPI 
intense sex body present in late pachytene. Metaphase nuclei were recognised by separate bivalent 
chromosome domains and the absence of a DAPI intense sexbody. At least 50 early first meiotic 
division nuclei (leptotene, zygotene) and 100 pachytene nuclei were studied, as well as 5 first 
metaphase nuclei. Images were captured with a Zeiss AxioCam MR digital camera with Axiovision 
3.1 software, using a Zeiss Axioplan fluorescence microscope (all Carl Zeiss).
Fixation and immunofluorescence of oocytes and embryos 
MI and MII oocytes were incubated with nocodazole (500 ng/ml, Sigma) for 30 min before fixation. 
Tripronuclear zygotes were incubated with colcemid (1,5 µg/ml) to arrest cells at prometaphase 
until pronuclei had disappeared. Good quality day 4 and 5 embryos were treated with nocodazole 
(500 ng/ml) for 4 h before fixation. 
 Oocytes and embryos were incubated in 0.1% Protease in G-IVF Plus medium (1-2 min) for removal 
of the zona pellucida and washed in G-IVF Plus medium. Fixation was performed as previously 
described, with minor modifications [53]. In short, cells were fixed in PFA buffer for 15 min at RT. 
After fixation, oocytes/embryos were rinsed in PBS-T and incubated with 0.2% (w/v) Triton X-100 
in PBS for 15 min at RT for permeabilization. Oocytes and embryos were washed in PBS-TB (PBS-T, 
2% w/v BSA), blocked with PBS-TB/ 5% NGS for 4h and incubated with primary antibodies at 4°C 
overnight. After washing with PBS-TB, oocytes and embryos were incubated with the appropriate 
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secondary antibodies conjugated with Alexa Fluor 488, 555, 594 or 647 (Invitrogen), washed with 
PBS-TB, and mounted on coverslips with vectashield mounting solution containing DAPI for DNA 
counterstaining (Vector Laboratories). To obtain chromosome spreads, arrested zygotes and day 4 
embryos were (after zona removal) submitted to the same hypotonic treatment as spermatogenic 
cells. After brief transfer to 100 mM sucrose, cells were placed on a slide dipped in a 1% (w/v) PFA 
solution, containing 0.15% (w/v) Triton X-100. Slides were dried and processed as described for 
spermatogenic cell surface spreads. 
 Images were obtained using a Delta Vision microscope and deconvolution software (Applied 
Precision) or with an AxioCam MR digital camera with Axiovision 3.1 software, using an inverted Axio 
Observer fluorescence microscope equipped with an ApoTome (all Carl Zeiss) for optical sectioning.
Results
Aurora C kinase is detected in human male and female meiotic cells
A commercially available polyclonal antibody against Aurora C, raised against a synthetic peptide 
corresponding to amino acids within residues 1-50 of Human Aurora C was used. To confirm 
that this antibody does not cross-react with the other Aurora kinases, specificity was tested by 
immunofluorescence on U2OS cells overexpressing GFP-AURKA, GFP-AURKB and GFP-AURKC 
(Supplemental Figure 1a). The antibody did not detect Aurora A or B, but co-localized with the GFP-
signal for Aurora C. We further tested the specificity of anti-Aurora C antibody using immunoblots on 
lysates of GFP-AURKA, -B and -C transfected U2OS cells. The antibody did not recognize GFP-AURKA 
or GFP-AURKB, but detected GFP-AURKC (Supplemental Figure 1b).
 Since Aurora C is reported to be highly transcribed in mouse spermatocytes [27,29], the staining 
pattern and intensity of Aurora C was first studied in human primary spermatocyte nucleus 
spread preparations. From leptotene to early pachytene a faint, evenly distributed, dotted Aurora 
C kinase signal was observed (not shown). In later pachytene nuclei the Aurora C signal localized 
to chromosome regions adjacent to the centromeres (CREST antigen), probably reflecting the 
centromeric heterochromatin regions (Figure 2a). In early meiotic metaphase nuclei the Aurora 
C signal was more dispersed over the chromosomes and not solely localized to the centromeric 
heterochromatin regions as in late pachytene (Figure 2b). However, more intense spots surrounded 
the centromeric signal (Figure 2b, see insert). 
 We next investigated the localization of Aurora C during human female meiosis in MI and MII 
oocytes. MI oocytes were available 4-6 h after oocyte retrieval if they had failed to progress to the 
MII stage by the time the ICSI procedure was completed. As a consequence, synchronization was not 
optimal and oocytes could be at any stage between early prometaphase and metaphase of meiosis 
I. MI oocytes (n=13) were treated with nocodazole for 30 min and fixed immediately. We detected 
Aurora C along the chromosome arms in some oocytes, but in other MI oocytes, Aurora C signal 
was observed to localize near the centromere (Figure 2c). This is consistent with Aurora C staining 
recently described in mouse oocytes for prometaphase I and metaphase I, respectively [34]. In all MII 
oocytes (n=19), Aurora C staining was observed to localize to the chromosome regions adjacent to 
the centromeres (Figure 2d) and only weakly along the chromosome arms. 
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Figure 2 — Immunolocalization of Aurora C in human primary spermatocytes and MI and MII oocytes. 
(a) Late pachytene spermatocyte nucleus, with Aurora C visible in concentrated clouds of various sizes. The 
merged image shows Aurora C localized adjacent to the centromeres (CREST antigen). (b) MI spermatocyte. 
Aurora C is not solely localized to the centromeric heterochromatin regions as in late pachytene, but also 
visible throughout the chromosome domains. In most of the dispersed clouds of Aurora C two intense 
spots colocalize with the centromeres (arrow heads). (c-d) MI and MII oocytes, with antibody staining for 
Aurora B and C and centromeric regions (CREST). (c) In MI oocytes, Aurora C was observed in a diffuse pattern 
surrounding the centromeres. (d) In MII oocytes, Aurora B localized more to the centromere, while Aurora C 
was observed in a more diffuse pattern surrounding the centromeres. DNA was counterstained with DAPI. 
Square boxes are blowups of each corresponding smaller box. Scale bars are 5 μm. 
Aurora B staining was also investigated together with Aurora C in MI and MII oocytes. In all MI 
oocytes investigated (n=10), Aurora B staining was either not detected, or observed very weakly 
at chromosome regions adjacent to the centromeres (Figure 2c). In three MII oocytes, Aurora B 
staining showed a more intense signal than Aurora C (data not shown), but in most MII oocytes 
(n=12), Aurora B staining was less intense than Aurora C (Figure 2d), with some oocytes showing 
no staining for Aurora B. This suggests that during female meiosis, both Aurora B and Aurora C are 
involved. However, in meiosis I Aurora B is hardly detected, while in meiosis II both kinases are found.
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mRNA expression and protein localization of INCENP, survivin and Borealin in human 
oocytes and embryos
To investigate if the CPC proteins INCENP, Borealin and survivin are expressed and functional in 
human oocytes and embryos, we first examined mRNA expression of these subunits in multiple 
individual oocytes and embryos of seven different preimplantation developmental stages (Figure 1). 
Normalization of gene expression is especially challenging in preimplantation embryos. Due to the 
absence of active transcription in the early embryo followed by activation of embryonic transcription 
later on, finding a reference gene with stable expression throughout all stages of development is 
problematic [54,55]. In rabbit embryos, where embryonic genome expression is activated at the 
same developmental stage as human embryos, HPRT1 was shown to be a suitable reference gene for 
preimplantation development, when in vivo and in vitro produced embryos are compared [55]. We 
found HPRT1 to be highly regulated during embryo development (Supplemental Figure 2a), similar 
to the pattern described for rabbit embryos [55]. Therefore, resulting gene expression levels were 
normalized using average expression levels of the gene in the metaphase II oocyte as a reference. As 
this method of normalization is not informative for the abundance of transcripts, average Ct values 
are presented for each gene investigated per developmental stage (Supplemental Table 1). 
 The expression levels of zona pellucida protein 3 (ZP3) and SWI/SNF related, matrix associated, 
actin dependent regulator of chromatin, subfamily a, member 4 (SMARCA4) were determined to 
further check the sensitivity of our single oocyte/ embryo RT-qPCR approach. ZP3 expression is 
expected to be maternal only [56]. Our results demonstrate high expression in oocytes and a steady 
decrease in transcript levels until barely detectable at the blastocyst stage (Supplemental Figure 
2b). SMARCA4 has been described to be present as a maternal transcript [57] and subsequently to be 
one of the first genes transcribed after zygotic gene activation in mouse embryos [58]. In our series, 
expression of this gene was shown to decline from the oocyte to the 8-cell stage and then showed 
an increased expression from the 8 cell stage onwards (Supplemental Figure 2c). This confirms 
that transcripts detected up to the 8 cell stage are likely maternal, and activation of the embryonic 
genome occurring from the 8 cell stage on [44]. 
 Normalized expression levels of INCENP, Survivin (BIRC5) and Borealin (CDCA8) were compared 
between the nine different stages of oocyte and preimplantation embryo development (Figure 3a-
c). Transcript abundance for INCENP was low in oocytes and embryos up to the 8 cell stage, after 
which an increase occurred, starting at the 12-16 cell stage, with significant upregulation at the 
blastocyst stage (Fig.ure 3a). Survivin and Borealin both showed a high transcript level at the MI 
oocyte stage, decreasing gradually until the 8 cell stage and increasing towards the morula and 
blastocyst stage (Figure 3b, c).
 To investigate expression of these CPC subunits at the protein level, human oocytes and 
tripronuclear zygotes treated with nocodazole or colcemid were immunostained for INCENP, Survivin 
and Borealin. In both oocytes (data not shown) and zygotes (Figure 3d-f ), each CPC protein was 
detected at the inner centromere in prometaphase and in a zygote escaping the nocodazole block, 
INCENP was also detected at the spindle midzone (Figure 3d’). These observations are consistent 
with findings in somatic mitotic cells. As INCENP forms the binding factor between the enzymatic 
subunit and Survivin and Borealin [18], double staining for Aurora C and INCENP was performed. 
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Figure 3 — Expression of the CPC members INCENP, Survivin and Borealin in human oocytes and 
preimplantation embryos. Relative expression levels after RT-qPCR of (a) INCENP, (b) BIRC5 (Survivin) and 
(c) CDCA8 (Borealin) in single oocytes and preimplantation embryos of nine developmental stages: oocytes 
at MI (n=2) and MII (n=5), zygotes (3PN, n=13), 2-cell embryos (3PN- 2 cell, n=10), 4-cell embryos (3PN- 4 
cell, n=4), 8-cell embryos (n=12), 12-16-cell embryos (n=6), morulas (MOR, n=5), and blastocysts (BLAS, 
n=10). The mean expression level at the oocyte MII stage was taken as a reference to calculate the relative 
levels of the other stages. Note the scale of the y-axis differs. Boxes indicate 25th and 75th percentiles, with 
the horizontal line representing the median value. Whiskers span the range observed, open circles and 
asterisks represent outliers. Stages with average expression levels significantly different from the zygote 
stage (a) and the 8 cell stage (b) are indicated (p<0.05). (d-h) Immunolocalization of CPC proteins in human 
tripronuclear zygotes at prometaphase: INCENP (d), Survivin (e) and Borealin (f) relative to centromeres 
(CREST). (d’) INCENP relocalization to the midzone during anaphase. (g) Immunolocalization of Aurora C 
and INCENP in human tripronuclear zygotes showing colocalization of Aurora C and INCENP at the inner 
centromere. (h) Immunolocalization of H3S10p along the chromosome arms in human tripronuclear zygotes 
at prometaphase. Zygotes used for immunostaining were arrested in prometaphase after treatment with 
nocodazole. DNA was counterstained with DAPI. Square boxes are blowups of each corresponding smaller 
box. Scale bars are 5 μm.
These two proteins co-localized on the inner centromere of prometaphase chromosomes in zygotes 
(Figure 3g). To investigate CPC function in these human zygotes, immunostaining with a H3S10p 
antibody was performed. This phosphorylation site is known to be targeted by active Aurora B, 
as well as Aurora C [37,41,43]. Histone H3S10 was phosphorylated along the chromosome arms, 
as previously described for somatic mitotic cells. These results suggest that a functional CPC is 
assembled in human oocytes and zygotes. 
Expression of AURKB and AURKC in human oocytes and preimplantation embryos
Aurora C has been described to fully compensate for loss of Aurora B as the enzymatic subunit of 
the CPC [40]. In oocytes, we detected both kinases in prometaphase of meiosis II (Figure 2). We 
therefore investigated the presence of Aurora B and Aurora C in human preimplantation embryos. 
First, mRNA expression of these kinases in nine different stages of oocyte and preimplantation 
embryo development was examined. AURKB mRNA levels were similar in MI and MII oocytes and 
then steadily decreased until the 8 cell stage, but increased significantly from the morula stage 
onwards (Figure 4a). AURKC mRNA levels were highest in MI oocytes and significantly decreased 
until the 4 cell stage. A gradual increase was observed starting from the 8-cell stage, with the morula 
stage reaching levels similar to the zygote. Subsequently, expression sharply decreased, until barely 
detectable at the blastocyst stage (Figure 4b). To better visualize differences in AURKB and AURKC 
expression patterns, the ratio between AURKB and AURKC was used. Both assays were verified to yield 
linear pre-amplification, as well as similar amplification efficiencies, enabling a direct comparison of 
transcript abundance in single oocytes and embryos. Plotting the levels of AURKB mRNA relative to 
levels of AURKC mRNA (Figure 4c) shows comparable levels of transcripts for AURKC and AURKB up 
to day 4 of embryo development, with an exception at the 4-cell stage, where AURKC transcripts 
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Figure 4 — Expression of AURKB and AURKC in human oocytes and preimplantation embryos. Relative 
expression levels after RT-qPCR of (a) AURKB and (b) AURKC in single oocytes and preimplantation embryos 
of nine developmental stages: oocytes at MI (n=2) and MII (n=5), zygotes (3PN, n=13), 2-cell embryos (3PN- 
2 cell, n=10), 4-cell embryos (3PN- 4 cell, n=4), 8-cell embryos (n=12), 12-16-cell embryos (n=6), morulas 
(MOR, n=5), and blastocysts (BLAS, n=10). The mean expression level at the oocyte MII stage was taken as a 
reference to calculate the relative levels of the other stages. Note the scale of the y-axis differs. Stages with 
average expression levels significantly different from the zygote stage (a) and the 8-cell stage (b) are indicated 
(p<0.05). (c) Relative expression of AURKB over AURKC for all developmental stages. (d-h) Immunolocalization 
of Aurora B and C relative to centromeres (CREST) in human preimplantation embryos: (d) haploid set of 
chromosomes in a tripronuclear zygote, (e) triploid 4-cell embryo, (f-g) diploid 12-16-cell embryo and (h) 
blastocyst. In zygotes (d) and 4-cell embryos (e) only Aurora C was detected near centromeric regions. In 
12-16-cell embryos, relative intensity of Aurora B and C was variable, but in blastocysts only Aurora B was 
abundant around the centromere and in small amounts on the chromosome arms. All embryos used for 
immunostaining were arrested in prometaphase. DNA was counterstained with DAPI. Square boxes are 
blowups of each corresponding smaller box. Scale bars are 5 μm.
are more severely depleted. After the 8 cell stage, AURKB expression increases rapidly, and together 
with the severe reduction of AURKC transcription by the blastocyst stage, results in a 16-fold higher 
expression of AURKB on day 5. 
 We next investigated the presence and localization of Aurora B and Aurora C in human 
preimplantation embryos. We performed triple immunolabeling for Aurora B, Aurora C and 
centromeric proteins in tripronuclear zygotes (n=17), 2 cell (n=4) and 4 cell (n=4) embryos from 
tripronuclear origin, as well as in good quality 8 cell (n=7), 12-16 cell embryos (n=10), and blastocysts 
(n=4). Aurora C was localized near the centromeres of prometaphase chromosomes from the 
zygote to the 12-16-cell stage (Figure 4d-f ). In contrast, Aurora B was barely detectable up to the 
8-cell stage. From the 8 cell stage onwards, staining intensity increased, with both Aurora B and 
C detected at prometaphase (Figure 5b) and one example where only Aurora B was detected. In 
12-16-cell embryos, the ratio between Aurora B and C signal intensity was variable (Figure 4d-h). In 
most embryos, both kinases were found to co-localize at the centromeric regions (Figure 4f ), but in 
one example only Aurora C was detected (data not shown). Other embryos revealed very little or no 
detectable Aurora C staining, but abundant Aurora B around the centromere and in small dispersed 
amounts along the chromosome arms (Figure 4g). In 23 prometaphases from 4 blastocysts, only 
Aurora B was found and abundantly present (Figure 4h).
 To investigate in more detail if Aurora B and Aurora C proteins co-localize at prometaphase, 
chromosome spreads from tripronuclear zygotes, as well as diploid 8 cell and 12-16 cell stage 
embryos treated with colcemid or nocodazole were prepared, allowing higher resolution images 
(Figure 5a-c). On prometaphase chromosomes from zygotes, Aurora C staining was observed on 
the chromosome region surrounding the centromere and along the chromosome arms (Figure 5a). 
Aurora B staining was only weakly detected and more localized to the centromeric region. In 8-cell 
and 12-16-cell embryos, staining intensity of Aurora B and C was observed to be more similar, as was 
the localization of the signal (Figure 5b and c).
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Figure 5 — Immunolocalization of Aurora B and Aurora C on chromosome spreads from preimplantation 
human embryos: (a) tripronuclear zygote, (b) 8-cell embryo and (c) 12-16-cell embryo. In zygotes (a), Aurora 
C signal was abundant at centromeric regions and dispersed along the chromosome arms, whereas Aurora 
B was weakly detected at the inner centromere. In 8-cell (b) and 12-16-cell (c) embryos, relative abundance 
and localization of Aurora B and -C was similar. Embryos were arrested in prometaphase after treatment with 
colcemid. DNA was counterstained with DAPI. Square boxes are blowups of each corresponding smaller box. 
Scale bars are 5 μm.
Although expression of AURKB mRNA was detected from the zygote to the 4-cell stage, Aurora B 
protein was weakly or not observed on prometaphase chromosomes. Immunofluorescence analysis 
from the 8-cell stage onwards confirms our observations at the mRNA level, with a joint performance 
for Aurora B and C from the 8 cell to the morula stage. After cavitation there is a progressive switch 
to Aurora B and at the blastocyst stage, Aurora B appears to be the only kinase involved in the CPC.
Discussion
In this study, we analyzed localization of the different members of the CPC in human oocytes and 
preimplantation embryos, with a focus on the kinase subunits Aurora B and Aurora C. Contrary to 
INCENP, Survivin and Borealin that were detected in all stages investigated, Aurora B and C showed 
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dynamic expression patterns at both the in situ protein and transcript level. We hypothesized a 
role for Aurora C during mitosis in the early stages of embryo development. Here we show that 
Aurora C is indeed the more prominent Aurora kinase present in cleavage stage embryos, based 
on fluorescent staining intensity at prometaphase in zygotes, 2 cell and 4 cell embryos (Figure 4d,e; 
Figure 5a). Aurora B was either not detected, or expressed at significantly lower levels than found 
from the 8-cell stage onwards (Figure 4d-h). Although we did detect Aurora B transcripts, we did 
not observe significant amounts of protein on prometaphase chromosomes in zygotes, 2 cell and 
4 cell stage embryos. Similarly, in mouse oocytes, although AURKB mRNA was present, western blot 
analysis failed to detect Aurora B, indicating regulation of expression at the translational level [34]. 
 Since Aurora C overexpression can completely restore cell cycle progression in Aurora B deficient 
HeLa cells [40], Aurora C may be able to replace Aurora B and perform the same essential functions 
in cleavage stage embryos. Nevertheless, although Aurora B and Aurora C show high sequence 
similarities, structural differences exist [26]. The N- and C-terminal domains of Aurora C exhibit 
unique sequences and Aurora C lacks the so-called KEN-box and A-box sequences which target 
Aurora B for degradation via the anaphase-promoting complex/cyclosome (APC/C) after mitosis 
[59]. This implies that Aurora C is less susceptible to degradation, thus more stable throughout the 
cell cycle. In line with this, Aurora C protein levels were observed to peak after Aurora B during the 
later part of the M-phase [37]. Thus, as the first embryonic cell cycles lack active transcription, there 
might be a need for an Aurora kinase that is independent of degradation at the end of M-phase, but 
with otherwise overlapping functions. However, our data also suggests a possible complementary 
role of Aurora B and C during the first embryonic cell divisions. Aurora C was observed to cover 
a larger area on zygotic prometaphase chromosomes, whereas Aurora B was more constricted to 
the centromeric regions. Although we can not exclude the possibility that Aurora B is present on 
the chromosome arms at amounts that fall below detection levels, similar observations regarding 
differences in Aurora B and C localization have been made in mouse MI oocytes [35,60]. This suggests 
that Aurora C may have a role during the first embryonic cell cycle that does not overlap with Aurora 
B. The observed association of Aurora C with pericentric heterochromatin in spermatocytes leads us 
to hypothesize that this function could be related to pericentric heterochromatin organization, an 
hypothesis that awaits further investigation. 
 We expected that the expression pattern of AURKC would be similar to ZP3, with maternal 
transcripts gradually disappearing during embryo development, to be replaced by AURKB after 
activation of the embryonic genome. However, we observed a brief upregulation of transcription 
of AURKC after embryonic gene activation, reaching similar levels as AURKB. The presence of both 
kinases was also detected on the protein level, but with a variation in staining intensity between day 
3 and 4 (Figure 4f, g). Our data indicate that a switch in the Aurora B to Aurora C ratio is gradually 
made on day 4 of embryo development, and that Aurora B is the chromosomal passenger of choice 
only after cavitation. 
 Due to ethical limitations, we used embryos developed from tripronuclear zygotes as a model 
for embryo development up to the 4-cell stage. In human embryos, the first cleavage divisions 
are maternally directed until activation of the embryonic genome [44] and it is therefore unlikely 
that the extra set of chromosomes present has an impact on expression and localization of CPC 
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proteins in those early stages. Further in support of our findings on the presence of Aurora C during 
preimplantation embryo development, a recent study on mouse embryos carrying a targeted 
disruption of the AURKB gene showed that these embryos were able to develop up to the blastocyst 
stage (Fernandez-Miranda et al., personal communication). This is in contrast to mouse embryos that 
lack other components of the CPC, which are unable to progress beyond the cleavage stages [61-63]. 
Fernandez-Miranda et al. (personal communication) demonstrated that Aurora C was responsible 
for compensating loss of Aurora B function. 
 Although findings in most embryos investigated by us are consistent with an increase in the Aurora 
B/ Aurora C signal ratio from day 3 to day 4, we observed one prometaphase cell in a day 3 embryo 
showing clear Aurora B staining around the centromeres with no Aurora C, and the opposite in a day 
4 (12-16 cell) embryo (data not shown). These variations are also visible at the mRNA level (Figure 
4c) and may be related to a variation in timing and extent of activation of the embryonic genome. 
In human embryos, this is reported to start between the four- and eight cell stages of development 
[44], with a major outburst of transcription occurring at the 8 cell stage [45]. However, human 
IVF embryos have been shown to demonstrate a lack of synchronicity in making the switch from 
maternal to embryonic gene activity [64]. It was further observed in human and bovine embryos 
that development to the morula stage is possible without activation of the embryonic genome [64-
66], but these embryos lack the ability to form a blastocyst [64,66]. 
 In a previous study by us on the incidence of chromosomal abnormalities in human IVF embryos, 
we reported the proportion of aneuploid cells within an embryo to decline after cavitation [8]. This 
coincides with the time of disappearance of Aurora C mRNA and protein at the inner centromere 
we observe here. It is tempting to speculate that the presence of Aurora C may contribute to the 
observed high incidence of chromosome segregation errors during embryo development before 
compaction. However, Aurora C was shown to be able to fully compensate for the absence of Aurora 
B in mediating SAC function, as measured by cell cycle progression in HeLa cells [37,40] and mouse 
preimplantation embryos (Fernandez-Miranda et al., personal communication). A possible cause for 
the high error rate may be found in the variation in the Aurora B to Aurora C ratio between embryos 
as observed in this study. Ectopic overexpression of Aurora B in cell lines results in polyploidy [67] 
and over-expression of Aurora B has been shown to be associated with cancer cell lines and primary 
tumors [67,68], indicating that tight regulation of Aurora B expression levels is crucial for accurate 
chromosome segregation. Moreover, overexpression of an Aurora C kinase-deficient mutant disrupts 
the Aurora B-INCENP complex and induces polyploidy [69], and overexpression of Aurora C has been 
reported in several cancer cell lines [70]. So the question arises if maintaining the correct balance in 
expression of both kinases, before and after activation of the embryonic genome, is the underlying 
problem causing chromosome segregation errors.
 Aurora C has already been described as an important kinase during human male meiosis [31], 
where lack of functional Aurora C severely disrupts the meiotic process. In the current study, we 
describe for the first time localization of Aurora C to the region surrounding the centromeres in 
human spermatocytes. Aurora C associates with pericentric heterochromatin during pachytene, 
then spreads onto the chromosome arms at diakinesis and condenses at the centromeres again at 
metaphase. In mouse spermatocytes, Aurora C has been described to appear at the diplotene stage 
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(an extremely short stage in the human male), following a similar pattern [28]. Our observations 
are also consistent with the phenotype observed in male patients carrying the Aurora C kinase 
c.144delC mutation [32] and a functional role for Aurora C during human male meiosis.
 In agreement with the high mRNA expression of Aurora C reported in human oocytes [33], we 
also observed Aurora C on the region surrounding the centromeres in MI and MII oocytes. Although 
timing of fixation in these human oocytes can not be performed optimally due to ethical reasons, our 
observations are similar to those recently described in mouse oocytes [34], pointing to a conserved 
role for Aurora C in female mammalian meiosis. However, this function may be partly redundant in 
human oocytes, as the two female homozygous AURKC mutants are apparently fertile and without 
further phenotypes [32]. We also detected Aurora B transcripts in human IVF oocytes, although at 
a lower level than Aurora C. On (pro)metaphase chromosomes in MI oocytes, signal intensity of 
Aurora C was greater than Aurora B (Figure 2c), whereas in MII oocytes this signal ratio was more 
variable. Evidence in mouse as to the relative importance of Aurora B and C during meiosis I and II 
are contradictory [34-36]. The interpretation of these studies is complicated by the lack of specific 
inhibitors for Aurora B and C, as well as the possibility of the two kinases binding to each other in vivo 
[41]. Thus overexpression of a kinase dead form of one kinase may affect functioning of the other 
[69]. To complicate matters further, polymorphisms in the mouse AURKC gene that result in an amino 
acid sequence change have been described in inbred strains [29], underscoring the need for proper 
knockout models. However, taken together, the evidence indicates that there is room for plasticity 
in the balance of Aurora B and C in the female germline, with the two proteins able to compensate 
for each other. The fact that human male patients with a mutation in AURKC are sterile may indicate 
differences in this plasticity between the male and the female germline. 
 Interestingly, in rhesus macaque oocytes, Aurora B mRNA expression was observed to decrease 
significantly when IVM oocytes where compared to in vivo matured oocytes [71]. A similar observation 
was made in human oocytes [72], indicating that oocyte maturation conditions may contribute to 
regulation of Aurora B mRNA expression. In future studies it will be interesting to explore whether 
the variability in the levels of AURKB and AURKC we observe in the current study can be related to 
oocyte or embryo quality and patient characteristics, such as maternal age. 
 We set out to characterize the CPC in human preimplantation development, in order to identify 
causes for the observed high post-zygotic chromosome segregation error rate. Although known as 
a meiotic kinase, we present evidence that Aurora C is the main enzymatic subunit of the CPC during 
preimplantation embryo development up to the 8 cell stage, and continues to be present next to 
Aurora B during the compaction stage. This is in contrast to the constitution of the CPC in somatic 
mitotic cells, and indicates a role for Aurora C during preimplantation embryo development. Even 
though it is unlikely that the presence of Aurora C alone explains the high chromosome segregation 
error rate, the data presented here provide novel information regarding possible mechanisms. 
Further investigation of differences between Aurora B and C substrates and binding partners, as well 
as regulation of expression of these kinases before and after activation of the embryonic genome in 
relation to oocyte quality, may help identifying crucial factors.
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Supplementary Figure 1 — Validation of a rabbit polyclonal antibody against Aurora C (ab38299, Abcam). 
(a) Immunolocalization of AURKC and CREST on U2OS cells transfected with empty GFP vector, GFP-AURKA, 
GFP-AURKB and GFP-AURKC. GFP-tagged AURKA was localized on microtubules near the spindle poles, 
whereas GFP-AURKB and GFP-AURKC were detected on the inner centromere of prometaphase chromosomes. 
AURKC antibody did not recognize GFP, GFP-AURKA or GFP-AURKB, but recognized GFP-AURKC. (b) Western 
blot of U2OS cells transfected with empty GFP vector, GFP-AURKA, GFP-AURKB and GFP-AURKC. Cell lysates 
were immunoprobed with antibodies to GFP, AURKB and AURKC. We are unsure as to the identity of the extra 
bands detected by AURKC antibody. 
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Supplementary Figure 2 — Relative expression levels after RT-qPCR of (a) HPRT1, (b) ZP3 and (c) SMARCA4 
in single oocytes and preimplantation embryos of nine developmental stages: oocytes at MI (n=2) and 
MII (n=5), zygotes (3PN, n=13), 2-cell embryos (3PN- 2 cell, n=10), 4-cell embryos (3PN- 4 cell, n=4), 8-cell 
embryos (n=12), 12-16-cell embryos (n=6), morulas (MOR, n=5), and blastocysts (BLAS, n=10). The mean 
expression level at the oocyte MII stage was taken as a reference to calculate the relative levels of the other 
stages. Note the scale of the y-axis differs.
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Abstract
Immunofluorescence has been widely used to study histone modification dynamics and 
chromosome-associated proteins that regulate the segregation of chromosomes during cell divisions. 
Since many of these regulatory proteins interact (in)directly to exert their proper function, it is of 
interest to detect these proteins simultaneously, to establish their spatiotemporal relation. However, 
the detection of multiple epitopes on the same material is limited by the availability of antibodies 
derived from different host species. For Western blot membranes, buffers were developed to remove 
antibodies after the first round of detection and enable a second round of detection. In this study, 
we establish that this “stripping” principle can also be applied for sequential immunofluorescence on 
chromosome preparations. We first adapted a drying down fixation technique for the use on cultured 
cells from different primary cells and cell lines. These chromosome spreads were subsequently used 
to optimize the stripping procedure for this application. We investigated feasibility and reliability 
of detection of histones and their posttranslational modifications as well as chromatin interacting 
proteins in two subsequent rounds of immunofluorescence. We conclude that this method is a 
reliable option when spatial resolution and co-expression need to be investigated and the material 
or the choice of antibodies is limited.
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Introduction
Immunofluorescence is a powerful tool to investigate protein expression and localization. By 
using this technique, our understanding of histone modification dynamics and different classes 
of chromosome-associated proteins that mediate the segregation of chromosomes during both 
meiotic and mitotic cell division has increased dramatically. A problem that had to be overcome 
in order to study chromosomes and chromosome-associated proteins in detail was that most 
such proteins are lost from the chromosomes during the fixation process in the conventional 
cytogenetic procedure, using methanol/acetic acid. Therefore, chromosome-associated proteins 
have been studied in whole mount fixed cells or in cells fixed by a cytospin procedure [1,2]. However, 
the cytospin method results in reduced chromosome resolution compared with the cytogenetic 
procedure. Chromosome analysis after whole mount fixation needs expensive imaging equipment 
for either confocal analysis or deconvolution techniques [3]. Chromosomal analysis of oocytes and 
preimplantation embryos is especially challenging, because of their large cytoplasmic volume that 
results in increased background staining and problems with antibody accessibility [4]. To circumvent 
these problems, a fixation technique was described for mouse oocytes and early cleavage stage 
embryos, with the aim to obtain analyzable chromosome preparations [5]. This method was 
developed by adapting the protocol established by Peters et al. [6] for male and female germline cells 
and shown to preserve chromosome-associated proteins [5]. In this method, cells are incubated in 
a hypotonic solution and subsequently transferred to 1% paraformaldehyde (PFA) containing 0.2% 
Triton on a glass slide, resulting in cell lysis and spread fixation of the chromatin after drying down. 
The application of this protocol allows the study of chromosomes and attached proteins in detail 
and has thereby increased our insight into chromosome segregation regulation in both mouse and 
human oocytes and preimplantation embryos [7,8]. 
 Mounting evidence demonstrates the complex interplay between posttranslational histone 
modifications and protein complexes involved in regulation of chromosome segregation and 
mitosis, such as the chromosomal passenger complex (CPC) [9]. In order to further elucidate 
mechanisms that regulate these processes, it is of interest to detect these epitopes simultaneously 
on the same chromosome. In addition, when material under investigation is scarce and valuable, e.g. 
in case of surplus human oocytes or embryos from in vitro fertilization (IVF) treatments, it would be 
optimal to investigate as many epitopes as possible on the same preparation. However, detecting 
multiple proteins on the same material is limited by the availability of reliable antibodies raised in 
different host species. Most of the primary antibodies that work best for immunofluorescent studies 
are derived from either rabbit or mouse. 
 This difficulty is also known for Western blot procedures, for which “stripping” buffers were 
developed to remove the antibodies after detection and thereby enable a second round of detection. 
These buffers interfere with protein-protein interactions through high salt denaturing conditions, 
the use of detergent, or a low pH, without removing or damaging the epitope from the blotting 
membrane [10-12]. In this study, we aimed to evaluate the application of the stripping principle 
on chromosome spreads and investigate the feasibility of developing a protocol for sequential 
immunofluorescence. To this end, we first adapted the surface spreading protocol for the use on 
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cultured cells from different cell lines and species. We subsequently optimized the stripping protocol 
for this application and investigated reliability for different antibodies and antibody combinations. 
We further illustrate some possibilities this method can offer and critically discuss the limitations. 
We conclude that the method is a reliable option and offers a solution when spatial resolution and 
co-expression need to be investigated and the choice of antibodies is limited and/or when material 
is scarce.
Methods
Culture and collection of cells and germ cells 
We cultured two different cell lines and two types of primary cells under routine conditions as 
described earlier: murine teratocarcinoma-derived chondrogenic cells (ATDC5) [13,14], immortalized 
human foetal osteoblasts (hFOB1.19) [15], primary porcine articular chondrocytes (PAC), and human 
articular chondrocytes (HAC) [16]. Cells were arrested by incubation with 250ng/mL nocodazole 
(Sigma) for 2h or overnight and harvested by mitotic shake-off.
 Failed fertilized oocytes were donated for research 1 day post-insemination by patients undergoing 
IVF treatment at the outpatient clinic of the Department of Obstetrics and Gynaecology of the 
Erasmus MC, University Medical Center, Rotterdam, The Netherlands. Ovarian stimulation, oocyte 
retrieval and in vitro fertilization (IVF) procedures were performed as described previously [17].
Surface spreading of different cell types
Mouse spermatocytes were obtained from the testis of an FVB male and nuclear spreads were 
prepared as described previously [6,18]. The spreads were made available to us by W. Baarends, 
Rotterdam, The Netherlands. Cultured primary cells and cell lines were also treated as described 
[6], but with minor modifications [19]. In short, cells obtained after mitotic shake-off in culture 
medium containing nocodazole were spun down for 10 minutes at 200 g. Supernatant was removed 
to leave 1 mL of medium and cells were resuspended. An equal volume of a hypotonic buffer 
(pH 8.2) containing 30 mM Tris-HCl, 17 mM trisodium citrate dihydrate, 50 mM sucrose, and 5 mM 
ethylenediaminetetraacetate (EDTA) was added. After 7 minutes incubation and spinning down 
for 7 minutes at 200xg, all supernatant was removed. Cells were resuspended in 100 mM sucrose 
(pH 8.2) to obtain a cell concentration of 5-15 × 106 cells/mL. From this suspension 10 μl was applied 
to a slide dipped in a freshly prepared and filtered (0.2 μm) 1% PFA, pH 9.2 solution, containing 
0.15% Triton X-100. The cell suspension was placed at the upper right corner of the slide and was 
slowly dispersed first in a horizontal direction, thereafter in a vertical direction, while exposing the 
cells to the fixative. After horizontal drying for 1.5-2 h in a humid chamber, slides were washed with 
0.08% Kodak Photo-Flo and air dried.
 Oocytes were fixed as described [7] with some minor modifications. After zona pellucida removal 
with Acidic Tyrode’s Solution (Sigma), oocytes were incubated in hyposolution (25% FCS, 0.5% 
sodium citrate) for 5 minutes and subsequently transferred to a drop of fixative (1% PFA, 0.2% Triton 
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X-100, 0.1 mM dithiothreitol (DTT), pH 9.2) on a glass slide. After horizontal drying for 1 hour, slides 
were washed with 0.08% Photo-Flo (Kodak) and air dried. 
 All slides were stored at -20°C for a maximum of 3 months until further use. 
Antibodies
The following antibodies were used: rabbit polyclonal antibodies against H3K9me3 (1:500, Abcam), 
H2ApT120 (1:2500, Active Motif ), H3pT3 (1:1,000, Upstate), H3pS10 (1:100, Cell Signaling) and 
SYCP3 (1:5000, Lammers et al., 1994 [20]), mouse monoclonal antibodies against AURKB (1:100, BD 
Biosciences), INCENP (1:1000; Upstate) and H3 (1:1000, Active Motif ), and human anti-centromere 
antibodies (ACA) (human centromere antiserum; 1:1000, Fitzgerald Industries). Primary antibodies 
were detected by labelling with the appropriate secondary antibodies conjugated with Alexa Fluor 
488, 594 or 633 (Invitrogen). 
Immunofluorescence
For immunofluorescence staining, chromosome spreads were rinsed in PBS-T (PBS with 0.01% v/v 
Tween-20), blocked with blocking solution (PBS-T, 2% w/v bovine serum albumin, 5% v/v normal 
goat serum) for 30 min and incubated with primary antibodies at 4oC overnight. After washing 
with PBS-T, chromosome spreads were incubated with the appropriate secondary antibodies for 
1h, washed with PBS-T and mounted with Vectashield® mounting solution containing 750 ng/ml 
4,6-diamidino-2-phenylindole (DAPI) for DNA counterstaining (Vector Laboratories). 
Stripping 
To explore the feasibility of stripping, we tested different solutions for the ability to remove H3K9me3 
staining from HAC chromosome spreads. We tested two different commercial stripping buffers: 
RestoreTM PLUS Western Blot Stripping Buffer and RestoreTM Fluorescent Western Blot Stripping 
Buffer (both Thermo Scientific). We also evaluated two stripping solutions described in the literature: 
a low pH glycine hydrochloride solution based on Legocki and Verma (0.1M GlyHCl, 0.15% Tween, 
pH 2.5) [21] and a guanidine hydrochloride solution based on Yeung and Stanley (6M GnHCl, 20mM 
Tris-HCl, 0.2% Triton, pH 7.5) [12]. 
 After microscopic inspection of the immunofluorescent staining, coverslips were removed and 
slides were washed in PBS-T to remove the Vectashield® mounting solution. To test the commercial 
stripping buffers, slides were then incubated for 5 or 10 minutes in RestoreTM PLUS Western Blot 
Stripping Buffer or for 10 or 20 minutes in 1x RestoreTM Fluorescent Western Blot Stripping Buffer, 
at room temperature under constant shaking, according to manufacturer’s protocol. To test the 
stripping solutions from literature, slides were incubated for 30 minutes in GlyHCl solution or for 
10 minutes in GnHCl solution, both at room temperature, as described in literature. Slides were 
then washed twice in PBS-T and mounted with Vectashield®. Microscopic inspection of residual 
fluorescence was performed at a high (630x) magnification and evaluated as clearly distinguishable, 
faint, barely, or not visible. Differences between the stripping solutions were further quantified as 
described below.
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After establishment of the optimal stripping procedure, slides in further experiments were treated as 
follows: after imaging the first round of immunofluorescent staining, coverslips were removed and 
slides were washed in PBS-T to remove the Vectashield® mounting solution. Slides were incubated 
in RestoreTM PLUS Western Blot Stripping Buffer for 10 minutes. After stripping, slides were washed 
twice in PBS-T before use for a second immunofluorescent staining.
Imaging 
Images were obtained using a Zeiss Axio Imager M1 microscope (Carl Zeiss), CoolCube 1m camera 
(MetaSystems) and Isis FISH Imaging System software (version 5.4.7, MetaSystems). During the first 
round of imaging, positions of metaphases imaged were recorded in the form of the XY-position 
of the microscope table. These coordinates were used to find the same chromosome spread in 
subsequent rounds of imaging. 
 For quantifications (Figure 1b, 2b and Online Resource 1), we used spreads of HAC and ATDC5 
cells. Images of the same metaphase before and after stripping and after a second round of 
immunostaining were acquired with identical microscope and illumination settings. Pixel intensities 
of areas containing chromosomes were determined in the various channels by using the Selection 
and Analyze-Measure tools in Image J (version 1.42n). For each set of chromosomes, the maximum 
fluorescence intensity was corrected for background intensities by subtracting the minimum 
fluorescence. The resulting pixel intensity after the first round of immunostaining was set to 1, and 
intensities after stripping and the second round of immunostaining were expressed as percentages. 
For each quantification experiment, 10 metaphase spreads were imaged sequentially. Significance 
was tested with the Wilcoxon Signed Rank Test using IBM SPSS Statistics (version 20.0.0.1). 
 For plotting the distribution of fluorescence intensities along one chromosome arm (Figure 3b), 
we used the images shown in Figure 3a. One chromosome arm was selected using the Segmented 
Line tool in Image J. This selection was copied to other images. Subsequently, using the Analyze- 
Plot Profile tool, the distribution of fluorescence intensities along the selected chromosome arm was 
obtained. 
 Images from different rounds of detection on the same chromosome spread were merged using 
the ROI Manager in Image J to copy a selected area of one image to the other images. Subsequently, 
selected areas were cropped and merged.
Results
A universal method for surface spreading of different types of cells
The surface spreading protocol could be successfully applied to a range of cultured cells and cell 
lines of human, murine and porcine origin (for examples see Online Resource 2). The quality of the 
spreads could be variable and we found this to be dependent on: 1) duration of prometaphase 
arrest, 2) cell density after resuspension in sucrose solution, and 3) the drying down procedure. 
Regarding the first, a shorter prometaphase arrest resulted in longer, less condensed chromosomes, 
but reduced the yield of mitotic cells. Regarding cell density, transferring too many cells onto the 
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slide resulted in poor spreading and compact chromatin. We found a density of 5-15 × 106 cells/mL 
to work well. Variation induced by the drying down procedure has been described before [5,6,19] and 
depends on a slow drying process. When optimized, however, good chromosome morphology can 
be observed after DAPI-staining. Spread chromosomes of human, murine or porcine origin could be 
successfully immunostained for the presence of trimethylation of histone 3 at lysine 9 (H3K9me3), 
a well conserved marker for constitutive heterochromatin (Figures 1, 3, 5, Online Resource 2). This 
illustrates differences in size and distribution of chromosome regions enriched for this mark between 
species and cell types (Online Resource 2). We were also successful in detecting histone associating 
proteins (AURKB: Figure 2 and INCENP: Figures 3, 5), histone H3 (Figures 1, 3, 5) and different histone 
modifications (H3pT3, H2ApT120: Figures 2, 4, 5).
Feasibility and optimization of the stripping protocol
Chromosomal spreads of human articular chondrocytes (HAC) were used to determine the optimal 
stripping protocol. As described in the Methods section, we tested four different stripping buffers and 
different durations of incubation. Residual fluorescence after incubation in RestoreTM PLUS Western 
Blot Stripping Buffer was scored as faint to barely visible after 5 minutes incubation and as not or 
barely visible after 10 minutes incubation. Incubation in GnHCl solution for 10 minutes also resulted 
in an obvious reduction of staining intensity. In contrast, residual fluorescence after incubation in 
both RestoreTM Fluorescent Western Blot Stripping Buffer and GlyHCl solution was scored as faint to 
clearly distinguishable in all cases. A five-fold increase in the concentration of RestoreTM Fluorescent 
Western Blot Stripping Buffer and an increased incubation time of 30 minutes, as recommended in 
the manufacturer’s protocol, improved stripping results. However, quantification of the decrease 
in fluorescence intensity on chromosome spreads of HAC cells shows incubation in RestoreTM PLUS 
Western Blot Stripping Buffer for 10 minutes to be most efficient in signal removal (Online Resource 
1). This buffer and incubation time were therefore used in subsequent stripping experiments. 
 To further illustrate the efficiency of stripping, chromosome spreads of HACs and ATDC5 cells 
were incubated with antibodies against histone H3 and H3K9me3 (Figure 1a). As expected, H3 was 
detected all over the chromosomes and H3K9me3 was detected mainly at the pericentric regions 
[22-24]. After stripping, chromosome morphology was still intact (Figure 1a, second panel). However, 
detected fluorescence of the secondary antibodies was significantly reduced. Subsequently, 
secondary antibodies were re-applied to investigate if stripping also removed primary antibodies. 
Imaging showed a slight increase of the signal, compared with the image directly after stripping, but 
still a convincing decrease of the initial signal (Figure 1a, third panel). Quantification of the decrease 
in fluorescence intensity on chromosome spreads of ATDC5 cells confirmed these observations, 
with a decrease to less than 10% of the initial intensity and a slight increase of intensity after re-
application of the secondary antibodies for the epitopes tested (Figure 1b). This shows that stripping 
results in efficient removal of both the primary and the secondary antibody of an immunostaining. 
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Figure 1 — (a) Efficiency of the stripping protocol, demonstrated by immunofluorescent detection of histone 
H3 and its trimethylation of lysine 9 (H3K9me3) on spread chromosomes from HACs. First, epitopes were 
visualized by immunofluorescent staining with primary and secondary antibodies (first panel). H3 can be 
observed all over the chromosomes and H3K9me3 was detected surrounding the centromeric area. After 
stripping, almost all signal had disappeared (second panel). Subsequent immunofluorescent staining 
with only secondary antibodies slightly increased the signal (third panel), indicating removal of most of 
the secondary, as well as the primary antibody. Scale bars are 25 µm. (b) Relative fluorescence intensity of 
H3K9me3 and H3 after stripping and after re-application of the secondary antibodies. Shown are mean 
values and standard deviations of 10 ATDC5 chromosome spreads. Values significantly different from the first 
round (a) and after stripping (b) are indicated (p<0.01).
Stripping does not compromise the epitopes investigated
As the stripping buffer is designed to interfere with protein-protein interactions, we investigated 
if epitopes are still present and intact after stripping. Chromosome spreads of ATDC5 cells were 
incubated with antibodies against H3pT3 and AURKB, followed by detection and imaging. After 
stripping, the same staining was repeated (Figure 2a). As expected [9,25], both H3pT3 and AURKB 
were detected at the centromeric region. Compared with the first staining, fluorescence intensity 
of the second round of immunolocalization was significantly reduced, but both epitopes were still 
clearly detectable. Quantification shows that the fluorescence intensity in the second round of 
detection still reached 59% and 78% of the original value for H3pT3 and AURKB, respectively (Figure 
2b). From this, we conclude that these epitopes are not severely affected by the stripping procedure, 
but some loss of fluorescence intensity does occur. 
Stripping efficiency for different antibodies
Different types of antibodies are known to have large differences in epitope affinities that are 
hardly predictable [26]. Therefore, we tested if the stripping procedure is robust enough to not only 
remove low, but also high affinity antibodies. We therefore subjected antibodies directed against 
the following targets to the stripping procedure: H3K9me3, H3pT3, H3pS10, H2ApT120, H3, ACA, 
AURKB, INCENP, and SYCP3. The protocol efficiently removed all tested antibodies as shown by the 
prominent reduction in fluorescent signal intensities after stripping, to less than 10% of the original 
value when imaged with identical exposure settings (Figure 1b and data not shown). For the H3pT3 
antibody, initial fluorescence intensities were very high, and we noticed that residual signal could 
still be detected in some metaphases. However, this was only obvious when imaging with increased 
exposure settings (Online Resource 3).
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Figure 2 — (a) Immunofluorescent detection of H3pT3 and AURKB on chromosomes from ATDC5 
cells. (first panel). After stripping, fluorescence is significantly reduced (second panel). In the 
subsequent second round of immunofluorescent detection, the same epitopes are again visualized 
(third panel). Scale bars are 25 µm. (b) Relative fluorescence intensity of H3pT3 and AURKB after 
stripping and after the second round of immunofluorescent detection. Shown are mean values and 
standard deviations of 10 ATDC5 chromosome spreads. Values significantly different from the first 
round (a) and after stripping (b) are indicated (p<0.01).
Stripping facilitates a second round of immunostaining
We next established if the stripping protocol facilitates a second round of immunostaining with 
different antibodies. We performed a first round of immunofluorescent detection and imaging, 
followed by stripping and a second round of immunostaining for different epitopes (Figure 3a). In 
the first round, we stained chromosomes of HACs with mouse-anti-INCENP antibodies and rabbit-
anti-phosphorylation of histone H3 at serine 10 (H3pS10) antibodies. As previously described, 
H3pS10 was detected along the chromosome arms and INCENP at the inner centromere [27-29]. 
Stripping efficiently removed the signal of both antibodies. In the second round of detection, we 
used mouse-anti-H3 and rabbit-anti-H3K9me3 antibodies, and both epitopes were readily detected. 
When fluorescence intensities of all epitopes were plotted along the length of the chromosome, 
centromeric enrichment of INCENP (first round) and H3K9me3 (second round) were clearly visible as 
a peak in fluorescence intensity (Figure 3b). 
 This application of the stripping procedure illustrates that in these HAC cells trimethylation of 
H3 at lysine 9 might interfere with recognition of H3 by the mouse monoclonal antibody we used, 
since pericentric areas positive for H3K9me3 are negative for H3 (Figure 3a, arrowhead, and Figure 
3b, second round). In contrast, phosphorylation of H3 on serine 10 does not interfere with H3 
antibody binding, as both epitopes are detected abundantly on the chromosome arms of the same 
chromosome spread.
 These results again show that stripping leaves epitopes intact for a second round of 
immunodetection and that we can successfully detect other epitopes in the second round. 
Applications of sequential immunofluorescent analysis
The combined recovery rate of chromosome spreads after imaging, stripping and a second round of 
immunostaining in the experiments above was 100% (30/30). The protocol can therefore be safely 
used on precious material. Next, we performed sequential immunofluorescent analysis on a variety 
of different cell types to demonstrate the broad applicability of the present stripping protocol.
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Figure 3 — The stripping protocol enables sequential immunofluorescent analysis of 4 different epitopes on 
the same chromosome spread, as demonstrated by immunofluorescent detection of INCENP and H3pS10 
on chromosomes from HACs (first panel), followed by stripping (second panel) and a second round of 
immunostaining for H3 and H3K9me3 (third panel). Note that it is likely that trimethylation of K9, but not 
phosphorylation of S10, interferes with recognition of histone H3 by the monoclonal antibody we used. 
Arrowheads indicate an example of a pericentric area where H3K9me3 and H3 are mutually exclusive. Scale 
bars are 25 µm. (b) Distribution of fluorescence intensity over one chromosome arm of the chromosome 
indicated with an arrowhead in panel a, both after the first and second round of immunostaining. Centromeric 
enrichment of INCENP and H3K9me3 are clearly visible as a peak in fluorescence intensity.
First, ATDC5 chromosome spreads were incubated with rabbit-anti-H2ApT120 and human anti-
centromere antibodies (ACA) (Figure 4). After stripping, the same slides were incubated with rabbit-
anti-H3pT3 and ACA. Dynamic phosphorylation patterns described for H3pT3 and H2ApT120 during 
mitosis [9] can be observed simultaneously on the same chromosome spread. In early prometaphase, 
small H2ApT120 foci are found localizing to the centromeres, whereas H3pT3 is detected both on 
chromosome arms and around the centromeres. At late prometaphase, H2ApT120 signal size has 
increased and H3pT3 has disappeared from the arms and is concentrated at the inner centromere. 
These results illustrate that the stripping method allows spatio-temporal localization of different 
epitopes when only antibodies raised in the same host species are available. 
 Second, we stained chromosomes of human oocytes (Fiure 5a) with mouse-anti-INCENP and 
H3K9me3 (rabbit) antibodies. After stripping, we immunostained these chromosomes using mouse-
anti-H3 and rabbit-anti-H3pT3 antibodies. Oocyte chromosomes had the typical, highly condensed, 
appearance [30] and showed an overall staining for H3K9me3 and H3, similar to what has been 
described in mouse oocytes [31-33]. INCENP and H3pT3 seem to only partially colocalize (Figure 5b) 
at the pericentric region, different from what has been described for somatic cells [9,25]. These results 
show that when material is rare, it can successfully be used for two rounds of immunofluorescent 
staining.
 Third, we stained nuclear spreads of mouse spermatocytes using rabbit-anti-SYCP3 antibodies 
(Figure 6). SYCP3 staining allows staging of meiocytes by detecting formation of the synaptonemal 
complex [34], and the antibody derived by Lammers et al. [20] is widely used for this purpose and 
well-characterized [35-39]. After imaging of different stages of spermatocytes, the slides were 
stripped and stained for H3K9me3. This way we were able to determine both the stage of the cells 
during meiotic prophase and the distribution of the histone mark in those same cells, while using 
two antibodies raised in rabbit. Shown are pictures of spermatocytes of three meiotic stages: early 
pachytene, mid pachytene and diplotene. In early pachytene H3K9me3 was enriched on the XY-
body, the transcriptionally silenced X and Y chromosomes in the meiotic prophase, followed by a 
reduction during mid pachytene, whereas by the diplotene stage, trimethylation levels on H3K9 were 
again increased on the X and Y chromosome [18,40]. Staging cells by an SYCP3 staining, followed 
by a staining for other proteins or epigenetic marks provides information about the presence and 
localization of these epitopes during specific stages of the meiotic prophase of spermatogenesis.
Chapter 4
104
Figure 4 — Application of the stripping protocol, demonstrated by immunofluorescent detection of 
H2ApT120 and the centromeres (ACA) on chromosomes from ATDC5 cells, followed by stripping and a 
second round of immunostaining for H3pT3 and ACA. In early prometaphase (left), H2ApT120 was detected 
around the centromeres and H3pT3 both around the centromeres and on the chromosome arms. In late 
prometaphase (right), H2ApT120 signal size has increased at the centromeres and H3pT3 is enriched at the 
inner centromere. Enlarged regions at the bottom show a single chromosome. Scale bars are 25 µm.
Figure 5 — (a) Application of the stripping protocol, demonstrated by immunolocalization of INCENP and 
H3K9me3 on a chromosome spread from a human oocyte, followed by stripping and a second round of 
immunostaining for H3 and H3pT3. Chromosomes show typical condensed morphology and high levels of 
H3K9 trimethylation. Scale bars are 10 µm. (b) Zoom-in of a chromosome from a merged image showing 
INCENP and H3pT3 signal. INCENP is localized at the inner centromere and H3pT3 at the centromeres, with 
only limited signal overlap.
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Figure 6 — Application of the stripping protocol, demonstrated by immunofluorescent detection of SYCP3 on 
mouse spermatocytes, followed by stripping and a second round of immunostaining for H3K9me3. Numbers 
indicate meiotic prophase stages (1: early pachytene, 2: mid pachytene, 3: diplotene) and arrowheads indicate 
XY-bodies. As expected, H3K9 trimethylation levels are high on sex body chromatin during early pachytene, 
decrease towards mid pachytene and are increased again at the diplotene stage. Scale bars are 25 µm.
Discussion
In this study we aimed to develop a protocol for sequential immunofluorescence on chromosome 
spreads. We were able to erase the first immunofluorescent staining using a stripping buffer 
designed for Western Blot membranes, while leaving chromosome morphology and epitopes intact 
for a second round of detection. 
 First, we optimized a surface spreading protocol described for gametes and embryos, for 
cultured cells from different cell lines and species. This protocol is a good alternative for the 
cytospin technique; it is cheaper, does not require special equipment and gives good chromosome 
morphology. However, some care should be taken when interpreting results, as the drying down 
procedure results in removal of soluble proteins and loss of the 3D structure [19]. Furthermore, the 
spreading technique may cause stretching of the chromosome and increased signal sizes. This has 
also been described when comparing cytospin preparations with whole mount preparations for 
localization of the chromosomal passenger complex for a chromosome with a neocentromere [41]. 
AURKB signal size was observed to be measurably increased after cytospin, but found to be normal 
in whole mount preparations. Therefore, results from chromosome spread techniques should 
preferably be compared with findings in whole mount fixed cells, as these techniques can provide 
complementary information [19]. 
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With chromosomes attached firmly to a microscope slide after surface spreading, we investigated 
if stripping buffers designed for Western Blots are able to remove antibodies from chromosome 
spreads. We tested four different stripping solutions and show that in our hands stripping with 
RestoreTM PLUS Western Blot Stripping Buffer was most efficient, as well as fast, with an incubation 
time of only 10 minutes. Different stripping solutions have been described in literature, based on 
high salt concentrations, detergent or low pH, or a combination of those. The manufacturer did not 
provide details on the composition of the RestoreTM PLUS Western Blot Stripping Buffer, but as the 
pH is 2.4, its formulation may be based on a low pH glycine hydrochloride solution. However, the 
GlyHCl solution we tested here, based on the solution described by Legocki and Verma [21], did not 
strip effectively. In contrast, the GnHCl solution we tested, based on the solution described by Yeung 
and Stanley [12], was almost as efficient as the RestoreTM PLUS Western Blot Stripping Buffer. This 
suggests that the RestoreTM PLUS Western Blot Stripping Buffer may combine a high concentration 
of chaotropic salts with a low pH. It also suggests that with some further optimization, a guanidine 
hydrochloride solution may constitute a cheaper alternative for this purpose. 
 Using the RestoreTM PLUS Western Blot Stripping Buffer, we show that stripping does not severely 
affect chromosomes and attached proteins, as they could be readily detected in a second round of 
immunofluorescent staining. However, a small but significant reduction of fluorescence intensity 
could be observed after the second round of detection (Figure 2b), indicating that some loss of 
epitope or protein may occur after stripping. This should be taken into account when quantification 
of signal is desired.
 Although we were able to efficiently remove every antibody tested, the stripping procedure 
shows some variation between different antibodies. As the reduction in fluorescence intensity we 
found was relative, antibodies with a very high epitope affinity and/or initial fluorescence intensity 
in the first round, may still be detectable after stripping, especially with increased exposure times. 
Stripping efficiency should thus be validated for every antibody separately. The problem of residual 
signals is known from Western blot membranes and can sometimes be remedied by increasing 
incubation times and temperatures of the stripping buffer. In general, we recommend that high 
affinity antibodies should be used in the second round of detection, or that interference of residual 
staining with interpretation of results from a second round of immunolocalization is otherwise 
excluded.
 We anticipate that this stripping protocol will provide a versatile new tool for the study 
of chromosomes and chromatin, and envision many applications. We show sequential 
immunofluorescent stainings on different cell types, among which mouse spermatocytes and 
human oocytes. The ability to perform two immunofluorescent stainings on the same material is 
particularly useful in our studies on chromosome segregation and chromatin structure in human 
oocytes and preimplantation embryos, since this material is rare and valuable. Nonetheless, this 
protocol is useful for broad variety of cell types, because it creates the possibility to investigate 
the localization of proteins that are detected by antibodies from the same species. In this way, 
it is possible to show direct colocalization and protein dynamics in different cell cycle stages on 
the same chromosomes. This method will therefore greatly increase our insight into the complex 
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interplay of control mechanisms governing chromosome structure and regulation of segregation 
during mitosis. 
Ethical standards
The experiments performed in this study comply with the current laws in The Netherlands. All 
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ethical committee (MEC2004-322). The use of human oocytes for research purposes was approved 
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Online Resource 1 — Relative fluorescence intensity of H3K9me3 after stripping with four different stripping 
solutions: GlyHCl, GnHCl, RestoreTM Fluorescent Western Blot Stripping Buffer (Fluorescent), and RestoreTM 
PLUS Western Blot Stripping Buffer (PLUS). Shown are mean values and standard deviations of 10 HAC 
chromosome spreads. 
Online Resource 2 — Immunolocalization of H3K9me3 on chromosome spreads of four different cell types 
(ATDC5, PAC, hFOB1.19, and HAC) illustrating the applicability of the spreading protocol. Chromosome 
spreads show good chromosome resolution and differences in localization of regions enriched for the 
H3K9me3 mark between species. Scale bars are 25 μm.
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Online Resource 3 — Same figure as Figure 2, but with a panel added showing that when the exposure time 
was increased using optimal exposure settings in the Isis software, residual signal could be detected after 
stripping (third panel). Scale bars are 25 μm.
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Abstract
Study question: Are the kinase feedback loops, that regulate activation and centromeric targeting 
of the chromosomal passenger complex (CPC), functional during mitosis in human embryos? 
Summary answer: Investigation of the regulatory kinase pathways involved in centromeric CPC 
targeting revealed normal phosphorylation dynamics of Histone H2A at T120 (H2ApT120) by Bub1 
kinase and subsequent recruitment of Shugoshin, but phosphorylation of Histone H3 at threonine 3 
(H3T3) by Haspin failed to show the expected centromeric enrichment on metaphase chromosomes 
in the zygote. 
What is known already: Human cleavage stage embryos show high levels of chromosomal instability. 
What causes this high error rate is unknown, as mechanisms used to ensure proper chromosome 
segregation in mammalian embryos are poorly described. 
Study design, size, duration: In this study we investigated the pathways regulating CPC targeting to 
the inner centromere in human embryos. We characterized the distribution of the CPC in relation to 
activity of its two main centromeric targeting pathways: the Bub1-H2ApT120-Sgo-CPC and Haspin-
H3pT3-CPC pathways.
Participants/materials, setting, methods: The study was conducted between May 2012 and March 
2014 on human surplus embryos resulting from in vitro fertilization treatment and donated for 
research. In zygotes, nuclear envelope breakdown was monitored by time-lapse imaging to allow 
timed incubations with specific inhibitors to arrest at prometaphase and metaphase, and to interfere 
with Haspin and Aurora B/C kinase activity. Functionality of the targeting pathways was assessed 
through characterization of histone phosphorylation dynamics by immunofluorescent analysis, 
combined with gene expression by RT-qPCR and immunofluorescent localization of key pathway 
proteins. 
Main results and the role of chance: Immunofluorescent analysis of the CPC subunit INCENP 
revealed the pool of stably bound CPC proteins not to be strictly confined to the inner centromere 
of prometaphase chromosomes in human zygotes, as observed in later stages of preimplantation 
development and somatic cells. Investigation of the regulatory kinase pathways involved in 
centromeric CPC targeting revealed normal phosphorylation dynamics of Histone H2A at T120 
(H2ApT120) by Bub1 kinase and subsequent recruitment of Shugoshin. However, phosphorylation 
of Histone H3 at threonine 3 (H3T3) by Haspin kinase failed to show the expected centromeric 
enrichment on metaphase chromosomes in the zygote, but not at later stages. Inhibition of 
Haspin revealed this activity to be essential for proper MCC activation in human zygotes, thus 
demonstrating an active mitotic checkpoint under normal conditions. Abolishment of H3pT3 
during zygotic prometaphase further shows that centromeric H2ApT120 alone is not sufficient for 
proper shugoshin and CPC localization. As removal of H3pT3 from the chromosome arms during 
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prometaphase normally contributes to further centromeric enrichment of the CPC in somatic cells, 
CPC targeting may be less accurate in human zygotes. 
Limitations, reasons for caution: Due to ethical limitations, tripronuclear zygotes were used in 
functional experiments. Although it is the best available model, it is unknown if they are completely 
representative for dipronuclear zygotes. In addition, further research is needed to determine to 
what extent the differences we observed in H3T3 phosphorylation dynamics and CPC localization 
affect chromosome attachment. 
Wider implications of the findings: In the zygote, paternal and maternal chromosomes coming from 
two separate pronuclei, and with contrasting epigenetic signatures, need to be aligned on a single 
metaphase plate. Our results suggest that adaptations in mechanisms regulating CPC targeting exist 
in the human zygote, to ensure symmetric recruitment despite the epigenetic asymmetry between 
maternal and paternal chromosomes. This adaptation may come at a price regarding chromosome 
segregation fidelity. 
Study funding/competing interest(s): This study was funded by the Portuguese Fundação para a 
Ciência e Tecnologia and the Netherlands Organisation for Scientific Research. The authors have no 
conflicts of interest to declare. 
Key words: human embryo research, chromosome segregation, Aurora kinase, Haspin kinase, 
histone phosphorylation
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Introduction
When cells divide, duplicated chromosomes (sister chromatids) have to be divided equally between 
the resulting daughter cells to ensure genome stability. Normally, errors in this process are rare, as 
cells are equipped with elaborate mechanisms that regulate and monitor chromosome segregation. 
Remarkably, chromosome aneuploidies are frequently observed in human pre-implantation IVF 
embryos [1-2]. Some of these aneuploidies are of meiotic origin, but we and others have shown that 
most of them occur post-meiotically, as a result of errors during the cleavage divisions [3-5]. The 
proportion of aneuploid cells within an embryo subsequently declines towards the blastocyst stage 
[4,6-8], suggesting that chromosome segregation mechanisms are especially error-prone during the 
cleavage divisions. This high error rate has been compared to that reported in human cancer cells [5], 
although the underlying molecular mechanisms contributing to errors during the cleavage divisions 
of human pre-implantation embryos remain largely unknown.
 At the onset of mitosis, chromatin is rearranged into mitotic chromosomes, and multi-protein 
structures called kinetochores are assembled on the centromeres. Accurate chromosome 
segregation is dependent on the ability of these kinetochores to capture microtubules of the mitotic 
spindle and subsequently form bipolar attachments. Anaphase onset is controlled by the ubiquitin 
ligase anaphase-promoting complex/cyclosome (APC/C) , together with cell division control protein 
20 (CDC20) [9-11]. This complex initiates anaphase by targeting two proteins for degradation: Cyclin 
B that regulates cyclin dependent kinase 1 (CDK1) and securing that protects sister chromatid 
cohesion [12]. Until bi-orientation of all chromosomes is achieved, anaphase is delayed by action of 
the mitotic checkpoint (MC), also known as the spindle assembly checkpoint. The MC is formed by 
the kinases monopolar spindle protein 1 (Mps1) and budding uninhibited by benomyl 1 (Bub1), the 
pseudo-kinase Bub1-related 1 (BubR1) and the non-enzymatic components mitotic arrest deficient 
1 (Mad1), Mad2 and Bub3. These proteins are recruited to unattached kinetochores, where they 
catalyze the formation of the mitotic checkpoint complex (MCC), consisting of CDC20 together with 
Mad2, Bub3 and BubR1. The MCC is released into the cytoplasm where it inactivates the APC/C (for 
review see [13-14].
 Chromosome attachment to the spindle is achieved through a stochastic trial-and-error process, 
whereby active destabilization of erroneous attachments is necessary to provide a new opportunity 
to attach in a bi-oriented fashion. Aurora B kinase is a key player in this mechanism of attachment-
error-correction [15]. Aurora B belongs to a family of serine-threonine kinases that is conserved from 
yeast to humans. This kinase is a member of the Chromosomal Passenger Complex (CPC), together 
with the Inner Centromere Protein (INCENP), Borealin and Survivin [15-16]. However, in human 
cleavage stage embryos the main kinetic subunit of the CPC is an alternative subunit called Aurora 
C kinase [17]. Aurora C is capable to fully support mitotic progression in the absence of Aurora B in 
human somatic cells [18] and mouse embryo development [19]. Although the need for an alternative 
Aurora kinase remains poorly understood, Aurora C has been shown to have improved protein 
stability during the cleavage divisions in mouse embryos [20]. In addition, the function of Aurora C 
seems to be distinct from Aurora B during female mouse meiosis I, where loss of Aurora C function 
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results in erroneous microtubule attachments, but the mitotic checkpoint and cytokinesis remain 
undisturbed [21]. 
 The mammalian CPC enriches at the inner centromere during prometaphase [22]. The inner 
centromere of the chromosome folds between the centromeres and within the pericentric 
heterochromatin (pHC). Pericentric HC is characterized by high levels of trimethylation on 
lysine residue 9 of histone H3 (H3K9me3; for review see [23] and disruption of this signature is 
associated with chromosome instability [24]. H3K9me3 is known to recruit the three iso-forms of 
heterochromatin protein 1 (HP1α, β, and γ), which are important for heterochromatin structure and 
function [25]. During mitosis, phosphorylation of serine residue 10 on histone H3 (H3pS10) by Aurora 
B disrupts the HP1-H3K9me3 interaction and releases HP1 from chromatin [26] (Figure 1a). HP1α also 
undergoes mitosis-specific phosphorylation, resulting in a population of HP1α that remains at the 
inner centromere, independent of H3K9me3 and possibly by interacting with INCENP [27-28]. This 
phosphorylated form of HP1α facilitates the localization of the shugoshin protein 1 (Sgo1), which 
is crucial for protecting centromeric cohesion and the prevention of premature sister chromatid 
separation [28-29]. Next to their role in cohesion protection, both shugoshin proteins Sgo1 and Sgo2 
are essential for CPC localization, as they bind to Borealin [30,31].
 During mitosis, the inner centromere shows further dynamic phosphorylation of histones, further 
promoting CPC recruitment and localization [30-34]. It has been proposed that CPC targeting 
depends on two distinct histone modifications: phosphorylation of histone H3 at Thr 3 (H3pT3) 
by the kinase Haspin and phosphorylation of histone H2A at Thr 120 (H2ApT120) by Bub1 kinase 
(Figure 1a) [34]. Bub1, a mitotic kinase that localizes to the kinetochores, phosphorylates histone 
H2A on centromeric heterochromatin, creating a binding site for Sgo1 and Sgo2 that in turn 
recruit the CPC through Borealin [31,35-36]. Since Aurora B activity is needed to recruit Bub1 to the 
kinetochore, a positive feedback loop is created in this Bub1-H2ApT120-Sgo-CPC pathway, ensuring 
CPC recruitment to the inner centromere [15,37]. 
 Phosphorylation of H3T3 by Haspin starts at late G2 / early prophase and by late prophase it has 
spread along the chromosome arms. This mark recruits the CPC, as Survivin binds to H3pT3 [32-33]. 
Phosphorylation of Haspin by Aurora B promotes full phosphorylation of H3pT3, creating a positive 
feedback loop between Aurora B and Haspin [37] (Figure 1a). At prometaphase, H3pT3 disappears 
from the arms and enriches at the inner centromeres [34,38]. The dephosphorylation of H3pT3 at the 
chromosome arms is specifically regulated by the phosphatase activity of protein phosphatase PP1γ 
together with its regulatory subunit Repo-Man [39]. Aurora B phosphorylates Repo-Man, thereby 
preventing its chromosomal targeting and supporting H3pT3 levels [40]. Repo-man also associates 
with the phosphatase PP2A, which opposes Aurora B phosphorylation of Repo-Man, thereby 
allowing the removal of H3pT3 from the chromosome arms during prometaphase [40]. These 
feedback loops between Aurora B and Haspin, as well as Aurora B and its opposing phosphatases 
regulate the levels of H3pT3 and ensure enrichment of the mark and the CPC at the inner centromere 
[22]. Mounting evidence also indicates that centromeric enrichment of the CPC through the Bub1-
H2ApT120-Sgo-CPC pathway enhances the Haspin-H3pT3-CPC phosphorylation pathway and vice 
versa [15,37,41]. Thus, extensive and elaborate feedback mechanisms exist, resulting in precisely 
timed events leading to robust CPC localization to the inner centromeres. 
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Although the embryonic cleavage divisions are mitotic divisions, as opposed to the previous meiotic 
divisions, they differ from normal mitosis in many aspects [42]. In mammalian zygotes, the paternal 
and maternal genomes exist in an asymmetric chromatin configuration, where only the maternal 
chromatin has high levels of H3K9me3 [43]. For the paternal chromatin configuration, important 
species differences exist: in the mouse zygote, the paternal chromatin is mostly devoid of H3K9me3 
and HP1, and pHC is formatted up to the 8-cell stage by an alternative mechanism involving the 
polycomb group proteins [44]. In contrast, human paternal pHC is marked by H3K9me3 that was 
transmitted to the zygote by the sperm [45]. During the first mitotic division, these asymmetric 
chromosomes, derived from two different pronuclei, need to align on the same metaphase plate. 
As described above, pHC structure underlies chromosome segregation regulation. We therefore 
hypothesize that the parental asymmetry in the early embryo may require adaptations in the 
mechanisms regulating chromosome segregation. 
 In this study, we aim to explore if the epigenetic asymmetry and the presence of Aurora C kinase 
affect the pathways regulating CPC targeting to the inner centromere in human embryos. We 
characterized CPC localization in relation to activity of the Bub1-H2ApT120-Sgo-CPC and Haspin-
H3pT3-CPC pathways. In addition, we explore the contribution of the H3K9me3/HP1α pathway 
to Sgo1 and CPC localization. Although our observations are mostly in line with the mechanisms 
described in somatic cells, the Haspin-H3pT3-CPC pathway is altered in zygotes and targeting of 
the CPC is less confined to the inner centromere. Furthermore, paternal and maternal chromosomes 
are differentially affected by interference with Haspin and Aurora kinase activity, leading us 
to hypothesize that the persisting Haspin activity on the arms is required for symmetrical CPC 
recruitment despite the underlying epigenetic asymmetry.
Materials and Methods
Ethical approval
The study was conducted between May 2012 and March 2014. The use of surplus embryos was 
approved by the Dutch Central Committee on Research Involving Human Subjects (CCMO 
NL38053.000.11) and the local institutional ethics committee.
Chemicals, reagents and inhibitors
All chemicals and reagents were from Sigma-Aldrich (USA) unless otherwise stated. The following 
inhibitors and concentrations were used: colcemid (1.5 µg/ml, Invitrogen, USA), MG132 (20 µM), 
5-Iodotubercidin (Itu) (10 µM, Tocris Bioscience, UK), ZM447439 (2 µM or 20 µM, Tocris Bioscience). 
Colcemid was dissolved in culture medium. Stock solutions for all other inhibitors were prepared at 
a 1000x concentration in DMSO, so the final concentration of DMSO in the culture medium never 
exceeded 0.1%. 
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Culture, collection and treatment of human pre-implantation embryos
Tripronuclear embryos (3PN) were used to study the first and second cleavage divisions (days 1 
and 2 post-fertilization). This type of abnormal fertilization occurs in ~4% of all inseminated oocytes 
and these embryos are unsuitable for transfer to the patient due to their triploid constitution [46]. 
3PN zygotes mostly originate from an oocyte that is fertilized by two spermatozoa, resulting in one 
maternal pronucleus and two paternal pronuclei [47]. Since the first embryonic divisions are under 
maternal control [48] and 3PN zygotes are capable of implantation, they provide a relevant model for 
the first stages of pre-implantation embryo development [17,45]. To study embryo developmental 
stages on day 3 and day 5, surplus fresh or cryopreserved diploid embryos donated for research 
were (Figure 1b). Tripronuclear zygotes and surplus embryos were donated with written informed 
consent by couples undergoing routine IVF at the Erasmus MC University Medical Centre. 
 Embryo culture and assessment of embryo morphology were performed as described previously 
[49]. Embryos were cultured in G1 v5 PLUS medium (Vitrolife, Sweden) up to day 3 after fertilization 
and from there onwards in G2 v5 PLUS medium (Vitrolife, Sweden), according to the manufacturers’ 
instructions. Cryopreservation was performed in straws using a slow freezing standard protocol and 
subsequent thawing was performed as described previously [4]. 
Time-lapse imaging and treatment of zygotes and embryos
Tripronuclear human zygotes were transferred to a time-lapse embryo monitoring system 
(EmbryoScopeTM, Unisense Fertilitech, Denmark) at approximately 20h post-insemination (hpi) 
(Figure 1b). This allowed monitoring of nuclear envelope breakdown (NEB), which marks entry into 
prometaphase. Zygotes were cultured individually in EmbryoSlidesTM (Unisense Fertilitech) in 25µl 
of G1 medium. In mouse embryos, metaphase plate formation occurs about 30 minutes after NEB 
and the first mitotic division is completed after 2h [50-51]. Our own time-lapse observations on 
human 3PN embryos have shown that the time interval between disappearance of pronuclei and 
completion of first cleavage was 2.83 +/- 0.73h (n=46). We estimated that incubation of human 3PN 
zygotes for 2h after NEB in G1 medium with colcemid would allow arrest at late prometaphase, 
whereas an incubation of only 30 minutes after NEB would correspond to early prometaphase. 
 All inhibitors were added to the culture drop within 5-25 min after NEB (Figure 1b). For the 
experiments in which the effect of Haspin kinase inhibition was investigated, 3PN zygotes were 
incubated for 1.5h in colcemid, followed by incubation for 1h in colcemid in combination with 
5-iodotubercidin (Itu). For the experiments in which Aurora kinase inhibition was investigated, 3PN 
zygotes were incubated for 2h in colcemid in combination with ZM447439 (2 µM or 20 µM). All 
embryos were then processed for chromosome spreads, unless stated otherwise. To investigate the 
effect of colcemid treatment on our results, some zygotes were fixed 30 minutes in the absence of 
any inhibitor. To arrest zygotes at the metaphase stage, zygotes were incubated in G1 medium with 
MG132 for 3h after NEB. 
 Embryos at the 2-cell stage and later were incubated in medium containing colcemid in a standard 
incubator at 5,8% CO2 in air. Tripronuclear 2-cell embryos were incubated in colcemid overnight. 
After thawing of cryopreserved embryos, day 3 (8-cell stage) embryos were cultured for 1-2h and 
then incubated for 5-8h with colcemid for cell cycle arrest at prometaphase. Thawed day 4 (morula 
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stage) embryos were cultured for 24h and embryos that had developed into blastocysts were then 
incubated for 5-8h with colcemid.
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Figure 1 — (a) Depiction of the models that explain the regulatory circuity in somatic cells of recruitment of 
the CPC to chromatin at prophase and early prometaphase, and enrichment at the inner centromere at late 
prometaphase. Aurora B phosphorylates H3S10, dispelling HP1 from chromatin. Phosphorylation by Aurora 
B further activates Haspin and Bub1, and inhibits Repo-Man from binding to chromatin. Phosphorylation of 
H3T3 by Haspin acts to bring the CPC to chromosomes. The Survivin subunit of the CPC binds specifically to 
H3pT3. Furthermore, Bub1 phosphorylation of histone H2AT120 recruits Shugoshin (Sgo1). Sgo1 acts as a 
centromeric adaptor that binds the CPC via Borealin. Dephosphorylated Repo-Man binds to PP1γ resulting 
in removal of H3pT3 from chromosome arms. Intersection of H3pT3 and H2ApT120 defines CPC localization 
to the inner centromeres at prometaphase. Arrows indicate phosphorylation, dotted lines indicate direct 
binding and arrow to bar indicates inhibition. See main text for further explanation. (b) Fresh tripronuclear 
(3PN) embryos were used to study the zygote and 2-cell stages, whereas surplus fresh or cryopreserved 
(2PN) embryos were used to study the 8-cell and blastocyst stages. Nuclear envelope breakdown (NEB) 
was monitored by time-lapse imaging to allow immediate incubation of prometaphase zygotes in medium 
containing colcemid, colcemid+Itu, colcemid+ZM or MG. Embryos at the 2-cell stage and later were 
incubated in medium containing colcemid in a standard incubator. All embryos were fixed with 1% PFA to 
obtain chromosome spreads on glass slides, unless stated otherwise.
Single embryo RT-qPCR
Quantification of mRNA levels was performed in individual single tripronuclear zygotes and 
blastocysts obtained after culture of day 3 or day 4 cryopreserved embryos in G2 medium, 
without addition of any of the cell cycle inhibitors mentioned above. Zygotes and blastocysts were 
incubated in EmbryoMax® Acidic Tyrode’s Solution (Millipore) for 1-2 min for removal of the zona 
pellucida and rinsed in G-MOPS Plus medium (Vitrolife) before transfer to the lysis buffer solution 
provided in the Taqman® PreAmp Cells-to-Ct Kit (Applied Biosystems, USA). Lysis, preamplification 
and RT-qPCR were performed according to the manufacturer’s protocol with minor adjustments, as 
described elsewhere [17]. The following Taqman Gene Expression Assays were used: HPRT1 (Assay ID: 
Hs99999909_m1; amplicon size 100bp); BUB1 (Hs00177821_m1; amplicon size 61bp); GSG2, Haspin 
(Hs01072471_s1; amplicon size 89bp); CDCA2, Repo-Man (Hs00299250_m1; amplicon size 93bp), 
PPP1CC, PP1γ (Hs01566021_m1; amplicon size 83bp). 
 Results were analysed using Sequence Detection Software version 1.2.3 (Applied Biosystems) 
and expressed as cycle threshold (Ct) values. Gene expression levels were normalized over HPRT1 
gene expression, according to the 2-ΔCT method [52]. Differences in BUB1, GSG2, CDC2A and PPP1CC 
expression between zygotes and blastocysts were analysed using the Mann-Whitney test performed 
with GraphPad Prism software. A p-value of 0.05 was considered statistically significant.
Antibodies for immunostaining
The following antibodies were used in this study: mouse monoclonal antibodies against INCENP 
(1:1000, Upstate, Germany), HP1α (1:500, Euromedex) and Sgo1 (1:100, Abnova, Germany); rabbit 
polyclonal against H2ApT120 (1:2500, Active motif, USA), H3pT3 (1:1,000, Upstate), Repo-Man 
(CDCA2) (1:200, Abcam, UK), H3pS10 (1:100, Cell Signaling, USA), H3K9me3 (1:500, Abcam) and 
HP1α (1:100, Bethyl Labs, USA); sheep polyclonal against Bub1 (1:100, a kind gift from G. Kops, The 
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Netherlands); human anticentromere antibodies (CREST) (human centromere antiserum; 1:1,000, 
Fitzgerald Industries). Primary antibodies were detected by labelling with the appropriate secondary 
antibodies conjugated with Alexa fluor 488, 594 or 633 (1:200, Molecular Probes, USA).
Chromosome spreads and whole mount fixation of embryos 
Before fixation, all embryos were subjected to zona pellucida removal with acidic Tyrode’s solution 
(Millipore, Germany). Chromosome spreads of human embryos were prepared as described previously 
[17] and used for all the stainings shown, with the following exceptions. For immunofluorescent 
analysis of HP1α, H2ApT120 and H3pT3 in zygotes at the pronuclear stage, and simultaneous 
detection of Sgo1 and H2ApT120, zygotes were fixed whole mount in 4% PFA as described [17]. 
For immunofluorescent analysis of Repo-Man, zygotes and 8-cell embryos were fixed whole mount 
for 15 minutes at RT using pre-extraction medium (PEM) containing 100 mM PIPES [pH 7.2], 5 mM 
MgCl2, 2.5 mM EGTA, 2% formaldehyde and 0.1% Triton X-100. Chromosome spread preparations 
were stored at -20oC, while whole mount-fixed embryos were stored in PBS/0.05% Sodium azide 
(NaN3) for a maximum of 3 months until used for immunostaining. For each embryonic stage and 
antibody investigated 5-12 embryos were analysed, unless otherwise stated.
Immunofluorescent imaging and antibody stripping
For immunofluorescence stainings, chromosome spreads and whole embryos were rinsed in 
PBS-T (PBS, 0.01% v/v Tween-20) and blocked with blocking solution (PBS-T, 2% w/v bovine serum 
albumin (BSA), 5% v/v normal goat serum (NGS) for 30 minutes and incubated with primary 
antibodies at 4oC overnight. After washing with PBS-T, chromosome spreads or whole embryos 
were incubated with the appropriate secondary antibodies for 1h, washed with PBS-T and mounted 
with Vectashield mounting solution containing 750 ng/mL 4’,6-diamidino-2-phenylindole (DAPI) for 
DNA counterstaining (Vector Laboratories, USA). Images were obtained using a Zeiss Axio Imager 
M2 confocal laser scanning microscope, equipped with four diode lasers (405, 488, 555, 639), an 
Axiocam camera, and Zen 2009 software (all Carl Zeiss, Germany). Images were processed with 
Image J (version 1.42n) and Adobe Photoshop CS3 (Adobe Systems, USA) software.
 For antibody stripping of chromosome spreads, a western blot stripping buffer (Pierce 
Biotechnology, USA) was used as described [53]. After incubation of chromosome spreads with the 
stripping buffer for 3 minutes at RT, slides were washed twice in PBS-T before undergoing a second 
round of immunofluorescence.
Quantification of immunofluorescence and statistical analysis 
Quantification of immunofluoresence on chromosome spreads of human embryos from the zygote 
to the blastocyst stage was carried out using ImageJ (version 1.42n) and using images obtained 
at identical illumination settings. For assessment of spreading of the stably bound pool of the 
CPC beyond the inner centromeric region, the length of the (peri)centromeric INCENP pool was 
measured and expressed relative to CREST signal length. To do so, a vertical line was drawn following 
the chromosome arms and perpendicular to the axis connecting the two sister centromeres. The 
lengths of the INCENP pool and CREST foci were measured in pixels along this line. The ratio of 
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INCENP/CREST signal length was calculated for all chromosomes within each metaphase plate that 
were spread in a way that allowed accurate immunofluoresence quantification. 
 Statistical analyses were carried out using GraphPad Prism software (GraphPad Software, USA). 
One-way ANOVA followed by Bonferroni’s multiple comparison test allowed comparison of INCENP/
CREST signal length at the zygote, 8-cell and blastocyst stages. A p-value of 0.05 was considered 
statistically significant. 
 For assessment of the localization and distribution of H2ApT120 and H3pT3 relative to INCENP, 
the Freehand Line Selection Tool in ImageJ was used to draw a line following the whole length of 
a representative chromosome. The line width was adapted to match chromosome thickness. The 
average pixel intensity of H2ApT120, H3pT3 and INCENP stainings registered along this line were 
determined using ImageJ and resulting values were plotted in graphs using Excel (Microsoft, USA). 
 To compare H3pT3 and H3pS10 levels between maternal and paternal chromosomes within 
zygotes, parental chromosome sets were identified using the differences in H3K9me3 levels. Mean 
intensities of H3pT3 and H3pS10 in maternal and paternal chromosomes were measured using 
Image J, and the ratio between the two parental areas was calculated.
Results
CPC localization at prometaphase becomes increasingly restricted to the inner 
centromere during development to the blastocyst stage
Our previous work studying CPC constitution in human pre-implantation embryos suggested a 
difference in localization of the CPC in zygotes compared to blastocysts during prometaphase, with 
the CPC being less constricted to the inner centromere at the zygote stage [17]. We aimed to explore 
and quantify this difference further during embryo development at the zygote, 8-cell and blastocyst 
stage (Figure 1b). During the previous study, we confirmed co-localization of INCENP with Aurora 
B and C in the human zygote and blastocyst, respectively. We therefore used immunofluorescence 
of INCENP to evaluate CPC localization relative to the inner centromeric region as delimited by the 
height of the centromeres (detected by a human autoantibody against the centromere (CREST)). We 
determined the size of the INCENP signal relative to CREST signal size on chromosome spreads of 
human embryos arrested at prometaphase with colcemid (Figure 2a).
 We observed a significant decrease of the relative size of the pool of INCENP stably bound to the 
inner centromeric region, when comparing the zygote to later stages of preimplantation embryo 
development. In zygotic prometaphases, INCENP was not confined to the inner centromere, but 
spread into the adjacent pericentric regions. At the blastocyst stage, however, INCENP was mostly 
confined to the inner centromeric region. These differences in INCENP localization were translated 
into a significantly higher mean ratio between the length of INCENP and CREST signals in the 
zygote compared to the blastocyst stage (Figure 2b). The mean INCENP/CREST length ratio in 8-cell 
embryos, although lower than in zygotes, was also significantly higher than in blastocysts. Together 
these results suggest that CPC localization at prometaphase becomes increasingly confined to the 
inner centromeres as embryo development progresses in time. 
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Figure 2 — (a) Immunolocalization of INCENP and centromeres (CREST) on chromosome spreads of colcemid 
arrested human embryos at the zygote, 8-cell and blastocyst stage. DNA was counterstained with DAPI. 
Square boxes are blow-ups of each corresponding smaller box. Scale bars represent 10 μm. (b) Grouped 
scatter plot showing the relative length of INCENP signal normalized over the diameter of the CREST signal 
as measured in pixels. Each dot represents the relative INCENP length measured on a single chromosome, 
as measured in six zygotes, two 8-cell embryos and three blastocysts, respectively (n=number of embryos 
analysed). Horizontal bars represent mean values. ***p<0.05.
Normal localization of H2ApT120, Bub1 and Sgo1 in human pre-implantation embryos
To investigate the mechanisms that determine CPC localization at the inner centromere in 
human zygotes, we first investigated the Bub1-H2ApT120-Sgo-CPC pathway. Immunolocalization 
of H2ApT120 together with INCENP was performed on colcemid induced prometaphase 
chromosomes in zygotes, 8-cell and blastocyst stage human embryos. Similar to somatic cells [31], 
phosphorylation of H2AT120 in all embryonic stages was strongly enriched at centromeric regions 
along the interkinetochore axis, but spreading to the pericentromere was also observed (Figure 
3a). Quantification of H2ApT120 staining intensities along the whole length of representative 
chromosomes showed that peak intensities of H2ApT120 co-localized with those of INCENP 
(Figure 3a). To more accurately analyse H2AT120 phosphorylation dynamics during mitosis 
in zygotes, H2ApT120 was investigated by immunofluorescence at late G2-phase (zygotes at 
20h post-insemination with pronuclei still visible), early prometaphase (30 minutes after NEB) 
and at metaphase (3h after NEB in the presence of the proteasome inhibitor MG132). H2AT120 
phosphorylation was observed from late G2-phase until metaphase, with enrichment along 
the interkinetochore axis from early prometaphase to metaphase (Supplemental Figure 1). CPC 
dynamics as observed by immunolocalization of INCENP followed the expected pattern: it was found 
to be present at pericentric regions at G2 phase and spread to the chromosome arms at prophase/
early prometaphase. INCENP subsequently enriched at the pericentromere at late prometaphase/
metaphase. Gene expression analysis of BUB1, the kinase responsible for phosphorylation of 
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H2AT120, showed similar levels of relative mRNA expression in zygotes and blastocysts (Fiure 3b). 
Consistent with these results and to what has been published before for somatic cells [31,36,54], we 
readily detected Bub1 at the kinetochores (Figure 3c). 
 Recently, it was shown that before bi-orientation of chromosomes is achieved, two distinct pools 
of Sgo1 exist: one at the inner centromere recruited by cohesins and another at the kinetochore 
recruited by H2ApT120 [35,55]. In human zygotes treated with colcemid (non-bioriented 
chromosomes) we observed Sgo1 as expected at both the kinetochore and inner centromeres co-
localizing both with Bub1 and H2ApT120  (Figure 3c). 
 Next to H2ApT120 and cohesins, in somatic cells HP1α is also implicated in Sgo1 recruitment [28-29]. 
Interestingly, early mouse embryos do not express HP1α until after implantation [44,56]. To investigate 
if HP1α has a role in Sgo1 recruitment in human embryos, we performed immunofluorescent 
analysis of HP1α in zygotes. At late G2 phase, we detected HP1α in an asymmetric pattern similar 
to H3K9me3, with high global levels on maternal chromatin and enrichment at heterochromatic 
regions at paternal chromatin (Figure 3d, arrowheads, [45]). In colcemid arrested zygotes at early 
prometaphase, HP1α localization was observed to become unrelated to parental origin and to 
become weakly associated with the centromeric regions (Figure 3d). 
 Together, these findings suggest a functional Bub1-H2ApT120-Sgo-CPC feedback loop in human 
zygotes and later stages investigated, including a possible interaction with HP1α for INCENP and 
Sgo1 recruitment [27-28,31,34].
H3pT3 fails to enrich at the inner centromere on (pro)metaphase chromosomes in 
human zygotes 
In somatic cells it has been shown that Haspin phosphorylates H3T3, providing a chromatin binding 
site for the CPC required for centromeric enrichment [37]. In HeLa and U2OS cells, phosphorylation of 
H3T3 becomes enriched at the inner centromere during prometaphase [34,38]. Similar enrichment 
was readily observed on colcemid-induced prometaphase chromosomes of 2-cell, 8-cell and 
blastocyst stage embryos (Figure 4a). However, on colcemid-induced prometaphase chromosomes 
in zygotes, immunolocalization of H3pT3 revealed ubiquitous phosphorylation on the whole length 
of the chromosome, without enrichment at the centromere (Figure 4a). To exclude an effect of 
incubation in colcemid or timing of fixation on this aberrant finding in zygotes, H3pT3 dynamics 
were further investigated in zygotes at late G2-phase, early prometaphase without spindle poison, 
and at MG132 induced metaphase arrest (Supplemental Figure 2). The absence of H3pT3 staining 
in late G2-phase zygotes indicates that H3T3 phosphorylation is probably initiated at the onset 
of mitosis as expected [38]. Subsequently, ubiquitous phosphorylation of H3T3 was consistently 
observed on chromosomes at prometaphase and metaphase, without centromeric enrichment. 
Simultaneous detection of INCENP revealed pericentric enrichment at metaphase, although H3pT3 
failed to enrich at centromeric regions. 
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Figure 3 — (a) Immunolocalization of H2ApT120, INCENP and centromeres (CREST) on chromosome spreads 
of colcemid arrested human embryos at the zygote, 8-cell and blastocyst stage. DNA was counterstained with 
DAPI. All scale bars represent 10μm. Asterisks indicate the area that is shown enlarged in the detail panel. For 
each stage of development, a graph was plotted representing the distribution of fluorescent intensity for 
H2ApT120 and INCENP along the entire length of a representative chromosome (*). Intensity was measured 
in arbitrary units and distance in pixels. (b) Relative mRNA expression of BUB1 over HPRT1 in human zygotes 
(n=5) and blastocysts (n=5). (c) Upper panel: immunolocalization of Bub1, Sgo1 and centromeres (CREST) on 
chromosome spreads of colcemid arrested human zygotes, 2h after NEB. Lower panel: immunolocalization 
of H2ApT120, Sgo1 and centromeres (CREST) on chromosomes of colcemid arrested human zygotes, fixed 
whole mount 2h after NEB. Shown is a full projection of Z-sections. DNA was counterstained with DAPI. Scale 
bars represent 10μm. Asterisk indicates the area that is shown enlarged in the detail panel. (d) Upper panel: 
immunolocalization of HP1α and H3K9me3 in human zygotes at late G2 stage, fixed whole mount 20h post 
insemination. Shown is a full projection of Z-sections. Lower panel: immunolocalization of HP1α and INCENP 
on chromosome spreads of colcemid arrested human zygotes. DNA was counterstained with DAPI. Scale bars 
represent 20 μm (upper panel) and 10 μm (lower panel). Asterisk indicates the area that is shown enlarged 
in the detail panel.
In U2OS cells the joint action of PP1γ and Repo-Man was shown to dephosphorylate H3T3 during 
prometaphase, ensuring centromeric H3pT3 enrichment [39,57]. The persistent phosphorylation of 
H3T3 on the chromosome arms at prometaphase and metaphase in human zygotes is reminiscent 
of the phenotype of Haspin overexpression or Repo-Man knockdown [39]. As the balance between 
PP1γ/Repo-Man and Haspin expression was demonstrated to be important for correct localization of 
the CPC, we analysed mRNA expression in human zygotes and blastocysts. Contrary to expectations, 
quantification of Haspin mRNA (GSG2) levels revealed low relative expression of Haspin in human 
zygotes, whereas Repo-Man mRNA (CDCA2) expression levels between zygotes and blastocysts were 
not significantly different (Figure 4b). However, this does not exclude the possibility of Haspin protein 
accumulation in the cytoplasm of human oocytes, as evidenced by the presence of H3pT3 on the 
chromatin. Immunodetection of Repo-Man showed similar levels of this protein on the chromosome 
arms of prometaphase-arrested zygotes, when H3pT3 is ubiquitous, and later embryonic stages, 
when H3pT3 is absent from the chromosome arms (Figure 4c). Interestingly, expression levels of 
PP1γ mRNA (PPP1CC) were found to be significantly lower in the zygote compared to the blastocyst 
stage (Figure 4c). However, removal of H3pT3 from the chromosome arms appears to occur normally 
during mitosis at the 2-cell stage (Figure 4a). As transcription is limited to only a handful of genes 
between the zygote and the 2-cell stage [48], transcription activation of Repo-Man or PP1γ in 
this interval is unlikely. The observed persistent phosphorylation of H3T3 on the chromosome 
arms of zygotes is therefore not likely to be explained by lack of Repo-Man or PP1γ expression. 
During prophase, Aurora B phosphorylates Repo-Man, preventing its recruitment to chromatin. 
The phosphatase PP2A normally counteracts this phosphorylation during prometaphase, allowing 
the targeting of Repo-Man to chromosomes and the removal of H3pT3. Our findings suggest this 
mechanism to be altered in human zygotes, as centromeric enrichment of H3pT3 is not necessary 
for inner centromeric localization of INCENP in the zygote. 
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Haspin activity is needed for mitotic checkpoint establishment and centromeric 
targeting of the CPC in the zygote 
To further investigate the importance of Haspin mediated H3T3 phosphorylation for CPC localization 
in human zygotes, we incubated zygotes with colcemid in combination with the Haspin inhibitor 
5-iodotubercidin (Itu) (Figure 1b). Colcemid inhibits spindle formation and chromosome attachment, 
normally leading to prometaphase arrest due to sustained mitotic checkpoint activity. Whereas 
human zygotes normally have completed cytokinesis by 3 hours after NEB, colcemid treatment 
induces cell cycle arrest for >24h (Supplemental Figure 3). However, when Itu was added directly 
after NEB, the presence of colcemid did not result in prometaphase arrest. Zygotes incubated with 
colcemid and Itu showed faster cell cycle progression and had cleaved already around 2 hours 
after NEB (n=5; Supplemental Figure 3). A similar effect of Itu addition on mitotic progression was 
reported in HeLa and U2OS cells, reportedly caused by the inability of Aurora B to efficiently recruit 
the MC subunits Bub1 and BubR1 to kinetochores during prophase [41,58]. In analogy to this, Haspin 
activity appears to be similarly needed for MC establishment in the zygote. 
 To further study the effect of Haspin inhibition on CPC activity and localization, zygotes were first 
treated with colcemid for 1.5h to induce prometaphase arrest and subsequently Itu was added. 
Immunolocalization of H3pT3 in these zygotes showed that Haspin inhibition at this stage results 
in a severe decrease of H3pT3 along the chromosome arms (Figure 5a) in comparison with zygotes 
arrested with colcemid only (Figure 4a). As levels of H3pT3 are already high on early prometaphase 
chromosomes in untreated zygotes (Supplemental Figure 2), the observed decrease in H3pT3 levels 
in Itu-treated zygotes is probably secondary and due to existing phosphatase activity. that is no 
longer be counterbalanced by Haspin activity. Further, Haspin inhibition also resulted in a reduction 
of centromeric INCENP levels, with a more diffuse localization when compared to untreated 
zygotes (compare Figure 4a and Figure 5a). Aurora B/C kinase phosphorylates H3S10 along the 
chromosome arms, as shown in colcemid treated zygotes (Figure 5b). Haspin inhibition by Itu 
addition at prometaphase does not obviously affect overall H3pS10 levels, however, different levels 
of H3pS10 were observed between chromosomes within a single prometaphase spread (Figure 
5b). We hypothesized that this difference was related to the parental origin of the chromosomes. 
Therefore, after detection of H3pS10 and image analysis, we performed antibody stripping followed 
by a second round of immunostaining to detect trimethylation of H3K9 [53]. This allows distinction 
between maternal (enriched for H3K9me3) and paternal (low levels of H3K9me3) chromosomes [47]. 
Indeed, altered levels of H3pS10 after Itu treatment correlate with parental origin of chromosomes: 
mean immunofluorescent intensities on maternal chromosomes were  63% (±19%, n=7) of that on 
paternal chromosomes (Figure 5b). Thus, Haspin inhibition and/or the reduction in H3pT3 levels 
results in lower levels of Aurora B/C activity on maternal chromatin. 
 To determine the effect of Itu treatment during prometaphase on Bub1 activity, H2ApT120 was 
investigated. This mark was detected at the kinetochores, comparable to zygotes treated with only 
colcemid (compare Figures 3a with 5c). This is in line with previous findings in somatic cells, where 
Haspin activity is important for recruitment of Bub1 to kinetochores, but not for Bub1 activity once 
it localizes to the kinetochore [41,58]. Notably, in the absence of H3pT3, the presence of H2ApT120 
alone was not enough to fully target the CPC to the inner centromere. Altogether, these data show 
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Figure 4 — (a) Immunolocalization of H3pT3, INCENP and centromeres (CREST) on chromosome spreads of 
colcemid arrested human embryos at the zygote, 2-cell, 8-cell and blastocyst stage. DNA was counterstained 
with DAPI. All scale bars represent 10 μm. Asterisks indicate the area that is shown enlarged in the detail 
panel. For each stage of development, a graph was plotted representing the distribution of fluorescent 
intensity for H3pT3 and INCENP along the entire length of a representative chromosome (*). Intensity was 
measured in arbitrary units and distance in pixels.  (b) Relative mRNA expression of Haspin (GSG2) (n=5), 
Repo-Man (CDCA2) (n=4) and PP1γ (PPP1CC) (n=4) over HPRT1 in human zygotes and blastocysts. *p<0.05 
compared to the zygote stage. (c) Immunolocalization of Repo-Man, INCENP and centromeres (CREST) on 
prometaphase-arrested human embryos, fixed whole mount at the zygote (n=2) and 8-cell (n=3) stage. DNA 
was counterstained with DAPI. Shown is a full projection of Z-sections. All scale bars represent 10 μm.
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Figure 5 — (a) Immunolocalization of H3pT3, INCENP and centromeres (CREST) on chromosome spreads 
of human zygotes 2.5h after NEB, after culture with colcemid and the Haspin inhibitor 5-iodotubercidin 
(Itu). DNA was counterstained with DAPI. Scale bar represents 10 μm. Asterisk indicates area that is shown 
enlarged in the detail panel. (b) Immunolocalization of H3pS10 and centromeres (CREST) on chromosome 
spreads of human zygotes 2.5h after NEB after culture with colcemid only or with colcemid and the Haspin 
inhibitor 5-iodotubercidin (Itu). Lower panel: immunolocalization of H3K9me3 after stripping and a second 
round of immunofluorescence on the zygote treated with colcemid and Itu. DNA was counterstained 
with DAPI. Scale bars represent 10 μm. (c) Immunolocalization of H2ApT120 and centromeres (CREST) on 
chromosome spreads of human zygotes 2.5h after NEB, after culture with colcemid and the Haspin inhibitor 
5-iodotubercidin (Itu). DNA was counterstained with DAPI. Scale bar represents 10 μm. Asterisk indicates area 
that is shown enlarged in the detail panel.
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Figure 6 — (a) Immunolocalization of H3pS10 and INCENP and of H3pT3, INCENP and centromeres 
(CREST) on chromosome spreads of human zygotes 2h after NEB, after culture with colcemid and 2 µM of 
the Aurora inhibitor ZM447439 (ZM). DNA was counterstained with DAPI. Scale bars represent 10 μm. (b) 
Immunolocalization of H3pS10 and INCENP and of H3pT3, INCENP and centromeres (CREST) on chromosome 
spreads of human zygotes 2h after NEB, after culture with colcemid and 20 µM of the Aurora inhibitor 
ZM447439 (ZM). Lower panel: immunolocalization of H3K9me3 after stripping and a second round of 
immunofluorescence on the zygote of the middle panel, treated with colcemid and 20µM ZM. DNA was 
counterstained with DAPI. Scale bars represent 10 μm. Asterisks indicate the area that is shown enlarged in 
the detail panel.
that Haspin-mediated H3pT3 is required for CPC localization, but centromeric enrichment of H3pT3 
may not be. 
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Aurora kinase inhibition reveals a functional feedback loop between Aurora B/C and 
Haspin in zygotes
In somatic cells, the CPC binds to H3pT3, where in return Aurora B phosphorylates Haspin to promote 
further phosphorylation of H3T3 [37]. The same authors showed that this positive feedback loop is 
disturbed when cells are treated with the Aurora kinase inhibitor ZM447439 (ZM), which leads to 
reduced phosphorylation of endogenous Haspin and concomitant reduction of H3pT3. As Aurora C 
is the main kinetic subunit of the CPC in human zygotes, we investigated whether a similar feedback 
loop is active. 
 As ZM treatment inhibits all Aurora kinase activity [59], we are not able to distinguish Aurora B from 
Aurora C kinase activity. To test the effect of ZM treatment on Aurora kinase activity in zygotes, we 
first applied a concentration that is commonly used in somatic cells [2 µM ZM; [59]] in combination 
with colcemid directly after NEB, and determined the levels of H3pS10 at late prometaphase. 
H3pS10 signal was high and well defined (Figure 6a), similar to what was observed in non-treated 
zygotes (Figure 5b). However, simultaneous detection of INCENP showed disturbed centromeric 
enrichment of INCENP with displacement to the chromosome arms (compare Figure 3a with Figure 
6a). In addition, ZM treatment resulted in reduced levels of H3T3 phosphorylation on most, but not 
all chromosomes (Figure 6a). This reduction of H3pT3 levels after Aurora B/C inhibition indicate a 
functional positive feedback loop between Aurora B/C and Haspin in human zygotes, similar to what 
has been described in somatic cells. 
Abolishment of H3pS10 reveals differences in Haspin activity and CPC recruitment on 
maternal and paternal chromatin 
The high levels of H3pS10 and residual Haspin activity may indicate an insufficient level of Aurora B/C 
inhibition at 2 µM ZM. We next tested a concentration previously shown to efficiently abolish H3pS10 
in mouse zygotes (20 µM ZM, [60]). At this concentration, a complete loss of H3pS10 was observed on 
human zygotic prometaphases (Figure 6b). This concentration also reduced H3T3 phosphorylation 
levels on all chromosomes, with a more severe reduction on a subset of chromosomes within a 
spread. INCENP localization reflected the asymmetric pattern of H3pT3: it was observed to locate 
along the arms on chromosomes with higher levels of H3pT3, whereas on the other chromosomes 
only some INCENP foci were observed (Figure 6b). Comparable to the effect of Haspin inhibition 
on H3pS10 levels, we investigated if the observed differences between chromosomes within one 
zygote after high concentration ZM treatment was related to their parental origin. Using a second 
round of immunofluorescence for H3K9me3, we observed that the effect of complete Aurora B/C 
inhibition on H3pT3 levels was less pronounced on maternal compared to paternal chromatin (Figure 
6b): mean immunofluorescent intensities of H3pT3 on paternal chromosomes were 33% (±6%, n=4) 
of that on maternal chromosomes. Thus, in the presence of a concentration of ZM that abolishes 
H3S10ph phosphorylation, maternally and paternally derived chromosomes have different levels of 
residual Haspin activity. 
 Notably, foci of accumulated INCENP did not localize to the inner centromere, but to H3K9me3-
positive regions of constitutive heterochromatin on the paternal chromosomes (arrows, Figure 6b). 
We have recently shown these regions to correspond to constitutive, pericentric heterochromatin 
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containing DNA Satellite II/III repeats in human zygotes [45]. In somatic cells, inhibition of Aurora B 
with the concomitant reduction in H3pS10, has been shown to result in retention of HP1 proteins on 
mitotic chromosomes [26,61]. As in the absence of H3pS10, HP1 is not evacuated from the chromatin 
and remains bound to H3K9me3, we asked whether the observed asymmetric distribution of 
INCENP in ZM-treated zygotes was due to an association to H3K9me3-anchored HP1α. Indeed, after 
disruption of H3pS10 with ZM treatment, HP1α fails to redistribute and is detected at high levels 
in the same asymmetric distribution on the parental chromosomes as H3K9me3 and as observed 
at G2-phase (Compare Figure 3d with Figure 7a). In addition, Sgo1 did not localize to the (inner) 
centromere after ZM treatment, but followed the same asymmetric pattern as HP1α and INCENP, 
with enrichment at H3K9me3 positive pericentric regions on paternal chromosomes (Figure 7a,b). 
 ZM treatment was previously shown also to abolish phosphorylation of H2AT120 at the centromeres 
in U2OS cells [15]. However, our immunofluorescence analysis shows that in 7 out of 10 zygotes ZM 
treatment did not abolish centromeric H2ApT120 (Figure 7c). Nevertheless, Sgo1 and INCENP still 
consistently failed to show centromeric enrichment indicating that H2ApT120 alone is not sufficient 
for their recruitment after Aurora B/C inhibition. These results are consistent with a role for HP1α in 
facilitating both Sgo1 and INCENP recruitment to chromatin. 
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Figure 7 — (a) Immunolocalization of Sgo1, HP1α and centromeres (CREST) on chromosome spreads 
of human zygotes 2h after NEB, after culture with colcemid and 20 µM of the Aurora inhibitor ZM447439 
(ZM). DNA was counterstained with DAPI. Scale bar represent 10 μm. Asterisk indicates the area that is 
shown enlarged in the detail panel. (b) Immunolocalization of Sgo1, INCENP and centromeres (CREST) on 
chromosome spreads of human zygotes 2h after NEB, after culture with colcemid and 20 µM of the Aurora 
inhibitor ZM447439 (ZM). Only the paternal chromosome set is shown. 2nd round panel: immunolocalization 
of H3K9me3 after stripping and a second round of immunofluorescence of the same zygote. DNA was 
counterstained with DAPI. Scale bars represent 10 μm. (c) Immunolocalization of H2ApT120 and centromeres 
(CREST) on chromosome spreads of human zygotes 2h after NEB, after culture with colcemid and 20 µM of 
the Aurora inhibitor ZM447439 (ZM). DNA was counterstained with DAPI. Scale bars represent 10 μm.
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Figure 8 — Schematic representation of the main findings, highlighting the altered CPC targeting pathways 
in zygotes. The distribution of HP1, Sgo1 and INCENP at the  G2 phase-prophase transition follows the 
epigenetic asymmetry for H3K9me3 on maternal and paternal chromosomes. Whereas the asymmetry for 
H3K9me3 remains, HP1a, Sgo1 and INCENP redistribute in a symmetric fashion during prometaphase by 
action of the mitotic kinases. The Haspin-H3pT3-CPC pathway remains active on the chromosome arms until 
metaphase, while the CPC is enriched around the pericentromeric area. H2ApT120 alone seems insufficient 
for CPC localization, suggesting the existence of additional recruitment factors, where HP1a is a candidate 
for X. See Discussion for further details.
Discussion
Cells of the early human embryo frequently mis-segregate chromosomes during cell division. What 
causes embryos to be so error-prone at this crucial stage during the formation of a new individual 
is largely unknown, as the mechanisms for chromosome segregation used by pre-implantation 
embryos are poorly described. In this work we aimed to explore CPC localization in human embryos 
and assess the functionality of the main kinase pathways regulating CPC targeting as described 
in somatic cells. By interfering in these pathways using specific kinase inhibitors, we demonstrate 
that they are functional in human cleavage stage embryos and we provide indirect evidence for a 
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functional mitotic checkpoint. Similar to somatic cells, CPC localization in cleavage stage embryos 
follows phosphorylation of H3T3 and H2ApT120. We also show that the feedback interactions 
between the three kinases are as expected: Haspin activity is crucial for Aurora kinase activation, 
and in turn Aurora kinase activity is needed for full Haspin activity. In addition, Aurora activity in is 
needed for Bub1 recruitment, but not for Bub1 activity once properly located. Thus, the presence 
of Aurora C in zygotes does not seem to alter the described feedback interactions with Bub1 and 
Haspin. However, we did observe an important difference in Haspin activity specifically in the 
zygote: phosphorylation levels of H3T3 on the chromosome arms remain high until metaphase. 
Notably, when persistent H3pT3 on chromosome arms is induced by either Haspin overexpression 
or phosphatase inhibition in somatic cells, this immediately results in severe CPC displacement to 
the chromosome arms [39,62]. Surprisingly, in zygotes pericentric enrichment of INCENP was already 
observed at early prometaphase, despite ubiquitous presence of H3pT3 on the arms. However, 
we did observe INCENP to be less confined to the pericentromere and we hypothesize that the 
persisting H3pT3 levels on the arms does interfere with precise CPC targeting. 
 The CPC is a key player in ensuring accurate chromosome attachment and alignment and 
also has a function in localizing and sustaining mitotic checkpoint complex activity. In all model 
organisms studied, the CPC becomes increasingly enriched at the inner centromeric region 
during prometaphase of normal mitosis. This enrichment is important for its proper function, as 
experimentally induced CPC displacement results in chromosome alignment defects [22]. Even 
subtle displacement of the CPC, as observed on chromosomes carrying a neocentromere and the 
concomitant lack of the typical pHC epigenetic signature, appears to affect the efficiency of such 
a chromosome to form bipolar attachments and align at the metaphase plate [63]. However, the 
importance of (inner)centromeric CPC enrichment has been recently questioned in budding yeast 
[64], where each kinetochore attaches to a single microtubule. Human kinetochores attach to several 
microtubules, creating the possibility of one kinetochore to attach to both spindle poles (merotelic 
attachment). It is hypothesized that centromeric CPC enrichment may be specifically needed for 
efficient resolution of merotelic attachments [22]. This type of erroneous attachment is not sensed 
by the MC and leads to anaphase lagging [65]. Interestingly, analysis of the type of chromosomal 
abnormalities observed within human pre-implantation embryos show them to be most frequently 
consistent with anaphase lagging events [66-69]. It is thus tempting to speculate that the “sloppy” 
CPC localization we observe here may contribute to an increase in merotelic attachments that 
escape correction, thus leading to chromosome mis-segregation. 
 Due to experimental limitations when working with human embryos, we were unable to resolve 
the underlying mechanism for persisting H3pT3 on metaphase chromosome arms. Net levels of 
H3pT3 are determined by the equilibrium between the phosphorylating activity of Haspin and 
the dephosphorylating activity of Repo-Man, together with the phosphatase PP1γ. Recruitment of 
Repo-Man-PP1γ to chromosome arms is opposed by the presence of Aurora B during prophase/
early prometaphase, but it is recruited to chromosome arms as the CPC becomes centromerically 
enriched (Figure 1a; [39-40]). Our results show similar levels of Repo-Man on chromosome arms 
in prometaphase arrested zygotes and 8-cell embryos. This may indicate that dephosphorylation 
dynamics may not be different between these stages, but that the persistent high levels of H3pT3 
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are the consequence of sustained Haspin activity on chromosome arms in human zygotes. Recent 
reports identified three different kinases to be involved in increased activation of Haspin: during 
interphase it is initially phosphorylated by Cdk1, followed at prophase by Polo-like kinase 1 (Plk1) 
and subsequently Aurora B [70-71]. It is not known if during prometaphase Haspin is subsequently 
dephosphorylated/deactivated at the chromosome arms to ensure centromeric enrichment of 
H3pT3. 
 Cohesion between sister chromatids, mediated by proteins called cohesins, is essential for accurate 
chromosome alignment, but needs to be resolved at anaphase onset. In vertebrate cells, cohesins 
are removed during mitosis in two steps [72]. Cohesins are removed from chromosome arms during 
prophase, while centromeric cohesins are protected from this removal by a mechanism involving Sgo1 
until they are cleaved by the protease Separase at anaphase onset. Cohesin removal during prophase 
involves phosphorylation of cohesins and the cohesion binding protein Sororin, involving the same 
mitotic kinases responsible for activating Haspin (Cdk1, Plk1 and Aurora B) [73-76]. Interestingly, 
overexpression of Haspin and concomitant persisting high levels of H3pT3 on chromosome arms 
is associated with persistent arm cohesins during prometaphase in HeLa cells [62]. In our series 
of both prometaphase and metaphase chromosome spreads prepared from human zygotes, we 
consistently observed chromosomes with closed chromosome arms (Supplemental Figures 1 and 
2), as opposed to chromosomes with the typical X-shape observed at later developmental stages 
(compare stages in Figures 3 and 4). This observation indicates persistence of chromosome arm 
cohesins until zygotic metaphase and is in line with similar observations in mouse zygotes [77]. 
We hypothesize that the persisting high levels of H3pT3 on chromosome arms may have a role in 
protecting arm cohesins from the prophase removal pathway, although the purpose of this odd 
phenomenon and its consequences for chromosome segregation remain unknown. 
 When H3pS10 was completely abolished by inhibition of Aurora B/C an asymmetry in H3pT3 
levels between chromosomes of maternal and paternal origin was revealed. Maternal H3K9me3-
rich chromosomes were able to attract higher levels of residual H3pT3 on the chromosome arms, 
whereas H3pT3 foci co-localized with the few H3K9me3-positive regions of constitutive HC on 
paternal chromatin. Due to the lack of specific antibodies for Haspin, little is known about Haspin 
localization and how it is targeted to chromatin [78]. Our findings suggest an association of Haspin 
with constitutive heterochromatin. This is in line with recent findings suggesting the cohesin binding 
protein Pds5B to promote cohesion establishment and maintenance at pericentric heterochromatin. 
In addition, Pds5B was also found to be required for Haspin recruitment [79]. Alternatively, maternal 
chromatin contains higher levels of HP1α and may thus be able to recruit higher levels of CPC proteins 
through the HP1α-INCENP interaction. This may lead to higher levels of residual Aurora B/C activity 
able to activate Haspin on maternal chromatin. However, when abolishing H3pT3 by inhibiting 
Haspin activity, we observed lower levels of H3pS10 on maternally derived chromatin. Although we 
have no conclusive explanation for this phenomenon, our findings illustrate the importance of full 
Haspin and Aurora B/C activity in ensuring accurate CPC localization in the face of the epigenetic 
parental asymmetry present in the zygote. It is thus conceivable that the observed persisting 
Haspin activity during prometaphase is an adaptation to the asymmetry. It is further conceivable 
that oocyte quality or culture condition-related disturbances in Aurora B/C or Haspin kinase activity 
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have differential effects on maternal and paternal chromosomes. As H3K9me3-rich maternal 
chromatin appears to have an advantage in recruitment of INCENP and Haspin, CPC recruitment to 
paternal chromosomes may be more easily compromised under conditions of suboptimal mitotic 
kinase activity. This may render paternal chromosomes more prone to attachment errors and mis-
segregation, a question that is currently under investigation. 
 We observed that inhibition of Aurora and Haspin kinase at prometaphase did not affect Bub1 
activity at the kinetochore, and H2AT120 phosphorylation was consistently observed at the 
centromeres. However, under these conditions this mark alone was not sufficient for full centromeric 
CPC enrichment, suggesting the existence of additional recruitment mechanisms. H2ApT120 
normally ensures CPC localization through recruitment of Sgo1. Research in somatic cells suggests 
that recruitment of INCENP and Sgo1 by HP1α at interphase is needed for their subsequent 
centromeric recruitment at prometaphase, but this matter is still under debate [27-28,80]. Under 
high ZM conditions, where H3pS10 was completely abolished in human zygotes, HP1α remained 
localized to H3K9me3, and did not relocate to the centromeric region at prometaphase. Both Sgo1 
and INCENP remained co-localized to H3K9me3/HP1α, suggesting that these proteins bound directly 
or indirectly to H3K9me3-anchored HP1α. These findings support a role for HP1α in recruitment 
of INCENP and Sgo1 at interphase and indicate that displacement of HP1α through Aurora kinase 
activity is needed to enable relocation of INCENP and Sgo1 to the centromeric region. 
 Using a more accessible model such as mouse embryos would enable more conclusive experiments. 
However, chromosome segregation regulation in mouse embryos may not be representative, 
as mouse embryos have very low spontaneous mitotic error rates [81]. Also, in the mouse zygote 
alternative mechanisms are used to format paternal pHC that do not rely on the H3K9me3 pathway 
[44]. As mouse embryos also lack HP1α expression [44], it is likely that different mechanisms have 
evolved for INCENP and Sgo1 recruitment. Therefore, despite the ethical and practical limitations, 
this study yields valuable insight into the possible origins of human embryo aneuploidy that could 
not have been obtained by the study of mouse embryos. 
 Our findings indicate differences in the dynamics of the Haspin-H3pT3-CPC feedback loop and 
H3pT3 dephosphorylation by Repo-Man/PP1γ during prometaphase in human zygotes compared 
to later embryonic stages and normal mitosis (Figure 8). It is conceivable that the observed 
persisting Haspin activity is an adaptation needed to ensure symmetric CPC recruitment, despite 
the parental epigenetic asymmetry. As removal of H3pT3 from the chromosome arms during 
prometaphase normally contributes to further centromeric enrichment of the CPC in somatic cells 
[40], we hypothesize that this adaptation may come at a price concerning accurate CPC targeting 
in zygotes. However, further research is needed to what extent the differences we observed in CPC 
localization affect the prevention and/or correction of erroneous attachments. In future studies it 
will be interesting to assess if the error correcting ability of the CPC is compromised in the zygote 
and if differences exist in this aspect between maternal and paternal chromosomes. 
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Supplementary Figure 1 — Immunolocalization of H2ApT120, INCENP and centromeres (CREST) on whole 
mount human zygotes at late G2/prophase, and chromosome spreads prepared at the early prometaphase 
and metaphase stage. Zygotes at early prometaphase were fixed 30 min after NEB in the absence of cell cycle 
inhibitors. Zygotes at metaphase were cultured directly after NEB in the presence of the proteasome inhibitor 
MG132 and fixed 3h later. DNA was counterstained with DAPI. Scale bars represent 10 μm.
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Supplementary Figure 2 — Immunolocalization of H3pT3, INCENP and centromeres (CREST) on whole 
mount human zygotes at late G2/prophase, and chromosome spreads prepared at early prometaphase and 
metaphase stage. Zygotes at early prometaphase were fixed 30 min after NEB in the absence of cell cycle 
inhibitors. Zygotes at metaphase were cultured directly after NEB in the presence of the proteasome inhibitor 
MG132 and fixed 3h later. DNA was counterstained with DAPI. Scale bars represent 10 μm.
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Many cellular processes in pre-implantation embryos are clearly different from what has been 
described in somatic cells. Our interest in chromosomal abnormalities in human pre-implantation 
embryos [1-4] has lead us to investigate two of these differences: the establishment of constitutive 
heterochromatin and the composition and targeting of the chromosomal passenger complex. In 
this chapter, we discuss the main findings of our studies and the implications of those findings for 
future clinical procedures and research.
Modified histones retained in human spermatozoa contribute to the 
establishment of embryonic chromatin structure
Chromatin structure re-establishment is one of the most important processes after fertilization, 
as chromatin structure is essential for the regulation of gene expression, differentiation and 
chromosome segregation (see chapter 1). In chapter 2 we describe our investigation on the re-
establishment of a prominent heterochromatin domain, constitutive heterochromatin (cHC), and 
the possible contribution of sperm chromatin to this process. 
 Our results show that histones carrying canonical cHC modifications (H3K9me3, H4K20me3, 
H3K64me3) are retained in spermatozoa and transmitted to the embryo. These modified histones 
contribute to the formation of paternal embryonic cHC, as they are recognized by maternal 
chromatin modifiers of the SUV39H/HP1 pathway and propagated over the embryonic cleavage 
divisions. These results indicate transgenerational epigenetic inheritance of cHC structure in human 
embryos and identify an additional role of sperm in embryo development. 
 The mechanism of cHC re-establishment has been studied extensively in mouse embryos 
and findings in this animal model are frequently assumed to be generally applicable for all 
mammalian species [5-8]. However, we now have shown that the mechanism in human embryos 
differs significantly from what has been described for mice. Mouse paternal cHC lacks canonical 
cHC marks and is formatted by a backup mechanism (Polycomb proteins) during the first stages 
of embryo development [9]. In contrast, we find human cHC to be transmitted in the canonical 
configuration from the spermatozoon to the embryo, which not appear to possess – or need – the 
backup mechanism. This indicates that in human embryos there is no need for complete chromatin 
structure re-establishment, as the canonical cHC structure is never entirely lost. This might also be 
true for other chromatin domains. We therefore hypothesize that the epigenetic contribution of 
the human spermatozoon allows human pre-implantation embryos to maintain a canonical-like 
chromatin structure and might thereby obviate the need for a complete epigenetic reprogramming. 
This may explain observations in stem cells research; human embryonic stem cells have shown 
reduced plasticity when compared to mouse embryonic stem cells [10-11]. Whether these species 
differences relate to differences in chromatin structure remains to be investigated. Importantly, 
our results show that mouse pre-implantation embryos are not a representative animal model to 
study epigenetic regulation of human pre-implantation embryo development. This underlines 
the importance of research on human embryos, which will improve our understanding of human 
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embryo development, embryonic stem cells and the influence of in vitro culture conditions during 
IVF treatments. 
 The epigenetic contribution of spermatozoa to embryo development raises the question whether 
there are variations between spermatozoa that might have an impact on embryo developmental 
potential. During mammalian spermiogenesis, histones are replaced by protamines. In humans, 
5-15% of the DNA appears to be protected against this histone removal and retains a nucleosomal 
structure (for review see [12]). Some studies have shown that modified histones are retained at 
promoters of genes involved in early embryo development [13-15]. In one of these studies, the authors 
describe that in infertile men, the number of retained histones is both higher and more variable 
than in fertile men, and that the histones are retained in a more dispersed pattern throughout the 
genome [15]. Another study demonstrated that there is an increase in the nucleosome/protamine 
ratio in spermatozoa from male factor subfertility patients [16]. Variations like these may interfere 
with the function of a specific histone retention pattern and thereby affect embryo development. As 
chromatin structure is important for regulation of gene expression and chromosome segregation, 
we hypothesize that variation in histone content between spermatozoa may have an impact on 
embryonic chromatin and thereby on developmental potential. It would be interesting to study the 
variation in chromatin structure between spermatozoa in more detail and to investigate whether 
it correlates with factors such as sperm quality based on morphological examination and patient 
characteristics, e.g. age, weight and lifestyle. These kind of studies might results in a marker for male 
fertility and lead to the development of new diagnostic, or even prognostic, tests which enable 
patient-tailored counseling and treatment. If future techniques provide tools to detect subtle 
differences in sperm chromatin structure, sperm selection could be based on sperm content, in 
addition to sperm morphology. This would be a novel approach to optimize IVF outcome. 
Chromosomal passenger complex composition and localization are 
different in the first stages of human embryo development
In somatic cells, the chromosomal passenger complex (CPC) plays a crucial role in the prevention 
of chromosome missegregation by ensuring accurate chromosome attachment and regulating 
mitotic checkpoint complex (MCC) activity (see chapter 1). In human pre-implantation embryos, 
chromosomal abnormalities are detected at high frequencies [1,4,17-26], which suggest impaired 
functionality of these mechanisms. Therefore, we investigated composition (chapter 3) and 
localization (chapter 5) of the CPC in human pre-implantation embryos derived from IVF. 
 In chapter 3, we describe a difference in composition of the CPC during the first embryonic 
cleavage divisions, as compared to somatic cells. In somatic cells, Aurora B is the kinetic subunit 
of the CPC. In pre-implantation embryos, from the zygote (embryonic day 1) up to the 8- to 16-cell 
stage (embryonic day 3 and 4), we found Aurora C to be the main kinetic subunit present in the CPC. 
Around the morula stage (embryonic day 4), Aurora C levels at the inner centromere decrease and at 
the blastocyst stage (embryonic day 5) Aurora C is completely replaced by Aurora B.
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Aurora C has been known as the meiotic counterpart of Aurora B and is thus present in oocytes. 
Due to different mRNA and protein characteristics, Aurora C is less susceptible to degradation in 
comparison with Aurora B [27-29]. This might explain why Aurora C is still present after meiosis, 
whereas Aurora B is degraded. Possibly, this also explains why Aurora C is needed during the first 
mitotic divisions of the embryo; before embryonic genome activation, embryos rely on maternal 
transcripts, which are stored in the oocyte.
 As Aurora C is present only during the first cleavage divisions of embryos, which are more prone 
to segregation errors than mitotic division later during development [4], it is tempting to speculate 
about a link between Aurora C and chromosome missegregation. Aurora C has been shown to 
compensate for the absence of Aurora B in HeLa cells [30-31] and mouse pre-implantation embryos 
[32], enabling normal progression of mitosis. Although possible subtle aneuploidies were not 
examined in these cells, there was no indication of reduced error-correction activity of Aurora C. 
However, several studies have shown that overexpression of the Aurora kinases and an imbalance 
in expression of Aurora B and Aurora C lead to chromosome segregation errors [33-35]. In our study, 
we detected varying ratios of Aurora B and Aurora C in human oocytes. Therefore, we hypothesize 
that these differences in concentration, rather than the presence of Aurora C, might influence the 
accuracy of the error-correction mechanism. Investigation of the differences between the two 
Aurora kinases, for example of their substrates and binding partners, and the regulation of their 
expression might provide some clues to understand the function of these kinases in the regulation 
of chromosome segregation in pre-implantation embryos. Also, since it is know that female age is an 
important factor in oocyte quality [36-37], it would be of interest to determine whether the Aurora 
B/C ratio is influenced by maternal age.
 Precise inner centromeric CPC localization is crucial for accurate function of the error-correction 
mechanism [38-39]. In chapter 5 we describe our investigation into the localization of the CPC in 
the first embryonic divisions. For this investigation, we made use of the technique we developed 
and described in chapter 4. With this ‘stripping’ technique, we were able to perform sequential 
immunofluorescent analysis on the same chromosome preparation, which allowed us to investigate 
co-localization of several proteins and histone modifications that play a role in CPC localization. 
The ability to perform two immunofluorescent analyses on the same material is particularly useful 
in our studies on chromosome segregation and chromatin structure in human oocytes and pre-
implantation embryos, since this material is rare and valuable.
 Previously, it was hypothesized that the extremely high incidence of chromosomal abnormalities 
in human embryos were due to a lack of a functional mitotic checkpoint [21]. Using different kinase 
inhibitors in our investigation of CPC localization pathways (chapter 5), we demonstrate that 
feedback loops between CPC and MCC proteins, as described in somatic cells [40-43], are functional 
and that the checkpoint is active. Therefore, we hypothesize that chromosomal abnormalities in 
human embryos do not arise because of a total lack of mitotic checkpoint function activity. However, 
this does not rule out the possibility of more subtle differences in checkpoint functionality. 
 In chapter 5, we found CPC localization to be less confined to the inner centromeric region in 
zygotes than at later developmental stages. Also, we found that in the zygote stage, one of the 
pathways for CPC targeting (see chapter 1) is different; H3T3 phosphorylation failed to enrich at the 
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centromeric region on metaphase chromosomes in human zygotes. From the 2-cell stage onwards, 
H3pT3 was detected in a normal pattern and towards the blastocyst stage, CPC localization slowly 
normalized too. These findings suggest that centromeric targeting of the CPC is controlled differently 
and possibly less accurate in zygotes and to a lesser extent also in cleavage stage embryos. It is 
tempting to speculate that altered CPC targeting and localization contribute to the occurrence of 
chromosomal abnormalities. Future research should elucidate if this is the case, for example by 
investigating the error-correcting ability of the CPC in the first mitotic division of embryos.
 Despite abundant H3pT3 on chromosome arms in zygotes, the CPC still localizes to the 
centromeric area, suggesting that centromeric CPC localization is not completely dependent on 
centromeric enrichment of H3pT3. Still, CPC localization is less restricted to the centromere, so 
the different H3pT3 pattern may have an impact on the accuracy of the CPC targeting. Studies in 
somatic cells support this hypothesis, as induced abundant H3pT3 on the chromosome arms leads 
to CPC mislocalization [44]. However, the pattern of H3pT3 normalizes already in the 2-cell stage, 
whereas CPC localization normalizes slowly towards the blastocyst stage. Thus, more factors will 
probably underlie the less accurate CPC localization during the cleavage divisions. Differences in the 
pathways that regulate CPC targeting may be an explanation for chromosome missegregation in 
embryos, as subtle changes in CPC localization are known to affect chromosome alignment and the 
error-correction mechanism [38-39,43]. Next to this, high levels of H3pT3 on chromosome arms were 
shown to affect mechanisms responsible for cohesion resolution in somatic cells [45], which leads 
to chromosome segregation defects. Thus, the observed difference in H3pT3 localization in human 
zygotes may have different consequences for the regulation of chromosome segregation and might 
cause chromosome segregation to be more error prone. 
 Taken together, results described in chapter 3 and chapter 5 show that there are differences in 
both CPC composition and localization in the first mitotic divisions of embryos, compared with 
mitotic divisions in later embryonic stages and somatic cells. Presence of Aurora C as the main CPC 
kinase and different targeting and localization of the CPC might lead to a less accurate regulation of 
chromosome segregation. Further research is needed to determine if the differences we observed 
indeed affect the prevention and correction of erroneous chromosome segregation, for example by 
assessing if the error correcting ability of the CPC is different in the first cleavage divisions. 
 Our knowledge on the high rate of chromosomal abnormalities is almost exclusively derived from 
embryos generated by IVF. It is possible that our observations are induced by the IVF procedure, for 
example through influence of hormonal treatment or in vitro embryo culture. However, chromosomal 
abnormalities are also observed after natural cycle IVF and in in vivo fertilized porcine and bovine 
embryos, indicating that embryo’s of certain mammalian species are predisposed to chromosome 
segregation errors. Whether (suboptimal) IVF procedures increase the chance on these errors is 
very hard to examine, because of ethical and practical difficulties in obtaining human in vivo pre-
implantation embryos. Still, our increasing knowledge on chromosome segregation in IVF-derived 
embryos is relevant for daily IVF practice and future optimization of IVF procedures.
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Is altered chromosomal passenger complex composition and localization 
an adaptation to epigenetic asymmetry between maternal and paternal 
chromatin? 
As described in chapter 3 and chapter 5, both the composition and the localization of the CPC in 
pre-implantation embryos differ from what has been described in somatic cells. Next to that, there 
are differences in the structure of chromatin, most prominent of which is the asymmetry between 
paternal and maternal chromatin, as described in chapter 2. In our investigation of CPC localization 
(chapter 5), we revealed an effect of this epigenetic asymmetry on CPC localization under certain 
experimental conditions.
 To investigate the mechanism of CPC targeting, we used an inhibitor of Aurora kinase activity. 
As a result, the histone modifications induced by Aurora kinase directly (H3pS10) and indirectly 
via Haspin activation (H3pT3) were dramatically reduced. Surprisingly, maternal and paternal 
chromosomes showed different effects of the inhibitor. On maternal chromosomes, which are 
H3K9me3-positive along the whole chromosome, both residual H3pT3 and CPC levels were higher, 
and CPC localization was less restricted to the inner centromere. On paternal chromosomes, which 
are H3K9me3-positive at cHC regions only, H3pT3 and the CPC were detected at lower levels and 
the CPC mainly localized to the cHC, which is localized not only pericentrically, but also in large 
blocks on certain chromosomes, referred to as knobs [46]. Based on these results, we propose that 
Aurora kinase activity, possibly Aurora C activity specifically, and the altered Haspin-H3pT3 pathway 
are necessary to compensate for the epigenetic asymmetry in zygotes. Possibly, Aurora C-mediated 
H3pS10 and Haspin-mediated H3pT3 equalize maternal and paternal chromatin, for example by 
inhibiting the binding of chromatin regulators to the DNA, and thereby cover the difference in 
H3K9me3 and related cHC marks. Hence, these mechanisms might be an adaptation to the extreme 
parental epigenetic asymmetry in zygotes, in order to ensure similar CPC localization on maternal 
and paternal chromosomes. As a consequence of these mechanisms having to deal with epigenetic 
asymmetry, chromosome segregation might become more error-prone. Therefore, the altered CPC 
targeting and the epigenetic asymmetry between parental chromosomes might together explain 
the high rates of chromosome segregation errors in human pre-implantation embryos.
 Similar to human embryos, extreme parental asymmetry has been described in mouse embryos. 
Also, Aurora C seems to be involved in early mouse development [29], and we detected persisting 
H3pT3 in mouse zygotes (unpublished observations). Interestingly, these features do not result in 
high rates of chromosomal abnormalities in mouse embryos. Possibly, different mechanisms for CPC 
targeting or the Polycomb backup mechanism for marking paternal cHC [9] create a more reliable 
error-correction mechanism. Therefore, the transfer and maintenance of H3K9me3 in paternal 
chromatin of human embryos may be an underlying cause of error-prone chromosome segregation.
 Until recently, research into the origin of chromosomal abnormalities has focused mainly 
on causative factors in the oocyte. Future research should focus on the possible contribution of 
the spermatozoon. It would be of interest to investigate the possible variation in the epigenetic 
signature of cHC in human spermatozoa, and to determine whether this variation is transferred 
to paternal embryonic chromatin. Since cHC is important for correct chromosome segregation 
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[47-48], we hypothesize that variations in the histone retention pattern of spermatozoa might affect 
chromosome segregation mechanisms in embryos. Analyzing the variation in the epigenetic make-
up of spermatozoa and the consequences of this for the regulation of chromosome segregation 
in early embryos, hope to underlying causes of aneuploidy in human embryos. Knowledge of 
the influence of sperm quality on embryo developmental potential may provide clues to further 
optimize IVF procedures in the future. 
Concluding remarks
The first embryonic cleavage divisions are mitotic divisions, but they differ from somatic mitosis in 
many aspects [49]. Paternal and maternal chromosomes coming from two epigenetically different 
gametes need to be aligned on a single metaphase plate, a situation likely to require adaptations 
in chromosome segregation regulation. Our findings show that the mechanisms that regulate 
CPC function and localization are altered in the first cleavage divisions of human embryos and 
we hypothesize that this is related to the epigenetic asymmetry between maternal and paternal 
chromatin. Although these mechanisms may be altered to ensure the best possible CPC targeting 
in a situation that is very different from somatic cells, CPC localization and function may be less 
accurate and that may lead to a reduced efficiency of the error-correction mechanism. This might 
be an explanation for the high rates of chromosome segregation errors in human pre-implantation 
embryos. Our hypothesis is supported by the observation that both the normalization of CPC 
composition and localization and the equalization of paternal and maternal chromatin marks around 
the morula stage (embryonic day 4) coincide with a decrease in chromosome segregation errors. 
Since we show that spermatozoa make a significant contribution to chromatin structure in embryos, 
it would be interesting to investigate the influence of sperm quality on chromosomal abnormalities 
and developmental competence of embryos. 
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Summary
Chapter 1
Currently, the average pregnancy rate per embryo transfer after in vitro fertilization (IVF) is around 
32%. In order to achieve better results in the future, we need to gain knowledge on all aspects of the 
treatment, including pre-implantation embryo development. 
 In this thesis, we describe the research we performed into epigenetics and chromosome 
segregation in human pre-implantation embryos derived from IVF. The term ‘epigenetics’ refers to 
heritable marks on the genome, such as DNA methylation and histone modifications. These marks are 
essential for chromosome structure, chromosome segregation and gene expression. Chromosome 
segregation is the process in which duplicated chromosomes are equally separated over two cells 
during cell division. 
 Chromosomal abnormalities are detected at high frequencies in human pre-implantation embryos. 
This suggests that mechanisms regulating chromosome segregation are less functional during the 
first cell divisions of an embryo. Next to that, epigenetic marks, which are also important for correct 
chromosome segregation, are different in oocytes and spermatozoa and need to be re-established 
in early embryos. The research described in this thesis aimed to investigate both the mechanisms 
regulation chromosome segregation and the re-establishment of epigenetics marks in human pre-
implantation embryos, in order to shed light on the causes of chromosomal abnormalities. 
Chapter 2
DNA is wrapped around histones, together forming chromatin. Epigenetic marks like histone 
modifications determine the structure of chromatin and define certain chromatin domains. 
Oocytes and spermatozoa have a very different chromatin structure, both from each other and from 
somatic cells, and after fertilization, canonical chromatin domains need to be re-established. In this 
chapter we investigated the re-establishment of a chromatin domain important for chromosome 
segregation, constitutive heterochromatin (cHC), in human pre-implantation embryos derived from 
IVF.
 We describe that human spermatozoa carry histones with canonical cHC modifications (H3K9me3, 
H4K20me3, H3K64me3). After fertilization, these modified histones contribute to the formation 
of paternal embryonic cHC. The histone modifications are recognized by maternal chromatin 
regulators (e.g. HP1, SUV39H) and propagated over the embryonic cell divisions. These results 
indicate transgenerational epigenetic inheritance of cHC structure in human embryos and show 
that there is an important contribution of the spermatozoon to embryo development.
 Until now, this process was studied only in mouse embryos, in which paternal cHC in spermatozoa 
and embryos lacks canonical modifications and is transiently established by other mechanisms, 
present in the oocyte. Often these results are assumed to be applicable for all mammalian species. 
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However, we now show that the mechanism in human embryos differs significantly from what has 
been described for mice. This points out that mouse embryos are not a representative animal model 
and underlines the need for research on human embryos. 
Chapter 3
One of the most important players in the regulation of chromosome segregation is a protein complex 
named chromosomal passenger complex (CPC). The CPC consists of the proteins Survivin, Borealin, 
INCENP and Aurora kinase B in somatic cells divisions (mitotis). In this chapter we investigated 
presence and composition of the CPC in human pre-implantation embryos derived from IVF. 
 We describe that the composition of the CPC in the first embryonic cell divisions is different from 
what has been described for somatic cells. In somatic cells, Aurora B is the kinetic subunit of the CPC. 
In pre-implantation embryos, from the zygote (day 1 of embryonic development) up to the 8- to 
16-cell stage (day 3), we found Aurora C to be the main kinetic subunit present in the CPC. Until 
now, Aurora C has been described only in the cell divisions of germ cells, which result in oocytes 
and spermatozoa (meiosis). Around the morula stage (day 4), Aurora C levels decreased and at the 
blastocyst stage (day 5) Aurora C was completely replaced by Aurora B again. As subtle differences 
between the Aurora kinases might lead to less accurate regulation of chromosome segregation, the 
different composition of the CPC may contribute to chromosome segregation errors, which lead to 
chromosomal abnormalities, in the first cell divisions of human embryos.
Chapter 4
Immunofluorescence has been widely used to study histone modifications and proteins involved 
in the regulation of chromosome segregation. Although it is important to study co-localization of 
these modifications and proteins, this is very difficult due to the limited availability of antibodies 
derived from different host species. For Western blot membranes, buffers were developed to remove 
antibodies after the first round of detection, called ‘stripping’, and thereby enable a second round 
of detection. 
 In this chapter, we describe that we were able to apply the stripping principle for sequential 
immunofluorescence on chromosome preparations of diverse cell types and human embryos. We 
show feasibility and reliability of detection of histone modifications and proteins in two rounds of 
immunofluorescence. This method is a reliable option when co-localization needs to be investigated 
and the choice of antibodies or the material, for example in case of human embryos, is limited.
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Chapter 5
Precise localization of the CPC at the inner centromeric area of chromosomes is crucial for accurate 
regulation of chromosome segregation. This localization is regulated by two histone modifications, 
H2ApT120 and H3pT3, which are catalyzed by the proteins Bub1 and Haspin respectively. In this 
chapter we investigated the localization of the CPC during the first cell divisions of human pre-
implantation embryos derived from IVF.
 We describe that CPC localization is less restricted to the inner centromere in the first embryonic 
cell division and that during the subsequent cell divisions, it becomes increasingly restricted, 
comparable with its localization in somatic cells. Of the two pathways that regulate inner centromeric 
localization of the CPC, we found the Bub1-H2ApT120 pathway to be comparable with what has 
been described for somatic cells. However, the Haspin-H3pT3 pathway was different in zygotes, 
during the first cell division of the embryo; instead of only centromeric, it was detected along 
the whole chromosome. This difference in the regulation of CPC localization may explain the less 
restricted CPC localization during the first cell divisions of embryos, which might be an explanation 
for chromosome segregation errors.
 We also describe that the (partly altered) distribution of histone modifications involved in CPC 
localization and function, such as H3pT3 and H3pS10, in human pre-implantation embryos seems 
to be related to the epigenetic asymmetry between maternal and paternal chromosomes. Possibly, 
all these differences together lead to less accurate chromosome segregation and thereby may be a 
cause of chromosomal abnormalities in human pre-implantation embryos.
Chapter 6
Our results show altered, and thereby probably less accurate, mechanisms that are involved in the 
prevention of chromosome segregation errors in human pre-implantation embryos. Also, our results 
show that human spermatozoa have an epigenetic contribution to embryo development. The 
altered error-correction mechanism and the epigenetic asymmetry between maternal and paternal 
chromosomes might together explain the high rates of chromosome segregation errors in human 
pre-implantation embryos. In our future research, we want to focus on the possible contribution of 
the spermatozoon to chromosome abnormalities in embryos. Knowledge of the influence of sperm 
quality on embryo developmental potential may lead to the optimization of IVF procedures in the 
future.
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Nederlandse samenvatting
Hoofdstuk 1
De laatste jaren is het gemiddelde aantal zwangerschappen na terugplaatsing van een embryo 
ontstaan na in vitro fertilisatie (IVF) ongeveer 32%. Om nog betere resultaten te behalen in de 
toekomst, moeten we meer inzicht krijgen in alle aspecten van de IVF behandeling, inclusief de 
ontwikkeling van pre-implantatie embryo’s. 
 In dit proefschrift beschrijven we het onderzoek dat we hebben gedaan op het gebied van 
epigenetica en chromosoomsegregatie in humane pre-implantatie embryo’s ontstaan na IVF. Het 
begrip ‘epigenetica’ verwijst naar erfelijke markeringen op het genoom, zoals DNA methylatie 
en histon modificaties. Deze markeringen zijn cruciaal voor de structuur van chromosomen, 
chromosoomsegregatie en genexpressie. Chromosoomsegregatie is het proces waarbij verdubbelde 
chromosomen gelijk verdeeld worden over twee cellen tijdens een celdeling.
 Chromosomale afwijkingen komen zeer frequent voor in humane pre-implantatie embryo’s. 
Dit doet vermoeden dat de mechanismen die chromosoomsegregatie reguleren minder goed 
functioneren tijdens de eerste celdelingen van een embryo. Daarnaast zijn epigenetische 
markeringen, die ook belangrijk zijn voor correcte chromosoomsegregatie, heel verschillend 
in eicellen en zaadcellen, waardoor ze opnieuw moeten worden opgebouwd in embryo’s. De 
studies die worden beschreven in dit proefschrift hadden als doel het onderzoeken van zowel 
mechanismen die chromosoomsegregatie reguleren als de opbouw van epigenetische markeringen 
in humane pre-implantatie embryo’s, om meer inzicht te krijgen in de oorzaken van chromosomale 
afwijkingen.  
Hoofdstuk 2
DNA is opgerold rond speciale eiwitten, histonen, en samen wordt dat chromatine genoemd. 
Epigenetische markeringen, zoals histon modificaties, bepalen de structuur van het chromatine 
en specificeren bepaalde chromatine domeinen. Eicellen en zaadcellen hebben een heel andere 
chromatine structuur, die in beide cellen ook afwijkt van somatische cellen. Na de bevruchting 
moeten de normale chromatine structuur en domeinen opnieuw worden opgebouwd. In dit 
hoofdstuk onderzochten we de opbouw van een chromatine domein dat belangrijk is voor 
chromosoomsegregatie, constitutief heterochromatine (cHC), in humane pre-implantatie embryo’s 
ontstaan na IVF.
 We beschrijven dat humane zaadcellen histonen bevatten met modificaties die in somatische cellen 
cHC specificeren (H3K9me3, H4K20me3, H3K64me3). Na de bevruchting, in het embryo, dragen deze 
gemodificeerde histonen bij aan de opbouw van cHC in paternale chromosomen (chromosomen 
van de vader). De histon modificaties worden herkend door maternale eiwitten (eiwitten van de 
moeder, aanwezig in de eicel) die een rol hebben in de opbouw van de chromatine structuur (b.v. 
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HP1, SUV39H). Vervolgens worden de modificaties behouden gedurende de celdelingen van het 
embryo. Deze resultaten wijzen erop dat er bij mensen sprake is van overerving van cHC structuur 
over generaties en laten zien dat humane zaadcellen een belangrijke bijdrage leveren aan embryo-
ontwikkeling.
 Tot op heden was dit proces alleen bestudeerd in muizenembryo’s. Bij de muis ontbreken de cHC 
modificaties in zaadcellen en op paternale chromosomen in het embryo, waardoor de opbouw van 
cHC tijdelijk gereguleerd wordt door andere mechanismen, die aanwezig zijn in de eicel. Vaak wordt 
aangenomen dat de resultaten verkregen in onderzoek naar muizenembryo’s ook van toepassing 
zijn op alle andere soorten zoogdieren. We laten nu echter zien dat het mechanisme voor cHC 
opbouw in humane embryo’s enorm verschilt van wat is beschreven voor muizenembryo’s. Dit 
toont aan dat muizenembryo’s geen representatief diermodel zijn en benadrukt het belang van 
onderzoek naar humane embryo’s.  
Hoofdstuk 3
Een van de meest belangrijke onderdelen van het mechanisme dat chromosoomsegregatie 
reguleert, is een eiwitcomplex genaamd chromosomal passenger complex (CPC). Het CPC bestaat 
uit de eiwitten Survivin, Borealin, INCENP en Aurora kinase B tijdens de celdelingen (mitose) 
van lichaamscellen (somatische cellen). In dit hoofdstuk onderzochten we de aanwezigheid en 
samenstelling van het CPC in humane pre-implantatie embryo’s die ontstaan zijn na IVF.
 We beschrijven dat de samenstelling van het CPC in de eerste embryonale celdelingen verschilt 
van wat is beschreven voor somatische cellen. In somatische cellen is Aurora B de enzymatische 
component van het CPC. We ontdekten dat in pre-implantatie embryo’s, van de bevruchte eicel 
(zygote, dag 1 van de embryonale ontwikkeling) tot en met het 8- tot 16-cellig stadium (dag 3), 
voornamelijk Aurora C aanwezig is als enzymatische component van het CPC. Tot op heden was 
beschreven dat Aurora C alleen een rol speelt in de celdelingen van geslachtscellen (meiose), 
die resulteren in eicellen en zaadcellen. Rond het morula stadium (dag 4) neemt de hoeveelheid 
Aurora C af en in het blastocyst stadium (dag 5) is Aurora C weer helemaal vervangen door Aurora 
B. Aangezien subtiele verschillen tussen de twee Aurora kinases zouden kunnen leiden tot een 
verminderde nauwkeurigheid van de regulatie van chromosoomsegregatie, zou de veranderde 
samenstelling van het CPC kunnen bijdragen aan fouten in chromosoomsegregatie, die leiden tot 
het ontstaan van chromosomale afwijkingen in de eerste celdelingen van humane embryo’s.
Hoofdstuk 4
Immunofluorescentie (kleuren met een fluorescerende antistof ) is een vaak gebruikte techniek 
om histon modificaties en eiwitten die betrokken zijn bij de regulatie van chromosoomsegregatie 
te bestuderen. Hoewel het belangrijk is om co-lokalisatie (op dezelfde plek voorkomen) van deze 
modificaties en eiwitten te onderzoeken, is dit erg moeilijk, omdat antilichamen vaak worden 
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opgewekt in dezelfde diersoorten (b.v. muis, konijn) en daardoor niet te combineren zijn in één 
kleuring. Voor Western blot experimenten zijn vloeistoffen ontwikkeld die het mogelijk maken om 
antilichamen na een eerste ronde van detectie te verwijderen, “stripping” genoemd, en daarna nog 
een tweede ronde van kleuring en detectie te doen.
 In dit hoofdstuk beschrijven we dat we in staat zijn om het stripping principe toe te passen voor 
het uitvoeren van meerdere rondes immunofluorescentie op chromosoompreparaten van diverse 
typen cellen en humane embryo’s. We laten zien dat het haalbaar en betrouwbaar is om histon 
modificaties en eiwitten te detecteren in twee rondes immunofluorescentie. Deze methode is een 
betrouwbare optie als co-lokalisatie bestudeerd moet worden, maar de keuze van antilichamen of 
de beschikbaarheid van materiaal, zoals in het geval van humane embryo’s, beperkt is.
 
Hoofdstuk 5
Precieze lokalisatie van het CPC in het ‘inner centromere’ gebied van chromosomen is cruciaal voor 
nauwkeurige regulatie van chromosoomsegregatie. Deze lokalisatie wordt gereguleerd door twee 
histon modificaties, H2ApT120 en H3pT3, die gemaakt worden door respectievelijk de enzymen 
Bub1 en Haspin. In dit hoofdstuk onderzochten we de lokalisatie van het CPC gedurende de eerste 
celdelingen van humane pre-implantatie embryo’s ontstaan na IVF.
 We beschrijven dat CPC lokalisatie in mindere mate is beperkt tot alleen het inner centromere 
gebied tijdens de eerste embryonale celdeling en dat de lokalisatie gedurende de volgende delingen 
steeds preciezer wordt, tot het vergelijkbaar is met CPC lokalisatie in somatische cellen. Van de 
twee mechanismen die CPC lokalisatie reguleren, is het Bub1-H2ApT120 mechanisme vergelijkbaar 
met wat eerder beschreven is voor somatische cellen. Echter, het Haspin-H3pT3 mechanisme is 
anders in zygoten, tijdens de eerste celdeling; in plaats van alleen in het inner centromere gebied, 
detecteerden we H3pT3 op het hele chromosoom. Dit verschil in de regulatie van CPC lokalisatie 
zou de oorzaak kunnen zijn van de minder precieze CPC lokalisatie tijdens de eerste celdelingen van 
embryo’s, en dit zou kunnen verklaren hoe de fouten in chromosoomsegregatie ontstaan. 
 We beschrijven ook dat de (deels veranderde) lokalisatie van histon modificaties die betrokken 
zijn bij CPC lokalisatie en functie, zoals H3pT3 en H3pS10, in humane pre-implantatie embryo’s 
gerelateerd lijkt te zijn aan de epigenetische asymmetrie tussen maternale en paternale 
chromosomen. Mogelijk leiden al deze verschillen samen tot een minder nauwkeurige regulatie 
van chromosoomsegregatie en zouden daardoor een oorzaak kunnen zijn van chromosomale 
afwijkingen in humane pre-implantatie embryo’s. 
Hoofdstuk 6
Onze resultaten laten zien dat er veranderde, en daardoor wellicht minder nauwkeurige 
mechanismen zijn om fouten in chromosoomsegregatie te voorkomen in humane pre-implantatie 
embryo’s. Ook laten we zien dat humane zaadcellen een epigenetische bijdrage leveren aan embryo-
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ontwikkeling. De veranderde mechanismen voor het voorkomen van fouten en de epigenetische 
asymmetrie tussen maternale en paternale chromosomen zouden samen een verklaring kunnen 
zijn voor de hoge frequentie van fouten in chromosoomsegregatie in humane pre-implantatie 
embryo’s. In toekomstig onderzoek willen we ons richten op de mogelijke bijdrage van de zaadcel 
aan chromosoomafwijkingen in embryo’s. Kennis over de invloed van zaadkwaliteit op embryo-
ontwikkeling kan in de toekomst leiden tot de optimalisatie van IVF procedures.
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Een boekje als dit schrijf je absoluut niet alleen en daarom wil ik hier iedereen bedanken die heeft 
bijgedragen aan de inhoud van mijn proefschrift, mijn tijd als onderzoeker en mijn leven naast het 
onderzoek.
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te wakkeren. Bedankt voor al je hulp, geduld en vriendschap. 
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om alles mee te bespreken, ook naast het onderzoek. Bedankt voor alle hulp bij de experimenten en 
bij het schrijven van de papers!
 
Beste Cindy, wat was ik blij dat je onderzoek kwam doen bij ons in de ‘groep’! Je kwam precies op 
het juiste moment en nam me al het praktische werk uit handen, zodat ik me kon concentreren op 
het schrijven van de inhoud van dit boekje. Ik had ook meteen weer iemand om tegenaan te kletsen 
(en zeuren soms…), dankjewel voor je steun en de gezelligheid! Ontzettend leuk dat je als paranimf 
naast me wilt staan!
Beste Hánah, Miriam, Joyce, Michelle en Line, wat leuk dat jullie onze groep uitkozen voor een stage. 
Toen iedereen weer weg was, was het wel erg stil. Ik heb jullie met veel plezier begeleid en op mijn 
beurt erg veel geleerd van jullie slimme vragen. Bedankt voor al het werk dat jullie gedaan hebben! 
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Beste Hikke, Ilse, Willy, Federica, Fabrizia, Maureen, Aristea en Catherine, bedankt voor jullie interesse, 
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Beste Peter, Marieke, Heleen en Liliana, bedankt voor de goede samenwerking. We hebben erg veel 
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gezellig. Daarnaast waren jullie er ook voor de praktische zaken rondom mijn promotie, super! Dank 
jullie wel!
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Beste collega’s van Synthon, bedankt voor de warme ontvangst, super goede werksfeer en al jullie 
interesse in en begrip voor het afmaken van mijn proefschrift.
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